SenzaGen signs its first distribution agreement with British XCellR8, a leader in animal-free testing

-       This agreement is important for us, not only because we now see that our business model works, we also see that there is an increased interest in our technology and we get access to a new market with a well-established and highly competent and renowned partner. XCellR8 is one of the industry's foremost ambassadors of non-animal tests, says Anki Malmborg Hager, CEO of SenzaGen. XCellR8 was established in 2008 with a mission to replace animal testing with methods that are both scientifically advanced and ethically sound. The company works with a number of leading global cosmetic companies and their ingredient suppliers, and has become the “go-to” laboratory for in vitro testing expertise for both product safety and efficacy / claim support. -       By working with GARD we take a step into the future. With the use of genomics based testing we are moving towards safer and better tests, and ultimately more reliable consumer products without the need for animal testing, says Dr Carol Treasure, CEO of XCellR8 About XCellR8XcellR8 offers animal-free testing for companies with products on the cosmetic, personal care and household product market and their ingredients suppliers. The company helps customers develop safe and innovative new products, to follow the law, and to choose non-animal test methods that are both scientifically advanced and ethical. XCellR8 's British laboratory is accredited according to GLP standard (Good Laboratory Practice), which means that the company can offer their customers test results that can be used according to regulatory requirements to prove product safety.  XCellR8 are proactive and contributing to the global commitment to replace animal testing through research and education programs.  About GARDBy analyzing 200 and 389 markers, depending on the test, GARD generates massive amounts of data and delivers results with 90 % prediction accuracy. This can be compared to the gold standard, animal tests in mice, that provides 72 % prediction. SenzaGen’s test also has the ability to measure potency (strength) of a substance and can thus determine the degree to which a substance is an allergen. About SenzaGenSenzaGen provides dermal and respiratory in vitro testing for the cosmetic, chemical and pharmaceutical industries replacing the need for animal testing. The company's unique test, GARD, is based on research from the Department of Immunotechnology at Lund University. SenzaGen is based at Medicon Village in Lund, Sweden.

Unibet Group announces share repurchase

The authority received on 17 May 2016 was regarding the buy back of a maximum number of 23,011,704 GBP 0.000625 Ordinary Shares/SDR´s in the Company. Acquisitions can be made as of 22 September 2016 until next year’s Annual General Meeting. However no acquisitions will be made during a 30-day period prior to the publication of quarterly results. Acquisitions of shares/SDRs may only take place on Nasdaq Stockholm at a price within the at each time prevailing price interval, being the interval between the highest buying price and the lowest selling price. Notification of any purchases will continuously be made to the Nasdaq Stockholm. The objective of the buyback is to achieve added value for the Company´s shareholders and to give the Board increased flexibility with the Company´s capital structure. Following repurchase the intention of the Board is to either cancel, use as consideration for an acquisition or issue to employees under a Share Incentive programme. Once repurchased under the Maltese Companies Act further shareholder approval will be required if the shares are to be cancelled. If used in connection with an acquisition, the intention would be to issue the shares/SDR´s as consideration, and not to sell them first. The total number of issued shares/SDRs in Unibet Group is 230,126,200 of which 381,144 shares/SDRs are held by the Company as a result of share buy back programmes in 2007 and 2011. Board of Directors Unibet Group plc 

Nomination Committee for the Saab Annual General Meeting 2017

The Nomination Committee shall, according to a Nomination Committee process adopted by the Annual General Meeting, consist of one representative from each of the four shareholders or group of shareholders with the largest numbers of votes, who wish to appoint a representative, as well as the Chairman of the Board of Directors. Members of the Saab Nomination Committee for the Annual General Meeting 2017 are:· Marcus Wallenberg, Chairman of the Board of Saab AB· Petra Hedengran, Investor AB· Peter Wallenberg Jr, Knut and Alice Wallenberg’s Foundation· Jan Andersson, Swedbank Robur Funds· Anders Algotsson, AFA FörsäkringThe Nomination Committee is assigned to prepare proposals regarding Chairman of the Annual General Meeting, Board of Directors, Chairman of the Board of Directors as well as Board remuneration and fee to the Auditor.The Nomination Committee represents approximately 55 percent of the total voting rights of Saab AB based on the ownership structure as of August 31, 2016.The Annual General Meeting of Saab AB will be held on Wednesday, 5 April 2017, in Stockholm.Shareholders, who wish to submit proposals to Saab’s Nomination Committee, may do so by e-mail: valberedningen@saabgroup.com or by ordinary mail to the address: Saab AB, Att: Nomination Committee, Box 12062, SE-102 22 Stockholm, Sweden. Proposals have to be received no later than 3 February 2017 to be considered by the Committee. For further information, please contact: Saab Press Centre, +46 (0)734 180 018, presscentre@saabgroup.com www.saabgroup.com  www.saabgroup.com/YouTube  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Major League Baseball Players Alumni Association Brings Legends for Youth Baseball Clinic to Jacksonville, FL

Colorado Springs, Colo. – Local youth will have an opportunity to play with their big league heroes at the Major League Baseball Players Alumni Association (MLBPAA) Legends for Youth baseball clinic series on Saturday, September 24th, 2016. In partnership with the Patriot Rail Company (http://www.patriotrail.com/), the free clinic features current and former Major League Baseball players who will teach baseball skills, drills and life lessons for approximately 200 local youth.   Players attending* include Hall of Famer and 1971 Cy Young Award winner Fergie Jenkins, World Series Champion and two-time All-Star Willie Wilson, as well as Travis Baptist, Joseph Boever, Curtis Leskanic, Joe McKeon, Rick Reichardt, Desi Relaford, and Billy Wynne. These nine players combine for 91 seasons, 5032 games and 3948 hits in Major League Baseball.   The clinic will take place at James P. Small Memorial Stadium, running from 9:00 a.m. to 11:00 a.m., located at 1701 Myrtle Avenue N, Jacksonville, FL 32209. Alumni players will train at stations including pitching, catching, base running and life skills. Registration will begin at 8:30 a.m. and the morning will conclude with an autograph session and baseball giveaways for children in attendance.   Registration is closed to the public at this time.   For more information regarding the clinic, please contact Nikki Warner, Director of Communications, at (719) 477-1870, ext. 105 or visit www.baseballalumni.com. *Clinicians subject to change.   About The Major League Baseball Players Alumni Association (MLBPAA) MLBPAA was founded in 1982 with the mission of promoting baseball, raising money for charity and protecting the dignity of the game through its Alumni players. The MLBPAA is headquartered in Colorado Springs, CO with a membership of more than 7,600, of which approximately 5,600 are Alumni and active players. Alumni players find the MLBPAA to be a vital tool to become involved in charity and community philanthropy. Follow @MLBPAA for Twitter updates.   About Legends for Youth Clinics MLBPAA’s Legends for Youth clinics impact more than 15,000 children each year, allowing them the unique opportunity to interact with and learn from players who have left a lasting impact on the game of baseball. The MLBPAA has reached children across America and internationally in Australia, Canada, Curaçao, the Dominican Republic, Germany, Italy, Nicaragua, the United Kingdom and Venezuela, through the Legends for Youth clinic series. To donate to this program, visit baseballalumni.com/donate (http://www.baseballalumni.com/donate). The official hashtag of the Legends for Youth clinic series is #LFYClinic. ###

Advantech announces Hans-Peter Nüdling as new Associate Vice President Embedded Europe

Munich , September 22nd, 2016. Advantech is pursuing further in its growth ambitions within Europe by appointing Hans-Peter Nüdling as the new Associate Vice President Embedded Europe. Rejoining Advantech after 4 years of absence in September 2016, Nüdling will be managing the European Embedded team adding over 25 years of General Management, Entrepreneurship and Change Management experience to the organization.   Nüdling will be responsible for Sales, Marketing, PM, BDM, FAE, Technical Center and HR across all European territories. His extensive knowledge and experience of working in Asia and USA as an Expatriate significantly reflects major benefits to Advantech in developing the business through combining various cultures. Nüdling, always strives for profitable growth and has professional expertise in direct and channel sales, business development and operational excellence. He will be providing solid best-practice processes and optimizing interfaces to Advantech Headquarters in Taiwan which will enhance the growth strategies.   “Most importantly, we will define a vertical strategy per target market in Europe by optimizing our Go to Market approach” says Hans-Peter (HP) Nüdling. “I am very excited to re-join Advantech as the European head for our embedded business. I am convinced that we will further strengthen the relationships with our partners and customers. I will focus on major market segments, on module, system and solution level, developing efforts within Advantech and in cooperation with Eco-partners” Nüdling, who holds a diploma in Electronics Engineering (BA), has served the last eight years as a CEO of two technology businesses in electronics and medical applications focusing on entrepreneurship, scalability, change management and successful M&A processes. Additionally, Nüdling has held several different senior management positions throughout Europe, Asia and the United States. 

AMETEK Power Instruments Hosts 6th Annual Power-Line Carrier Users Group Meeting

Fort Lauderdale Marriott Hotel and Convention Center, Coral Springs, FL, March 7 to 9, 2017 Contact: Christina Sherman, 585-238-4752, Christina.Sherman@ametek.com CORAL SPRINGS, FL – AMETEK Power Instruments has set March 7-9, 2017 for its 6th annual Power-Line Carrier (PLC) Users Group Meeting at the Fort Lauderdale Marriott Hotel and Convention Center in Coral Springs, FL. The three-day conference will be used to provide training on AMETEK’s latest UPLC-II, hybrids, and TC-10B/TCF-10B product lines. Day one is intended for new users who require basic training in power line carriers along with hands-on training with AMETEK’s UPLC-II and TC/TCF-10B products. Sessions on days two and three will cover more advanced features as well as new product developments and include discussion forums to provide users an opportunity to meet and interact with AMETEK PLC experts. The meeting will discuss the 2016 release of AMETEK’s new line of Power Line Carrier Hybrids in a 1-RU chassis and the new 50W Power Amp in a 2-RU chassis. It also will cover the latest UPLC-II features and improvements based on user feedback. The UPLC-II continues to maintain full compatibility with AMETEK’s original UPLC as well as the TC/TCF-10B products. To register for the event, users need to contact AMETEK Power Instruments by January 10, 2017. For more information, contact AMETEK Power Instruments at (585) 238-4752 or visit www.ametekpower.com AMETEK Power Instruments is a unit of AMETEK, Inc., a leading global manufacturer of electronic instruments and electromechanical devices with annual sales of $4.0 billion.

Sir Clive Woodward to be keynote speaker at Retail IT event

When most people think of Sir Clive Woodward they think rugby and not retail….However this inspirational leader and motivator knows an incredible amount about making changes to strategy and operations that can benefit all sorts of businesses and teams – including small and mid-sized retailers. Sir Clive is the keynote speaker at Retail IT’s now annual event, which this year will be held in the afternoon on October 19 at the China Exchange in Central London. The theme of this year’s event is: How Growing Retailers can Harness Technology to Compete with Larger Chains. Retail IT work with a number of independents and growing retailers and the event is designed to show how expanding retailers can compete with the big chains by harnessing technology. Sir Clive will discuss how incremental changes to a business approach can yield significant results - featuring examples, insights and case studies from his glittering sporting and business career. It is a must see. Other presentations cover ‘How digital and social media can help independent retailers boost footfall, grow brands & help sales flourish’ while attendees will also hear from PureNet’s Development Team Lead, Douglas Radburn, who will dissect ‘How ecommerce can bridge the gap between online and offline’. There are other presentations and panel discussions – featuring key personnel from Intersport and Drapers - as well as the chance for attendees to demo the software and hardware Retail IT offer, such as YourCegid Retail CBR. The event, which includes refreshments, is completely complimentary to anyone working in the retail industry. It is being held in the fabulous China Exchange on 32A Gerrard Street, London, W1D 6JA from 2pm until 5pm.  

Latest research achieves “zero simulator-induced latency” on a driving simulator

Study using automotive OEM and Formula 3 driving simulators shows how prediction algorithms can be applied to synchronize and minimize latency, leading to a more accurate driving experience. PARIS – Cruden has shared details of its latest breakthrough research on how to minimize latency when using a driving simulator, together with Audi AG and the University of Stuttgart, at the Driving Simulation Conference (DSC) in Paris (September 7-9, 2016).  Cruden’s researchers achieved “zero simulator-induced latency” through the use of predictive algorithms that synchronize and reduce latency. This new approach will allow car manufacturers and motorsport teams to use validated car models directly on the simulator without having to make modifications to compensate for simulator hardware and software delays. “Latency has always been a challenge in the design of driving simulators when trying to replicate exactly the handling characteristics and driving experience of a real car caused primarily by sampling delays, processing time and data transfer,” explains Maarten van Donselaar, Cruden CEO. “This latency means that additional time elapses between the model output and the resulting feedback from the simulator when compared to the real vehicle. Minimizing latency is something of a holy grail in driving simulation and this research is the culmination of years of work to identify, measure and eliminate latency, to finally be able to put numbers behind the claims.” To reduce perceived simulator-induced latency even further, Cruden predicts the visuals from the output of the vehicle model in order to synchronize them with the simulator’s motion platform and other feedback channels. The second step involves applying additional prediction algorithms to all system channels based instead on inputs using the available information about steering wheel position and velocity. This prediction can compensate for all delays that are not a result of the dynamics of the vehicle model, to effectively reach a state of zero simulator-induced latency. This methodology was tested on two 6-DOF simulators: an automotive simulator with an off-board projection screen used for chassis development at Audi AG and a motorsport simulator with three screens mounted on the top platform and a Formula 3 car model. “Cruden is a designer of the complete simulator architecture, with in-house experts not only for the hardware of the motion base, top platform and integration of vehicle mock-ups, but also the various software packages, including not only the rendering engine or pipe-line but also the operator and engineering GUI, motion cueing and its integration with third party engineering software and vehicle dynamics capabilities. This puts Cruden in an ideal position to lead latency research. The importance of the integration of all the complex simulator elements, in the design, manufacturing and commissioning phases, is often underestimated,” says van Donselaar. For a fuller explanation of the approach, please follow this link (http://www.cruden.com/DSC2016-driver-simulator-latency-article.html) to a longer web article. To request the technical paper, Implementing prediction algorithms to synchronize and minimize latency on a driving simulator" by van Doornik, Jelle, Brems, Willibald, de Vries, Edwin and Wiedemann, Jochen, please contact c.dumbreck@cruden.com.      ## About Cruden Cruden is the world’s leading designer and manufacturer of professional, open architecture HIL/DIL driving simulators, simulator components and software. Originating from Fokker Aircraft Company in the late 1990s, Cruden was formed in 2006 and today serves the automotive, motorsport and marine industries.  The company’s complete simulator packages interface with SIMULINK-based customer vehicle models and include on- and off-board projection systems. Cruden also produces vehicle, road/track and tire models in-house. The company launched its open architecture Panthera software suite in 2015. www.cruden.com  Press Enquiries Claire Dumbreck, Unit 4, Manor Farm Offices, Fenny Compton, Warwickshire, UK, CV47 2YY. +44 (0)1295 770602 / +44 (0) 7768 773857. c.dumbreck@cruden.com

Storebrand ASA – resolution by Extraordinary General Meeting of 22 September 2016

On 22 September 2016 an Extraordinary General Meeting of Storebrand ASA adopted the following resolution:                              Agenda Item 6               By-election to the Board of Directors Resolution:   Jan Christian Opsahl shall be elected as a new member of the Board of Directors until the Annual General Meeting in the spring of 2017, which will be held no later than 30 June 2017. The composition of the Board of Directors of Storebrand ASA after the election is as follows:                        Birger Magnus               (Board Chairman)                         Laila S. Dahlen                (member)                         Håkon Fure                     (member)                         Gyrid Skalleberg Ingerø (member)                         Jan Chr. Opsahl             (member)                         Karin Bing Orgland         (member)                         Knut Dyre Haug             (employee-elected member)                        Arne Fredrik Håstein       (employee-elected member)                        Heidi Storruste                (employee-elected member) Lysaker, Norway, 22 September 2016  Contact Person: Kjetil Krøkje: T: +47 934 12 155

Visit Arctic Europe project aims to create up to 100 000 new sleepovers in the northern region

Since its launch in autumn 2015, Visit Arctic Europe project (VAE) has signed co-operation agreements with several European tour operators. The target of this co-operation is to create up to 100 000 new sleepovers in the region this winter.  Participating tour operators currently have about 23 000 plane seats reserved. One visitor stay is estimated to be 4-5 nights, on average. Tour operators believe that in the future more and more visitors will want to combine multiple destinations in their trips. Participating countries share a number of common attraction factors, but they also have regional, unique strengths. ”Nature, purity, the Northern Lights, midnight sun and northern lifestyle are common to all participating countries. In addition, Finnish Lapland has an extensive variety of tourism activities, as well as Santa Claus. Sweden can offer high end -accommodation, such as the Tree Hotel and the Ice Hotel. Norway has fjords, whale safaris and red king crabs”, Rauno Posio from the Finnish Lapland Tourist Board lists.  The project aims to prolong the conventional operating period, as tour operators have committed themselves to a 3-year co-operation agreement to sell and market activity packages, also for shoulder- and low seasons.   Cees van den Bosch from Voigt Travel says crossboarder co-operation is vital for the sustainable development of year around travel in the northern region. ”A strong image of the destination is very important. Developing seasons and regions can never be done by a tour operator alone on any market. Especially for a niche destination on a highly competitive market like the Netherlands.”A strong focus has also been placed on accessibility. Companies and tour operators are especially concerned about the logistics within the region. VAE plans to carry out investigations concerning accessibility issues, such as the demand for direct flights.”From our perspective, the focus on accessibility across borders and the removal of bottlenecks is a very good thing”, Hans Paul Hansen from Scandic Northcape admits.  VAE aims to market the northern regions of Finland, Sweden and Norway, in co-operation with national and regional destination marketing organizations. Partners include Northern Norway Tourist Board, Swedish Lapland Visitor Board and Finnish Lapland Tourist Board, which is also the lead partner of the project. VAE is funded by EU / Interreg Nord -program, the public sector and 90 companies in three countries. The duration of the project is 2.5 years and the budget 6.4 million euros.  Contact: Rauno Posio, project director, Visit Arctic Europe projectFinnish Lapland Tourist Board, Lapin Matkailuelinkeinon liitto+358 40 653 99 00 rauno.posio@lme.fi Trond Øverås, Administrerende DirektørNordNorsk Reiseliv as +47 906 26 170 trond@nordnorge.com Erica Mattsson, vd och projektledareSwedish Lapland Visitor Boarderica@swedishlapland.com+46 70-388 60 2

Arise and Fortum agree to investigate a possible sale of the Kölvallen wind project

Arise AB (publ) group (“Arise”) has signed a letter of intent (“LOI”) with Fortum Sverige AB (“Fortum”) regarding a possible sale of the more than 200 MW Kölvallen wind farm currently in final development (the “Project”). The LOI targets a sale of the Project to Fortum during the second quarter of 2017. However, such a sale will be subject to among other a successful final development of the Project, including that the Project obtains necessary legal force permits, as well as due diligence and an investment decision by Fortum. The timeline represents a delay from what has previously been communicated by Arise regarding Kölvallen. This is due to longer than expected permitting processes which are still pending. Halmstad 23 September, 2016ARISE AB (publ)  For further information, please contactDaniel Johansson, CEO Arise AB, +46 702 244 133Linus Hägg, CFO Arise AB, +46 702 448 916Tero Era, Head of Communications Solar, Wind and New Ventures Fortum, +358 50 541 6337   This information is information that Arise AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on 23 September 2016. About AriseArise is one of Sweden´s leading wind power companies, with the business concept to develop, build and manage onshore wind farms for its own account and on behalf of investors. The company is listed on NASDAQ OMX Stockholm.Arise AB (publ), P.O. Box 808, SE-301 18 Halmstad, Sweden, telephone +46 (0)35 20 20 900, corporate id .no. 556274-6726, E-mail info@arise.se, www.arise.se   About FortumFortum's vision is to be the forerunner in clean energy. We provide our customers with electricity, heat and cooling as well as other energy solutions that improve present and future life. Already 64% of our electricity generation is CO2 free. Our main markets are the Nordic and the Baltic countries, Russia, Poland and India. In 2015, we employed some 8,000 energy sector professionals, and our sales were EUR 3.5 billion. Fortum's share is listed on Nasdaq Helsinki. www.fortum.com 

The Board of Directors of Attendo has resolved to utilise its authority to repurchase shares

The repurchase will be conducted in accordance with the Regulation (EU) No 596/2014 of the European Parliament and of the Council, and the Commission Delegated Regulation (EU) 2016/1052 (together the “EU Regulations”) and will be administered by SEB, which will take trading decisions independently of Attendo with regard to the timing of the repurchases. The buy-back programme will be subject to the following conditions. The purchases will be made on Nasdaq Stockholm in accordance with its Rule Book for Issuers and in accordance with the EU Regulations. The repurchases will be made on one or several occasions but no later than the Annual General Meeting 2017 and at a price per share within the price spread registered from time to time. In addition, the limitations with regard to price under Regulation (EU) 2016/1052 shall be observed. A maximum of 200,000 shares at a total value not exceeding SEK 20m may be repurchased. Payment for the shares will be made in cash. Reporting will take place through the stock exchange in accordance with applicable rules. The transactions will also be made public and published on Attendo’s website at www.attendo.com. Repurchases may not result in Attendo’s holding of own shares at any time exceeding 10 percent of the total number of shares in the company. At the time of this press release the total number of registered shares in the company amounts to 160,000,000 and at the time of this press release Attendo does not hold any own shares. Attendo AB (publ) For further information, please contact: Andreas Koch, Communications and IR-Director AttendoPhone: +46 705 09 77 61E-mail: andreas.koch@attendo.com Stefan Svanström, Communications Director AttendoPhone: +46 708 67 38 07E-mail: stefan.svanstrom@attendo.com  This information is such that Attendo AB (publ) is required to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 23 September 2016 at 08.00 CET. ________________________________________________________Attendo - the leading care and healthcare company in the Nordics Attendo is the leading private provider of publicly financed care and healthcare services in the Nordic region. The company was founded in 1985 and was first to provide outsourced care for older people in Sweden. In addition to care for older people, Attendo provides care for people with disabilities, individuals and families, and, in Finland, healthcare and dental care. Attendo has 19 000 employees and is locally anchored with over 500 operations in more than 200 municipalities in Sweden, Finland, Norway and Denmark. www.attendo.com 

Clas Ohlson launches initiative for greater product innovation

With the Clas Ohlson Product Innovation Challenge, the ambition is to identify new innovative products that can help Clas Ohlson's customers to live a more sustainable lifestyle. The challenge is being launched today, and provides an opportunity to submit your contribution and win an attractive place in Clas Ohlson product range. – We can change customer attitudes and behaviour through the products we sell and the knowledge we convey. We therefore have a responsibility and an opportunity to influence, why we with Clas Ohlson Product Innovation Challenge hope to accelerate the development of our range of more sustainable products, says Eva Berg, head of assortment at Clas Ohlson. To participate, you must have a product idea that is not yet available in the market, which fits into Clas Ohlson's product range, and contributes to a more sustainable lifestyle. To register go to www.clasohlsoninnovation.com. Linda Krondahl, CEO of Things, who work with innovators and start-up companies on a daily basis, is a member of the jury. – In my job I often meet entrepreneurs who, although they have a very good idea, find it difficult to reach out to the market. The winners of Clas Ohlson Product Innovation Challenge will get a huge boost into the market, says Linda Krondahl. Deadline to submit entries is 30 November 2016. Ten finalists will be selected and the winning products will be announced by the end of January 2017. The aim is to launch the winning products in all Clas Ohlson’s sales channels within a year. Clas Ohlson Product Innovation Challenge is part of Clas Ohlson's sustainability agenda From here to sustainability.

SCA and WSSCC issue Joint Global Report on Hygiene Matters

The latest edition of the Hygiene Matters report, which was launched during a special side session of the 71st United Nations General Assembly today, is based on a survey with 12,000 respondents in twelve countries. The survey explores three themes: an economic perspective on the value of hygiene, a social perspective focused on taboos and stereotypes around hygiene and the role hygiene will play in social and economic development in emerging and developed markets in the future. The special side session during the General Assembly  brought together stakeholders and influencers from around the world to provide recommendations for policymakers in both developed and developing countries to address hygiene challenges meaningfully and systematically. Since 2008, SCA has conducted a total of five surveys to gather insights about global hygiene perceptions, issues and behaviors to contribute to a knowledge-based public debate with the goal of improving hygiene for people everywhere and breaking taboos around incontinence and menstruation.  “SCA offers hygiene products that make life easier for millions of people around the world.  We share our expertise and educate on the importance of good hygiene practices and engage in activities across the globe such as educating young women about menstruation and children about the importance of proper hand hygiene. In 2014, WSSCC and SCA started working together to break the silence on Menstrual Hygiene Management, a partnership that has evolved and now includes the entire human life cycle. Today, we’re announcing the next step in our efforts to raise hygiene standards globally,” said Magnus Groth, President and CEO, SCA. “Partnerships are one of the United Nations Sustainable Development Goals and by pairing WSSCC’s technical expertise on sanitation and hygiene issues in developing countries with SCA’s global brands, knowledge and commitment to sustainability, education and innovation, we will increase awareness around  taboos surrounding personal hygiene and make a meaningful difference,” Magnus Groth continues. At any given time, 800 million women are experiencing their period. Yet, even in the US, women face limited access to education, products, school and work environments that make it possible to participate fully in society when menstruating. According to the Hygiene Matters report, more than half of the female populations in the majority of countries surveyed say they feel uncomfortable in social situations when on their period – a discomfort that’s strongly connected to norms and social stigma. “Public-private partnerships are essential to global progress related to personal hygiene,” said Amina Mohammed, chair of WSSCC. “By working together, we can more effectively inspire decision-makers and champions to act, whether on policy, practice or even advocating for hygiene.” With the launch of the Hygiene Matters report, SCA and WSSCC continue a global conversation around hygiene issues and opportunities across organizations, sectors and countries, sharing successes and opening the dialogue on what is often an unspoken topic: personal hygiene. Learn more: www.hygienematters.com 

Elocta® obtains national reimbursement in Spain, now available in the five largest markets in the EU

Swedish Orphan Biovitrum AB (publ) (Sobi™) (http://www.sobi.com/) today announces that the company’s product Elocta® (efmoroctocog alfa), a recombinant human factor VIII Fc-fusion protein with an extended half-life for the treatment of haemophilia A, has received national reimbursement approval in Spain. Elocta is already available in the UK, France, Italy, Germany, Sweden, Denmark, Norway, Switzerland, the Netherlands, Slovenia and the Republic of Ireland. “This approval is an important reimbursement milestone for Elocta, representing the last of the five largest markets in the EU. Our focus is to continue our work to ensure timely access to Elocta for people living with haemophilia A in these countries and in the rest of the Sobi territory”, said Geoffrey McDonough CEO and President at Sobi. ------------ About Haemophilia AHaemophilia is a rare, genetic disorder in which the ability of a person's blood to clot is impaired. Haemophilia A occurs in about one in 5,000 male births annually, and more rarely in females.   People with haemophilia A experience prolonged bleeding episodes that can cause pain, irreversible joint damage and life-threatening haemorrhages. Prophylactic infusions of factor VIII can temporarily replace the missing clotting factors that are needed to control bleeding and prevent new bleeding episodes.[i] (http://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/042_Elocta%20reimbursement%20Spain/042e_Elocta%20reimbursed%20in%20Spain_final.docx#_edn1) The World Federation of Hemophilia recommends prophylaxis as the optimal therapy as it can prevent bleedings and joint destruction.[ii] (http://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/042_Elocta%20reimbursement%20Spain/042e_Elocta%20reimbursed%20in%20Spain_final.docx#_edn2) About Elocta®/Eloctate®Elocta (efmoroctocog alfa), the first recombinant clotting factor VIII therapy that offers an extended half-life in the body, is approved in the European Union, Switzerland, Iceland, Liechtenstein and Norway, as well as the United States, Canada, Australia, New Zealand, Brazil, Taiwan and Japan (as Eloctate). It was developed for haemophilia A by fusing factor VIII to the Fc portion of immunoglobulin G subclass 1, or IgG1 (a protein commonly found in the body). This enables Elocta to use a naturally occurring pathway to prolong the time the therapy remains in the body. While Fc fusion technology has been used for more than 15 years, Sobi and Biogen are the first companies to utilise it in the treatment of haemophilia. As with any factor replacement therapy, development of inhibitors may occur following administration of Elocta/Eloctate. About Sobi™Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2015, Sobi had total revenues of SEK 3.2 billion (USD 385 M) and about 700 employees. The share (STO: SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com. About the Sobi and Biogen Collaboration Sobi and Biogen collaborate on the development and commercialisation of the haemophilia products Elocta and Alprolix. Sobi has final development and commercialisation rights in the Sobi territory (essentially Europe, North Africa, Russia and most Middle Eastern markets). Biogen has manufacturing responsibility for Eloctate and Alprolix and has final development and commercialisation rights in North America and all other regions in the world excluding the Sobi territory. For more information please contact Media relations    Investor relationsLinda Holmström, Jörgen Winroth, Vice President, Head of InvestorExternal RelationsCommunications Manager                          T: + 46 708 73 40 95, + T: +1 347-224-0819, +1 212-579-0506, +46 8 69746 8 697 31 213574                        linda.holmstrom@sobi.com j (jorgen.winroth@sobi.com)orgen.winroth@sobi.com  ---------------------------------------------------------------------- [i] (http://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/042_Elocta%20reimbursement%20Spain/042e_Elocta%20reimbursed%20in%20Spain_final.docx#_ednref1) World Federation of Hemophilia. About Bleeding Disorders – Frequently Asked Questions. Available at: http://www.wfh.org/en/page.aspx?pid=637#Difference_A_B. Accessed on: June 17, 2016. [ii] (http://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/042_Elocta%20reimbursement%20Spain/042e_Elocta%20reimbursed%20in%20Spain_final.docx#_ednref2) Guideline for the management of hemophilia, World Federation of Hemophilia, 2nd edition, http://www1.wfh.org/publication/files/pdf-1472.pdf. Accessed December 2015 (http://www1.wfh.org/publication/files/pdf-1472.pdf.%20Accessed%20December%202015) 

Q-FREE – CONTEMPLATED PRIVATE PLACEMENT

Trondheim, Norway, 23 September 2016 The Board of Directors of Q-Free ASA (the “Company”) is contemplating raising new equity and has retained ABG Sundal Collier as manager to advise on and effect a private placement of new shares directed towards Norwegian and international institutional or professional investors ("Private Placement"). The order price will be determined through an accelerated book-building process. The increase in the share capital, if the Private Placement is completed, will be carried out according to the authorization given by the general meeting on 19 September 2016 and the maximum number of shares to be issued in the Private Placement is 17,844,689 new shares. The minimum application and allocation amount will be the NOK equivalent of EUR 100,000.  The book-building period will commence today (23 September 2016) at 09:00 CET and closes on 28 September at 16:30 CET. The Board of Q-Free and ABG Sundal Collier may, however, at any time resolve to shorten or extend the book-building period at their own discretion. The net proceeds from the Private Placement are intended to be used to strengthen the Company's balance sheet and liquidity position. This will also provide a good basis for further growth for the Company. Completion of the Private Placement is inter alia subject to necessary corporate resolutions. The Company has submitted a draft prospectus for review by the Financial Supervisory Authority of Norway which is currently expected to be approved on or about 7 October 2016.  This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. For further information, please contact: President & CEO, Håkon Volldal: +47 977 19 973 Chairman of the Board: Charlotte Brogren Karlberg: +46 70 593 56 46 CFO, Roar Østbø: +47 932 45 175 ABG Sundal Collier: +47 22 01 60 00 About Q-Free Q-Free is a leading global supplier of ITS (Intelligent Transportation Systems) products and solutions. The company has approximately 470 employees, offices in 20 countries, and presence on all continents. Headquartered in Trondheim, Norway, Q-Free is listed on the Oslo Stock Exchange. www.q-free.com Twitter: @Q-FreeASA IMPORTANT INFORMATIONThis communication may not be published, distributed or transmitted in the United States, Canada, Australia, Singapore, Thailand, United Arab Emirates or Japan. These materials do not constitute an offer of securities for sale or a solicitation of an offer to purchase securities of the Company in the United States, Norway or any other jurisdiction. The securities of the Company may not be offered or sold in the United States absent registration or an exemption from registration under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"). The securities of the Company have not been, and will not be, registered under the U.S. Securities Act. Any sale in the United States of the securities mentioned in this communication will be made solely to "qualified institutional buyers" as defined in Rule 144A under the U.S. Securities Act. No public offering of the securities will be made in the United States. The distribution of this announcement and other information in connection with the Private Placement may be restricted by law in certain jurisdictions. Persons into whose possession this announcement or such other information should come are required to inform themselves about and to observe any such restrictions.

Safety Review Committee supports dose escalation with Betalutin® in Lymrit 37-01 trial pending safety data from cohort receiving higher pre-dosing

Oslo, Norway, 23 September 2016Nordic Nanovector ASA (OSE: NANO) announces that the independent Safety Review Committee (SRC) for the ongoing Lymrit 37-01 clinical trial of Betalutin® in follicular lymphoma (FL) has given its support to the continuation of the trial potentially at a higher dose of Betalutin® and increased pre-dosing with lilotomab, as soon as safety data from Arm 4 of the same study become available. FL is one of the most prevalent forms of non-Hodgkin lymphoma (NHL).Lymrit 37-01 is a Phase 1/2 open label, single injection dose-ascending study investigating different dose levels of Betalutin® and different pre-dosing regimens in patients with relapsed NHL with the aim of identifying an optimal dose regimen to take into the Phase 2 PARADIGME study.After a planned review of  the interim safety data from the Phase 1 and 2 parts of Arm 1  of Lymrit 37-01, based on 15 patients with relapsed/refractory FL treated with 15 MBq/kg Betalutin® and pre-dosed with 40 mg lilotomab*, the SRC concluded the following:•    The regimen of 15 MBq/kg Betalutin® administered after pre-dosing with 40 mg lilotomab is safe and the safety profile observed to date supports a possible dose escalation of Betalutin®•    The efficacy profile is promising compared to other candidates in development, particularly with regard to complete responses•    The limited safety data available to date from the first cohort of three patients in Arm 4 (receiving 15 MBq/kg Betalutin® and pre-dosed with 100mg/m2 lilotomab**) is encouraging and appears to show that an increase in pre-dosing with lilotomab improves the safety profile of Betalutin®•    Safety and dosimetry data from Arm 4 should confirm if and to what level the doses of Betalutin® and lilotomab in Phase 2 can be increased to further improve the risk/benefit profile seen so far.The company does not expect any impact to previously communicated timelines, neither for the dose definition date (Q1 2017) nor the planned pivotal PARADIGME trial, which is scheduled to start in 2H 2017.Luigi Costa, Nordic Nanovector CEO, commented: “We are pleased with the conclusions of the SRC meeting, which provide us with further confidence that we are closing in on the optimal dose regimen.”    *Lilotomab is a murine anti-CD37 antibody, previously referred to as HH1. The way the dose of lilotomab is referred to has been changed (from 50 mg/patient to 40mg/patient) following further characterisation of lilotomab, which has determined the actual absorbance factor of lilotomab reference standard (1.74 vs. the previous estimate of 1.4). The absorbance factor is used to measure the concentration of lilotomab drug product.**The change in dose units for lilotomab from mg to mg/m2 is because a more accurate way of calculating the administered concentration of antibody is now being applied, as described in previous footnote.For further information, please contact:IR enquiries:Luigi Costa, Chief Executive OfficerCell: +41 79 124 8601Tone Kvåle, Chief Financial OfficerCell: +47 91 51 95 76Email: ir@nordicnanovector.comMedia enquiries:Mark Swallow/David Dible (Citigate Dewe Rogerson)Tel: +44 207 282 2948/+44 207 282 2949Email: nordicnanovector@citigatedr.co.ukAbout Nordic Nanovector:Nordic Nanovector is a biotech company focusing on the development and commercialisation of novel targeted therapeutics in haematology and oncology. The Company’s lead clinical-stage product opportunity is Betalutin®, the first in a new class of Antibody-Radionuclide-Conjugates (ARC) designed to improve upon and complement current options for the treatment of non-Hodgkin Lymphoma (NHL). NHL is an indication with substantial unmet medical need and orphan drug opportunities, representing a growing market worth over $12 billion by 2018.Betalutin® comprises a tumour-seeking anti-CD37 antibody, lilotomab (previously referred to as HH1), conjugated to a low intensity radionuclide (lutetium-177). The preliminary data has shown promising efficacy and safety profile in an ongoing Phase 1/2 study in a difficult-to-treat NHL patient population. The Company is aiming at developing Betalutin® for the treatment of major types of NHL with first regulatory submission anticipated in 1H 2019.Nordic Nanovector intends to retain marketing rights and to actively participate in the commercialisation of Betalutin® in core markets, while exploring potential distribution agreements in selected geographies. The Company is committed to developing its ARC pipeline to treat multiple selected cancer indications.Further information about the Company can be found at www.nordicnanovector.comThis information is subject to the disclose requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. 

Rejlers wins major contract with Hafslund

Hafslund Nett has awarded the contract for the supervision of electrical installations in Oslo 2 to Rejlers Elsikkerhet. The Oslo 2 area includes the districts of Bjerke, Grorud, Grünerløkka, Nordre Aker, Sagene and Stovner. The grid distribution companies are obliged to supervise electrical safety in their supply areas. This supervision is conducted through “the local electrical supervisor”, which must ensure for example that electrical installations in both new buildings and existing facilities are executed in accordance with the regulations.“We are extremely happy to have been awarded this contract. Hafslund Nett is Norway’s largest grid distribution company and imposes considerable demands on its suppliers. By winning this assignment in the face of tough competition, we are showing that we are competitive as regards to competence, price and quality,” says Asbjørn Hilde, Managing Director at Rejlers Elsikkerhet.Future-oriented solutions“Hafslund Nett is an extremely important customer for us. Rejlers is now seeing the results of the investments we have made regarding the use of future-oriented digital solutions for supervision activities,” says Morten Thorkildsen, CEO at Rejlers Norway.The local electrical supervisor within Hafslund Nett is part of the public supervisory apparatus for electrical safety, and is obliged to supervise electrical installations in accordance with instructions and guidelines issued by the Norwegian Directorate for Civil Protection (DSB).The assignment includes:• Supervision of electrical installations and equipment in businesses and properties of all types.• Auditing electrical installation contractors.• School education for all pupils in Years 6 and 9.• Information about electrical safety through participation in nationwide campaigns such as “Aksjon Boligbrann” (“Action property fire”), and education for special target groups such as asylum seekers.• Information about electrical safety for employees in businesses, such as homecare nurses.• Following up of institutions and businesses that use electromedical equipment.Hafslund Nett is Norway’s largest grid distribution company, supplying electricity to 1.5 million people in 34 municipalities – 24 hours a day, 365 days a year. Hafslund Nett owns and operates the regional grid in Akershus, Oslo and Østfold. Every year, around 17.7 billion kilowatt-hours (kWh) are delivered through this power grid.  See also www.hafslundnett.no For further information:Peter Rejler; President and CEO, email: peter.rejler@rejlers.seMorten Thorkildsen, CEO Rejlers Norway, +47 951 82 695, email: morten.thorkildsen@rejlers.noAsbjørn Hilde, Managing Director at Rejlers Elsikkerhet, +47 911 47 042, email: asbjorn.hilde@rejlers.noRejlers is one of the largest engineering consultancy firms in the Nordic region. Our 2,000 experts work with projects in the areas of Building and property, Energy, Industry and Infrastructure. At Rejlers, you will meet specialist engineers with the knowledge, cutting edge expertise and energy to achieve results. We are still experiencing rapid growth and can now be found in 80 locations in Sweden, Finland and Norway. Rejlers recorded revenue of SEK 1.9 billion in 2015 and its class B share is listed on NASDAQ Stockholm.This information is information that Rejlers AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on September 23rd 2016.

Knorr-Bremse acquires additional shares in Haldex and adjusts the terms of the Offer

Knorr-Bremse AG ("Knorr-Bremse") has acquired 1,575,039 additional shares in Haldex AB (publ) ("Haldex"), corresponding to 3.56 per cent of all shares and votes in Haldex, at a price of SEK 125 per share. The purchase agreement contains provisions on potential additional consideration. The terms of Knorr-Bremse's offer to the shareholders of Haldex is adjusted with a corresponding additional consideration.“The acquisition of a further stake in Haldex again confirms the attractiveness of our offer to the shareholders of the company. It reflects the positive feedback from investors which we received over the last days”, said Klaus Deller, Chairman of the Executive Board of Knorr-Bremse. “We have clear indications that the recent statements by the management of Haldex with regard to our offer are not shared by a number of investors. We continue to pursue the compelling combination of Knorr-Bremse and Haldex due to its strong strategic rationale and the clear benefits for customers, employees and all other stakeholders.”On 5 September 2016, Knorr-Bremse announced an all-cash offer (the "Offer") for all shares in Haldex of SEK 110.00 in cash per share. The consideration in the Offer was increased to SEK 125.00 in cash per share on 16 September 2016.Knorr-Bremse has through an agreement on 22 September 2016 acquired 1,575,039 shares in Haldex outside the Offer, corresponding to 3.56 per cent of all shares and votes in Haldex, from Carnegie Fonder AB ("Carnegie") at a price of SEK 125.00 in cash per share. If Knorr-Bremse increases the Offer consideration, Carnegie is entitled to an amount equal to the increase as additional consideration. Furthermore, if Knorr-Bremse were to resell the shares acquired from Carnegie within 12 months from the date of the purchase agreement, Carnegie will be entitled to an additional consideration corresponding to 100 per cent of Knorr-Bremse's net profit (after deduction of any sales commission) from such resale. If the shares were to be resold after 12 months but within 18 months from the date of the purchase agreement, the additional consideration will instead be 50 per cent of the net profit.On account of the agreement with Carnegie, the Offer terms are adjusted so that all shareholders in Haldex whose shares are acquired by Knorr-Bremse in the Offer are entitled to a corresponding additional consideration.At the time of this announcement Knorr-Bremse owns in total 6,595,039 shares in Haldex, corresponding to 14.91 per cent of all shares and votes in Haldex. Other than that Knorr-Bremse does not hold any financial instruments that give financial exposure to Haldex shares. None of the shares in Haldex held byKnorr-Bremse have been acquired at a price which is higher than the consideration in the Offer.AdvisorsJoh. Berenberg, Gossler & Co. KG is financial advisor and Roschier Advokatbyrå is legal advisor to Knorr-Bremse in connection with the Offer.Knorr-Bremse AGFor additional information contact:Knorr-Bremse AGDr. Detlef HugEmail: Detlef.Hug@knorr-bremse.comPhone: +49 89 3547 1402Eva DopplerEmail: Eva.Doppler@knorr-bremse.comPhone: +49 89 3547 1498Additional contacts for media in GermanyFTI Consulting SCCarolin AmannEmail: Carolin.Amann@fticonsulting.comPhone: +49 69 92037 132Thomas M. KrammerEmail: Thomas.Krammer@fticonsulting.comPhone: +49 89 71042 2116Additional contacts for media in SwedenComirJohan HähnelEmail: Johan.Hahnel@comir.sePhone: +46 8 31 17 70For information and documentation regarding the Offer: www.Knorr-BremseandHaldex.comThis press release was submitted for publication on 23 September 2016 at 08.15 a.m. CEST.Important noticeThe Offer is not being made, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand or South Africa by use of mail or any other means or instrumentality (including, without limitation, facsimile transmission, electronic mail, telex, telephone and the Internet) of interstate or foreign commerce, or of any facility of national security exchange, of Australia, Canada, Hong Kong, Japan, New Zealand or South Africa, and the Offer cannot be accepted by any such use, means, instrumentality or facility of, or from within, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. Accordingly, this announcement and any documentation relating to the Offer are not being and should not be sent, mailed or otherwise distributed or forwarded in or into Australia, Canada, Hong Kong, Japan, New Zealand or South Africa.This announcement is not being, and must not be, sent to shareholders with registered addresses in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. Banks, brokers, dealers and other nominees holding shares for persons in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa must not forward this announcement or any other document received in connection with the Offer to such persons.Statements in this announcement relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “intends”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Knorr-Bremse AG. Any such forward-looking statements speak only as of the date on which they are made and Knorr-Bremse AG has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations.Special notice to shareholders in the United StatesThe Offer described in this announcement is made for shares of Haldex AB, a company incorporated under Swedish law, and is subject to Swedish disclosure and procedural requirements, which are different from those of the United States. The Offer is made in the United States in compliance with Section 14(e) of, and Regulation 14E under, the U.S. Securities Exchange Act of 1934, as amended (the “U.S. Exchange Act"), subject to the exemptions provided by Rule 14d-1(d) under the U.S. Exchange Act and otherwise in accordance with the requirements of Swedish law. Accordingly, the Offer is subject to disclosure and other procedural requirements, including with respect to withdrawal rights, the offer timetable, settlement procedures and timing of payments that are different from those applicable under U.S. domestic tender offer procedures and laws.To the extent permissible under applicable law or regulation, Knorr-Bremse AG and its affiliates or brokers (acting as agents for Knorr-Bremse AG or its affiliates, as applicable) may from time to time, and other than pursuant to the Offer, directly or indirectly purchase, or arrange to purchase, shares of Haldex AB, that are the subject of the Offer or any securities that are convertible into, exchangeable for or exercisable for such shares. To the extent information about such purchases or arrangements to purchase is made public in Sweden, such information will be disclosed by means of a press release or other means reasonably calculated to inform U.S. shareholders of Haldex AB of such information. In addition, the financial advisors to Knorr-Bremse AG, may also engage in ordinary course trading activities in securities of Haldex AB, which may include purchases or arrangements to purchase such securities. Knorr-Bremse AG and/or its affiliates or brokers have purchased shares of Haldex AB during the period following the announcement of the Offer on 5 September 2016.NEITHER THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION NOR ANY U.S. STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THIS OFFER, PASSED UPON THE FAIRNESS OR MERITS OF THIS ANNOUNCEMENT OR DETERMINED WHETHER THIS ANNOUNCEMENT IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE IN THE UNITED STATES.

Lund University biologist receives the Ig Nobel Prize

The Ig Nobel Prize was presented at a ceremony at Harvard University in Boston this Thursday. Susanne Åkesson, who works at the Faculty of Science at Lund University, was there to receive the award which consists of a diploma, a statuette – and a tremendous honour. Far from all research is even considered for such an award. Only research that involves unexpected results where seriousness is combined with laughter, that is entertaining while getting people to think, may be nominated. The prize carries weight internationally, which is reflected not least by the fact that the diploma presented to the winner is signed by 10 Nobel Prize winners. The research that is now recognised, conducted by Susanne Åkesson and her colleagues in Hungary and Spain, was presented six years ago in an article in the scientific journal Proceedings of the Royal Society B. The article reveals that white horses are not bothered by blood-sucking horse-flies in the same way as their darker fellow species members. When the sun shines on a dark, black or brown coat, it reflects a signal – a linear polarised light – in the same direction as the horizon. The signal is the same as when sunlight is reflected from a water surface. It can be detected by horse-flies (tabanidae) looking for water where they can lay eggs on aquatic plants and in shrubs near the water. This is an important part of the life cycle of the horse-fly as the larvae, once they have hatched, fall into the water where they continue to develop. The polarised light reflected from a dark coat also sends out a signal to females that this is a place where they can find blood, and a solid meal of blood can enable the female horse-fly to lay more eggs. In contrast, white horses reflect an unpolarised light, that is, the light vibrates not only in one but in several directions perpendicular to that of the light, and for the horse-fly this is very hard to detect. In later studies, Susanne Åkesson and her colleagues have continued their research in this area and concluded that a striped coat is even better than a white one at avoiding being bitten by blood-sucking horse-flies. Ever since Alfred Russel Wallace and Charles Darwin discussed the topic in the late 1800s, the prevailing theory has been that zebras initially developed their striped patterns to avoid attacks from predators. But in light of their results, the present researchers argue that the zebra developed its stripes to protect them from blood-sucking horse-flies, rather than a lion on the hunt. One of the results of Susanne Åkesson’s research is that there are now zebra-striped horse covers. The Ig Nobel Prize has been given to researchers at Lund University once before, in 2013, also at the Department of Biology. Marie Dacke, Eric Warrant and Emily Baird received the award for their discovery that dung beetles use the light of the Milky Way to navigate across the Savannah. Further informationSusanne Åkesson, Professor of Evolutionary EcologyLund University, Department of Biology Tel +46-46-222 37 05; +46-46-70 245 04 23Email: susanne.akesson@biol.lu.se Susanne Åkesson: “It feels amazing to receive recognition for a study that was both unexpected and at the same time has resulted in a lot of practical advice for animal owners whose horses suffer from blood-sucking horse-flies. I consider this award proof that it pays off to go against the stream as a researcher, collaborate across disciplinary boundaries and not be scared of tackling problems that the scientific community considered to already have been resolved.”

MIV-711 Osteoarthritis Trial: Recommendation to Go Ahead based on independent review of safety data, and first patient enrolled in extension study

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces new information about its phase IIa program for the treatment of osteoarthritis: · The independent Data Monitoring Committee (DMC) has recommended continuation of the ongoing randomized, double-blind phase IIa study (MIV-711-201) based on a review of unblinded safety data. · The first patient has been enrolled into an open label phase IIa extension study, MIV-711-202. The objective of MIV-711-201 is to evaluate the safety, tolerability and efficacy of six months of treatment with MIV-711 in patients with moderate knee osteoarthritis. As part of the study, an independent DMC is periodically scheduled to review the unblinded safety data from the trial. The DMC’s voting members are two expert physicians and one biostatistician. The possible recommendations from such a review, based on the analysis of the accumulated safety data, could be 1) Go ahead, 2) Go ahead but with modification, 3) Suspend enrollment or 4) Stop enrollment. Based on the review of the accumulated safety data after the first 50 subjects had completed three months of treatment, the DMC has recommended that the phase IIa trial of osteoarthritis should go ahead. In addition, the first patient has been enrolled in an open label extension study that will enroll approximately 50 patients from MIV-711-201. All patients in the study will receive 200mg MIV-711 once daily. Patients will be eligible to roll over into the extension if they have a favorable response to MIV-711 treatment, or if their disease has worsened following placebo treatment. The first objective of the study is to assess the safety and tolerability of six additional months of treatment with MIV-711, as well as its effect on knee joint structure assessed using magnetic resonance imaging (MRI), in patients who have shown evidence of a response to MIV-711 treatment. The other objective of the study is to explore the safety, tolerability and efficacy of six months of treatment with MIV-711 in patients previously on placebo whose osteoarthritis has worsened over the preceding six month period. It is expected that data from MIV-711-201 will be available in the second half of 2017 and that data from the extension study will be available in the first half of 2018. “The DMC’s recommendation to continue MIV-711-201 as planned based on the unblinded assessment of the available safety data is an encouraging milestone for MIV-711 and has enabled us to start the MIV-711-202 extension study”, says Dr Richard Bethell, CSO at Medivir. “The DMC ruling confirms and extends the phase I data, which indicated that MIV-711 has a favorable safety profile. Long term safety will be of particular importance for disease modifying OA drugs (DMOADs) such as MIV-711, since OA patients require long term treatment and are frequently burdened by co-morbidities. We will continue to closely monitor the safety profile throughout the course of these studies. We are also excited by the opportunity to obtain longer-term safety, tolerability and efficacy data on MIV-711 in patients who have shown evidence of a response to treatment, while at the same time studying the drug in patients from the placebo arm of MIV-711-201 whose disease worsened over a six-month period as these patients may be in particular need of a disease-modifying treatment”. MIV-711 is being developed as a DMOAD, i.e. a drug to slow or reverse the progressive degeneration of joints affected by OA. There are no DMOADs approved for use currently, and the standard of care for OA patients is based on analgesics , with the potential for associated side effect risks such as GI-bleeding and opioid dependency, and changes in life style. DMOADs for osteoarthritis therefore represent a very large and attractive market opportunity. Medivir estimates that the US market alone is greater than USD 6 billion annually for a drug that impacts disease progression, even if its use was restricted just to patient populations with moderate osteoarthritis in weight-bearing joints. Further information on the trial planning and conduct can be found on www.clinicaltrials.gov with identifier NCT02705625. For further information, please contact:Richard Bethell, CSO Medivir AB, mobile +46 (0)72-704 3211Ola Burmark, CFO Medivir AB, mobile: +46 (0) 725 480 580 Medivir is required under the Securities Markets Act to make the information in this press release public.The information was submitted for publication at 8.30 CET on 23 September 2016. About MedivirMedivir is a research based pharmaceutical company with a research focus on oncology and infectious diseases. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical need. Our commercial organization provides a portfolio of specialty care pharmaceuticals on the Nordic market.Medivir is listed on the Nasdaq Stockholm Mid Cap List.

University Medical Center Groningen selects RayStation

University Medical Center Groningen (UMCG) in the Netherlands has selected RayStation® as its treatment planning system. RayStation will replace the hospital’s existing system for conventional (photon) radiation therapy and will be the treatment planning system for its new proton therapy center. UMCG will have 30 clinical and 16 development licenses in total. UMCG’s new proton therapy center, currently under construction, will be equipped with IBA’s ProteusPLUS two-gantry room configuration, including pencil beam scanning (PBS) and cone beam CT capabilities. UMCG anticipates the center will treat around 600 patients per year, with the first treatments taking place end of 2017. The RayStation installation will include adaptive radiation therapy, multi-criteria optimization and radiobiology. In addition, a cluster computing platform will provide optimized performance for the Plan Explorer feature in RayStation. Plan Explorer automatically generates a large number of high-quality treatment plan alternatives, saving time and giving the clinician a wide range of options to consider. UMCG will also be one of the first clinics in the world to implement RayCare®, a groundbreaking oncology information system currently in development at RaySearch. RayCare is designed to improve workflows across treatment techniques and to meet the demands of new techniques and approaches in cancer treatment. Professor Hans Langendijk, chair of the Department of Radiation Oncology at UMCG, says: “Advanced techniques such as adaptive therapy and proton therapy demand software solutions that are equally cutting edge. We are a pioneer of radiation therapy in the Netherlands, and RaySearch is a partner that helps us improve treatment for all of our patients.” Johan Löf, CEO of RaySearch, says: “UMCG is a leading clinic and I am delighted to be able to meet their treatment planning needs for both photon and proton therapy. Our longstanding research collaboration is important and will continue with the department’s early adoption of RayCare. Together we are pioneering the future of cancer care.”

Invitation to Attend the Extraordinary General Meeting of Shareholders of Oncology Venture Sweden AB (publ)

Right to attend the Shareholders Meeting and Notification of Intention to attend  Shareholders who wish to attend the General Meeting of Shareholders must  · be registered on Wednesday, October 5, 2016 in the share register maintained by Euroclear Sweden AB, and  · provide written notification to the company no later than Wednesday, October 5, 2016 of the intention to attend, submitted to Oncology Venture Sweden AB, Venlighedsvej 1, DK-2970 Hørsholm, Denmark. Notification may alternatively be made by telephone: +45 21 70 10 49 or by e-mail to: info@oncologyventure.com. The notification of intention to attend must include the full name, civic registration number or corporate identity number, number of shares owned, mailing address, daytime telephone number, and where applicable, information about any proxies or assistants (maximum of two). Where necessary, the notification must be accompanied by letters of proxy, registration certificates and other authorizing documents.  Nominee shares  Shareholders whose shares are nominee-registered through a bank or other nominee must, in order to be entitled to participate at the General Meeting of Shareholders, temporarily register the shares in their own name with Euroclear Sweden AB. Such re-registration must be completed by Wednesday, October 5, 2016. Which means that shareholders desiring such re-registration must inform the nominee in due time before said date.  Proxy, etc.  If a shareholder is to be represented by a proxy, the proxy must bring to the meeting a dated written letter of proxy, signed by the shareholder. The letter of proxy may not be older than one year, unless a longer period of validity (up to five years) is specified in the letter of proxy. If the letter of proxy is issued by a legal entity, the proxy must also bring with them a current registration certificate or equivalent document of authority for the legal entity. In order to facilitate entry, a copy of the letter of proxy and other documents of authority should be enclosed with the Notification of Intention to attend the meeting. Proxy forms are available from the company’s website www.oncologyventure.com, or alternatively will be sent by mail to shareholders who contact the company and provide their address.  Number of shares and votes  The number of outstanding shares and votes in the company at the time of this Invitation to Attend amounts to 9,299,810 shares. The company holds no treasury shares.   Proposed Agenda: 0.       Opening of the Meeting. 1.       Election of Chairperson for the Shareholders Meeting. 2.       Preparation and approval of the list of shareholders entitled to vote. 3.       Approval of the Agenda. 4.       Election of one or two persons to check and verify the minutes. 5.       Determination of whether the Shareholders Meeting has been duly convened. 6.       Approval of the Board of Director’s decision concerning a preferential rights issue. 7.       Closing of the Shareholders Meeting.  Summary of proposed decision:  Approval of the Board of Directors’ decision concerning a preferential rights issue (item 6)  To increase the company’s share capital, via a preferential rights issue, by a maximum of SEK 108,497.76 by means of the issuance of up to 774,984 new shares each with a par value of SEK 0.14, at a subscription price of SEK 29.00 per share. The total value of the shares to be issued amounts to a maximum of SEK 22,474,536.  The following terms and conditions will apply to the new share issue:1.       The issuance of new shares is to occur with preferential rights for existing shareholders. One (1) subscription right will be received for each existing share. Twelve (12) subscription rights provides an entitlement to subscribe for one (1) new share.  2.       The record date in the share register maintained by Euroclear Sweden AB for determining which shareholders are entitled to the preferential rights to participate in the new share issue shall be October 21, 2016. Other parties can also subscribe for new shares.  3.       For each share subscribed for, SEK 29.00 in cash is to be paid.   4.       The subscription for shares will occur during the period from October 27, 2016 to November 10, 2016. Subscription with preferential rights is to occur with simultaneous cash payment. Subscriptions made without subscription rights shall be made on a separate subscription list and payment must be made no later than the fourth banking day after the notice of allocation has been sent to the subscriber. The Board of Directors shall be entitled to extend the subscription period and the time for payment.  5.       In the event that not all shares are subscribed for within the framework of preferential rights according to the above, the Board of Directors shall, within the framework of the maximum amount of the new share issue, make a determination concerning the allocation of shares to others without preferential rights who subscribed for shares and decide how the allocation between the subscribers is to be made.   With the allotment of new shares subscribed for without subscription rights, priority shall be given to those who have also subscribed for new shares with subscription rights, irrespective of whether the subscriber was a shareholder on the record date or not, and in the event that full allotment to these cannot be made, the allotment shall occur pro rata in proportion to the number of subscription rights utilized for the subscription of new shares and, to the extent this is not possible, by drawing of lots.  After that, the allotment of new shares subscribed for without subscription rights shall be made to others who have subscribed without subscription rights, and in the event that full allotment to these cannot be made, the allotment shall occur pro rata in proportion to the number of new shares that each one subscribed for and, to the extent this is not possible, by drawing of lots. 6.       The new shares shall carry rights to dividends for the first time on the record date for dividends occurring after the new shares have been registered at the Swedish Companies Registration Office.  7.       The Board of Directors, or the party the Board appoints, is authorized to decide on minor corrections that may be required for registration with the Swedish Companies Registration Office and Euroclear Sweden AB.  Other matters  The complete proposal for decision, documents pursuant to Chapter 13, § 6 of the Swedish Companies Act, and proxy forms, will be available at the company’s offices, Venlighedsvej 1, DK-2970 Hørsholm, Denmark and on the company’s website (www.oncologyventure.com) at the latest two weeks before the shareholders meeting and will be sent to the shareholders who so request and provide their mailing address.  The shareholders present at the general meeting of shareholders have the right to request information in accordance with Chapter 7, § 32 of the Swedish Companies Act (2005:551).  Malmö, September 2016  Oncology Venture Sweden AB (publ)  THE BOARD OF DIRECTORS  For further information, please contact Ulla Hald Buhl, COO and Chief IR & Or Peter Buhl Jensen, CEOMobile: +45 21CommunicationsMobile: +45 2170 60 89 22E-mail:1049uhb@oncologyventure.com  pbj@oncologyventure.com  This information is information that Oncology Venture Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on September 23rd 2016. About Oncology Venture Sweden AB  Oncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish subsidiary Oncology Venture ApS. Oncology Venture has a license to use Drug Response Prediction – DRP™ – in order to significantly increase the probability of success in clinical trials. DRP™ has proven its ability to provide a statistically significant prediction of clinical outcomes from drug treatment in cancer patients in 29 of the 37 clinical studies that were examined. The Company uses a model that alters the odds in comparison with traditional pharmaceutical development. Instead of treating all patients with a particular type of cancer, patients’ tumors genes are screened first and only those who are most likely to respond to the treatment will be treated. Via a more well-defined patient group, the risk and costs are reduced while the development process becomes more efficient. The current product portfolio: LiPlaCis for Breast Cancer, Irofulven developed from a fungus for prostate cancer and APO010 – an immuno-oncology product for Multiple Myeloma. 

RayStation innovations and RayCare on show at ASTRO 2016

During September 25–28, RaySearch will be exhibiting at the ASTRO 2016 Annual Meeting in Boston, US. The company will demonstrate new features in the upcoming release of its proprietary treatment planning system, RayStation®. In addition, RaySearch will demonstrate its oncology information system, RayCare®, which is under development and due to be launched in the second half of 2017. Attendees are welcome to visit RaySearch at booth #12012, and demonstrations can be booked now at www.raysearchlabs.com. New features in RayStation 6The upcoming release of RayStation will include some exciting new functionality. One of the highlights is treatment planning* for the Accuray TomoTherapy® and Radixact™ Systems. Demonstrations will be available at both the RaySearch and Accuray booths. RayStation 6 will also include MR-based planning and new developments for proton therapy planning, including Monte Carlo dose calculation*, which will all be on show. Automated planning and Plan ExplorerRayStation has extensive automated planning features that help optimize workflows and create new treatment possibilities. Plan Explorer, for example, makes it possible to automatically generate a large number of high-quality treatment plan alternatives, saving valuable time and giving the clinician a wide range of options to consider. Adaptive therapy is now!RayStation is designed to make adaptive therapy easy to implement and perform in clinical practice. At the RaySearch booth, attendees can discover how automation features and smart tools in the fully integrated dose tracking and adaptive planning modules make it straightforward to get started. The next-generation OISRayCare has been developed from the ground up by RaySearch to support the complex logistical challenges in modern, large-scale radiation therapy centers. RayCare integrates the high-performance radiation therapy algorithms available in RayStation and adds advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. 

Multifaceted genetic impact of training

Regular endurance training is very beneficial to health and wellbeing, and can be used to prevent cardiovascular disease, diabetes, obesity and other such conditions. However, just how this works on a molecular level is not fully known.  Researchers at Karolinska Institutet have now analyzed RNA, the molecular copies of the DNA-sequence, in muscle tissue before and after endurance training. They found approximately 3400 RNA variants, associated with 2600 genes, that changed in response to training. One implication of the study is that training can induce the same gene to increase the production of one RNA variant and reduce that of another. According to the researchers, this can mean that genes can change function as a result of exercise and, for example, start to promote the production of certain protein variants over others. “It has not been previously shown that training changes the expression of genes in this particular way. The study also provides new basic information about how the body adapts to regular endurance training and what role many of our genes play in the adaptation,” says Dr Maléne Lindholm at Karolinska Institutet’s Department of Physiology and Pharmacology. The study began with an exercise programme for 23 individuals that involved working one leg but not the other. Muscle samples were taken before and after the training period. After a nine months rest period, they then exercised both legs in the same way as in the initial period of exercise, with muscle samples taken from both legs. “We were looking for any residual effects of previous training, a kind of muscle memory as it were, and trying to find out if this could influence the response to repeated training.” The changed genetic activity in the previously trained leg was no longer present when exercise resumed. However, the repeated response to training was somewhat different in the trained and previously untrained legs in the second training period, which suggests that the exercise could have left other lasting impacts. According to Dr Lindholm, the study is important above all for the fundamental understanding of how muscles operate and how we adapt to endurance training. “The results can also contribute to the future optimisation of training effects in different individuals,” she says. “In the long run, it is conceivably of some significance to the possibility of preventing cardiovascular disease and the development of new, more precise drugs for people who, for whatever reason, are unable to exercise.” The study was financed by the Swedish National Centre for Research in Sports, Karolinska Institutet and the Knut and Alice Wallenberg Foundation Publication: ”The impact of Endurance Training on Human Skeletal Muscle Memory, Global Isoform Expression and Novel Transcripts” Maléne Lindholm, Stefania Giacomello, Beata Werne Solnestam, Helene Fischer, Mikael Huss, Sanela Kjellqvist, Carl Johan Sundberg. PLOS Genetics, published online 22 September, 2016, doi: PGENETICS-D-16-01025 If you have any questions, please contact: Maléne Lindholm, PhD, Department of Physiology and Pharmacology, Karolinska Institutet Tel: +46 70 749 49 52 E-mail: Malene.Lindholm@ki.se

The Switch, a Yaskawa company, to acquire Wärtsilä Drives’ products

PRESS RELEASE: For release on September 23, 2016(For German and Norwegian versions see attached) The Switch, a Yaskawa company, to acquire Wärtsilä Drives’ products, R&D and manufacturing to strengthen its core advanced electrical drive train offering.  Finland, September 23, 2016 – The Switch, a technology specialist of advanced drive trains, announced its acquisition of Wärtsilä’s marine drives business that encompasses specialized megawatt-class power drives targeting marine applications. The Yaskawa-backed investment gives The Switch a stronger foothold in its growing marine business area. Together, The Switch and the Norway-based marine drives business aim to benefit from a number of inherent added-value synergies, including a stronger machine and drive package offering, a broader product range and a wider market access.  As part of the deal, The Switch will gain part of Wärtsilä’s Electrical & Automation (E&A) business line’s test center and the manufacturing facilities in Stord, Norway, that are associated with its marine drives. The Switch will then become a supply chain partner of Wärtsilä for marine drives while also being able to open up the product offering to other customers. The business transition from Wärtsilä to The Switch is due for completion once the operations have been transferred to The Switch. Stronger core offering The Switch investment in the marine drives business enables both companies to fully focus on developing their core competences and creating drive train solutions with better synergy together. Wärtsilä aims to focus on systems, whereas The Switch strives to be the best in providing drive train components to future proof vessels. The specialized marine R&D teams of the synergetic group will collaborate closely, enabling The Switch and Yaskawa to bring additional technical resources to ongoing and future solutions. Additionally, the two will be able to take advantage of building on each other’s solid technical knowledge. Broader product range This acquisition gives The Switch an opportunity to enhance its offering of world-class products since Wärtsilä’s drive offering is optimized for marine applications. This allows The Switch to broaden its marine business, an area which is taking off with the growing acceptance of the company’s permanent magnet technology. The power drive products are used as proven elements within Wärtsilä’s systems that have already passed various approval requirements and are used in applications ranging from propulsion to drilling. There are currently hundreds of ships sailing with Wärtsilä marine drives. This makes them attractive to other marine customers who are seeking to reduce risk while upgrading to more advanced drive train solutions and hybrid systems. “The Wärtsilä drive products are specially made without compromise for marine applications. These products are ready for integration with various other systems because of their superior communication features, including de facto industry standard interfaces and remote management possibilities. It is also possible to separate the logistics for cabinets and power modules by shipping them later to avoid damages during the long installation times at shipyards,” says Jukka-Pekka Mäkinen, President and CEO of The Switch.   Wider market access As part of The Switch, the power drives unit will be able to explore new audiences to expand its business. It will also be better positioned to serve customers thanks to The Switch’s extensive international sales and marketing network as well as to offer customers strong after-sales support. Thanks to Yaskawa’s involvement in the investment, the mother company will demonstrate its continued support and interest to ensure that The Switch becomes a major player in its chosen area. For the marine segment, The Switch works closely with Yaskawa as an integrated team and thereby is able to offer this wider product range globally. “At the moment, the oil and gas market is in a slump. Yet, we are taking a longer perspective in our views of this market. Now is good time to engineer future-proof solutions for marine. Once the market picks up, we’ll be ready to implement them,” says Jukka-Pekka Mäkinen. About The Switch The Switch, a Yaskawa company, is a pioneer in advanced drive train technology. The company has an installed base of over 11 GW of megawatt-class permanent magnet machine and converter packages. The main focus areas are wind, marine and special industrial solutions. The company’s innovative drive trains make an impact on profitable power generation and energy use, with the ultimate goal of lowering the cost of energy and operations. The Switch is headquartered in Helsinki, Finland. For more information, visit: www.theswitch.com. About Yaskawa Yaskawa Electric Corporation is a world-leading provider of core technologies focused on motion control, robotics automation, and systems engineering. Since it was founded in 1915, Yaskawa Electric has provided motor applications, advancement of industrial automation, the creation of mechatronics and cutting-edge robotics. Yaskawa today employs over 14,000 persons globally in its core divisions. The company reported net sales of EUR 3.3 billion in 2015. For more information, visit  www.yaskawa.co.jp  FOR MORE INFORMATION, PLEASE CONTACT: Lisa Kettman-Kervinen, Marketing Communication SpecialistThe Switch: Tel. +358 50 554 5044, lisa.kettman-kervinen@theswitch.com  Jukka-Pekka Mäkinen, President and CEOThe Switch: Tel. +358 40 8080 580, jukka-pekka.makinen@theswitch.com 

Composition of YIT Corporation’s Nomination Board

YIT Corporation’s three largest shareholders according to Euroclear’s shareholder register on August 31, 2016 and according to the principles of the standing order have had the right and have be willing to use their right to nominate representatives to the Nomination Board. The following representatives have been nominated to the company’s Nomination Board: The CEO of Varma Mutual Pension Insurance Company, Risto Murto The CEO of OP Fund Management Company Ltd., Kalle Saariaho Antti Herlin  The Chairman of YIT Corporation’s Board of Directors, Matti Vuoria, will serve as the Nomination Board's expert member. Risto Murto will serve as the Chairman of the Nomination Board.  YIT Corporation's Annual General Meeting decided on March 15, 2016 to establish a Nomination Board for the time being. The Nomination Board is to prepare proposals on members of the Board of Directors and their remuneration for the next Annual General Meeting. For further information, please contact:  Kari Kauniskangas, President and CEO, YIT Corporation, tel. +358 40 570 1313, kari.kauniskangas@yit.fiHanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi     YIT CORPORATION  Kari KauniskangasPresident and CEO  Distribution: NASDAQ Helsinki, major media, www.yitgroup.com   YIT creates sustainable cities and better living environment by developing and constructing housing, business premises, infrastructure and entire areas. We focus on providing a first-class customer experience, high quality and continuous development of our diverse expertise. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2015, our revenue amounted to nearly EUR 1.7 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com  

World’s First RISC-based Mini-ITX Mother Board- RSB-6410 Supports Triple Displays and Multiple I/O

September, 2016, -Advantech, a global leader in embedded computing, is glad to announce the launch of RSB-6410 (http://www.advantech.eu/products/d7a50c36-8311-4633-a2c2-90f026065bce/rsb-6410/mod_84ecc1d7-729f-4bb8-8cc7-f79c918a0eca), the world’s first RISC-based Mini-ITX motherboard which drives up to three 1080P displays powered by an NXP i.MX6D/Q Cortex-A9 1.0GHz high performance processor. To facilitate application development, RSB-6410 (http://www.advantech.eu/products/d7a50c36-8311-4633-a2c2-90f026065bce/rsb-6410/mod_84ecc1d7-729f-4bb8-8cc7-f79c918a0eca) supports both Linux Yocto and Android OS images, a board support package (BSP), middleware and corresponding documents and design guides for reference. RSB-6410 (http://www.advantech.eu/products/d7a50c36-8311-4633-a2c2-90f026065bce/rsb-6410/mod_84ecc1d7-729f-4bb8-8cc7-f79c918a0eca) industrial motherboard provides powerful multi-display capability, multiple I/O, and wireless connectivity with low power consumption for industrial applications such as machine control, self-service machine systems and digital signage. Powerful Multi-display Capability and Multiple I/Os for Device Connection and Control Powered by the NXP i.MX6D/Q Cortex-A9 1.0GHz processor, RSB-6410 drives up to three 1080P displays via LVDS, HDMI and VGA, and also supports dual independent displays and audio output. RSB-6410 (http://www.advantech.eu/products/d7a50c36-8311-4633-a2c2-90f026065bce/rsb-6410/mod_84ecc1d7-729f-4bb8-8cc7-f79c918a0eca) builds on the standard 170 mm x 170 mm Mini-ITX form factor with abundant connectivity for multiple I/O including 6 x USB 2.0, 5 x COM, 20 x GPIOs,1 x Gigabit Ethernet port and 1 x PCIe slot for extending I/O modules. RSB-6410 (http://www.advantech.eu/products/d7a50c36-8311-4633-a2c2-90f026065bce/rsb-6410/mod_84ecc1d7-729f-4bb8-8cc7-f79c918a0eca) supports wireless connectivity, including 1 x M.2 E-key slot for WiFi and BT module, and 1 x Mini-PCIe for 3G/4G modules. RSB-6410 (http://www.advantech.eu/products/d7a50c36-8311-4633-a2c2-90f026065bce/rsb-6410/mod_84ecc1d7-729f-4bb8-8cc7-f79c918a0eca) is not only the best hardware solution for the industrial market, but is also flexible enough to be applied to various applications such as digital signage, Kiosk, ATM/VTM, industrial controllers and IoT device related applications. Complete Software Support Services RSB-6410 (http://www.advantech.eu/products/single_board_computer/rsb-4221/mod_2283ad78-b2b3-4754-a6c7-ff1d99aa20c3) supports both Linux Yocto1.7 V3.14 and Android 4.2, and comes bundled with an evaluative Android image. It also provides complete Board Support Package (BSP) to help users develop their own applications. The BSP provides source code examples and tools for testing and evaluation. What’s more, it also provides sample code for setting up dual and triple independent displays and audio output, to help users quickly develop their own applications. Furthermore, the BSP includes peripheral drivers like WiFi, BT, 3G/4G modules and touch panels. With a dedicated Advantech service team and complete documentation and reference guides, RSB-6410 (http://www.advantech.eu/products/d7a50c36-8311-4633-a2c2-90f026065bce/rsb-6410/mod_84ecc1d7-729f-4bb8-8cc7-f79c918a0eca) is easier for both new application development and integration with Advantech’s hardware platforms. RSB-6410 Key Features l     NXP ARM® Cortex®-A9 i.MX6 Dual/Quad 1GHz high performance processor l     On board DDR3 1066MHz 1GB/2GB memory and 8GB EMMC NAND flash l     Supports triple display: VGA+HDMI+LVDS  l     Supports 1 x PCIe, 5 x serial ports, 6 x USBs, 20 x GPIOs, 1 x CAN l     Supports 1 x mini-PCIe socket, 1 x M.2 socket l     Hardware watchdog timer for system protection l     Low power consumption, fanless design l     Supports Linux and Android BSP RSB-6410 (http://www.advantech.eu/products/d7a50c36-8311-4633-a2c2-90f026065bce/rsb-6410/mod_84ecc1d7-729f-4bb8-8cc7-f79c918a0eca) is available now. Please contact Advantech sales and authorized channel partners to learn more about it. For more information on Advantech’s RISC products and services, visit risc.advantech.eu (http://www.risc.advantech.eu/) now!

Stena Line to add extra North Sea freight capacity on Rotterdam to Killingholme route

The RoRo ship Caroline Russ, has been brought in to operate three times weekly from Europoort in the Netherlands and Killingholme in the UK, with the first departure from Europoort on October 31, 2016. The ship will join current RoRo ship, the Stena Scotia, on the route. The frequency will hereby increase to six departures per week in each direction. The Stena Scotia was introduced on the route September 2014 as a complement to the two freight ships, the Stena Transit and Stena Transporter on the Hoek van Holland – Killingholme route. Annika Hult, Route Manager at Stena Line North Sea says: “We have seen a strong growth in the transport market to the UK over the past several years. We introduced our freight ship the Stena Scotia in 2014 in order to accommodate growing volumes of traffic. I am very pleased to announce that we will now take the next step in the strategic development of our Rotterdam (Europoort) – Killingholme route.” “We expect trade to remain strong and want to be in the best place to service our customers and meet additional demands. Europoort continues to develop as an important freight hub for Stena Line and we are confident our customers will react positively to our expanded service”, she continues. Facts Caroline Russ Type of ship: RoRoYear of construction: 1999Length: 153 mWidth: 20.6 mMax speed: 20 knTrailers: 102Passengers: 12 Sailing Schedule Caroline Russ and Stena Scotia: By introducing a second ship the frequency is increased to daily departures (6 days a week).  +---------------------------------------+------------------------+|Killingholme – Europoort (local times) |  |+---------------------------------------+------------------------+|Departure:  |Arrival:  |+---------------------------------------+------------------------+|Monday / Friday 22:00 hrs  |Following day 12:00 hrs ||Sunday 16:30 hrs  |Following day 06:45 hrs |+---------------------------------------+------------------------+|  |  |+---------------------------------------+------------------------+|Europoort – Killingholme (local times) |  |+---------------------------------------+------------------------+|Departure:  |Arrival:  |+---------------------------------------+------------------------+|Monday / Friday 16:45 hrs   |Following day 05:00 hrs ||Sunday 14:45 hrs  |Following day 03:00 hrs |+---------------------------------------+------------------------+ For more timetable information, please visit www.stenalinefreight.com Stena Line, Gothenburg 23 September 2016

Unique molecular atlas of pancreas produced

Although knowledge of what the body looks like and how it operates at a molecular level is still limited, researchers can now examine the organs of the body in a higher resolution than before] (http://file:///G:/Ka/Ek/Press/3.%20PRESS%20forskning/Sandberg_Cell_Metabolism/PR%200922_en.doc#_msocom_1) using a new technique developed by researchers at Karolinska Institutet based on single-cell transcriptomics, which makes it possible to sort out individual cells from complex tissue, study them and analyse the activity of all their genes. Using this technique, scientists can now map out the cells of an organ along with molecular patterns in organs and tissues.“We hope that our atlas of the pancreas will serve as a catalyst for research into the metabolic diseases that affect it,” says Rickard Sandberg, professor at the Department of Cell and Molecular Biolog, who is also a researcher at the Ludwig Institute for Cancer Research and at the Cardio Metabolic Centre.The pancreas is an important organ that regulates the body’s metabolism through hormones that it secretes into the blood from special cells. By studying thousands of individual cells, the team has made up a molecular atlas of the pancreatic cells with a focus on the hormone-producing ones in the Islets of Langerhans. An analysis of data revealed many interesting genes that were active in specific cell types, particularly the delta cells, in which they found expressed genes that give these cells a unique ability to operate as signalling centres in the pancreas, where they are able, for example, to gauge the body’s energy balance and hunger through the hormone leptin. To conduct their study, the researchers examined the pancreas of ten deceased individuals, of whom six had been healthy and four had died of type 2 diabetes. Using single-cell transcriptomics, they were able to compare the genetic activity of all cell types while examining the presence of any disease-related changes. “This is the first time someone has compared normal and morbid pancreatic tissue using this technique,” says Professor Sandberg. Carina Ämmälä is a researcher at AstraZeneca and a member of the team working at the Integrated Cardio Metabolic Centre. “Our study indicates that the different endocrinal cells of the pancreas express distinct and unique pattern genes that regulate cellular function, which changes in diabetes,” she says. “It’s now time to start looking for treatments for type 2 diabetes that restore the function of the network of cells that make up the Islets of Langerhans rather than just trying to make the beta cells work harder.” The study was financed by grants from the Swedish Research Council, the European Research Council, the Swedish Foundation for Strategic Research, the Swedish Cancer Society and the Centre for Innovative Medicine. Publication “Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes”Åsa Segerstolpe, Athanasia Palasantza, Pernilla Eliasson, Eva-Marie Andersson, Ann-Christine Andreasson, Xiaoyan Sun, Simone Picelli, Alan Sabirsh, Maryam Clausen, Magnus Bjursell, David M. Smith, Maria Kasper, Carina Ämmälä and Rickard SandbergCell Metabolism, online 22 September 2016, doi: 10.1016/j.cmet.2016.08.020 For more information about the research, please contact Rickard Sandberg, professorDepartment of Cell and Molecular Biology Researcher at AstraZeneca and Karolinska Institutet Integrated Cardio Metabolic CentreKarolinska InstitutetAssistant member, Ludwig Institute for Cancer Research, Stockholm Phone: +46 (0) 8-524 839 86 (http://tel:08-524%20839%2086)E-mail: rickard.sandberg@ki.se

Amigo Loans guarantor agreement deemed unenforceable by court

Guarantor loan provider Amigo Loans, which markets itself as a loan option for people with bad credit, has had a recent claim against a guarantor dismissed by a district judge after it was found that the company had breached principal obligations under the Consumer Credit Act 1974, as well as other acts and regulations. This has resulted in the guarantor agreement being deemed unenforceable. Amigo Loans was seeking a guarantor, Miss Abbas, to pay debt in excess of £5,000. However, the case was dismissed and permission to appeal refused after District Judge Beck concluded that the guarantor agreement could not be enforced because there was no evidence to suggest that a copy of the borrower’s agreement was provided to the defendant, who was supported by Landlord Advice UK, before numerous requests from Miss Abbas. Initially, it is understood that Amigo Loans believed the guarantor was not entitled to the agreement due to data protection laws. The evidence also indicates that Amigo Loans failed to serve a cancellation notice on the guarantor. Sasha Charles, Housing Lawyer and Director of Landlord Advice UK, said, “The case highlights the poor conduct of Amigo Loans and their failure to protect consumers as required. The conduct of Amigo Loans puts all of their guarantors at an unfair disadvantage due to non-compliance. The case should also serve as a warning for landlords and agents, who commonly use unenforceable guarantor agreements and may not be able to claim back their debts should their tenants default on payments.” The Amigo Loans Limited v Abbas trial took place at Reigate Country court on 14th September 2016. Amigo Loans did not attend the court but was represented and submitted a witness statement as evidence. The district judge advised that the evidence was heavily disputed on a point of law before adjourning the hearing so the claimant’s representative could take instructions. To find out about Landlord Advice UK visit http://www.landlordadvice.co.uk/.

camexpo 2016 opens this weekend

camexpo – the UK’s largest professional event for complementary and integrative health practitioners, therapists, students, healthcare professionals, pharmacies, and health store retailers – opens at Olympia, London on Saturday 24 September. The two day show combines a 200-strong trade exhibition – showcasing everything from VMS and natural beauty to essential business services and supplies, and training, with a packed programme of Keynotes, business seminars and workshops. Big name speakers Caring for an ageing population, cancer, vitamin deficiencies, obesity, chronic disease, Lyme Disease, diet, and brain health are just some of the subjects under discussion in the Keynote and Nutrition Theatres at camexpo 2016.  While Business Clinic sessions include everything from business basics and marketing tips to social media promotion. Further highlights from the camexpo National Complementary & Natural Health ‘Industry Snapshot’ Survey will be unveiled at a dedicated session in the Demo Theatre at 11.20am on Sunday 25 September.  To read a summary of the results, please visit www.camexpo.co.uk/camexpo-announces-results-first-ever-national-complementary-natural-health-survey. The Demo Theatre will also feature sessions by Joe Hoare; John Holman; Guy Hudson; Chris James; Catalina Fernandez de Ana Portela; Emma Lane; Nadia Brydon; Gillian Crowther; Tim Spector; Graham Botfield; Judy Rocher; Claire Muller; Juliet Hayward; and Matt Hudson. Full timings and seminar summaries for the Keynote Theatre, Nutrition Theatre, Demo Theatre and Business Clinic are available to view at www.camexpo.co.uk/education. Saturday 24 September: Keynote Theatre (sponsored by the FHT) · Professor Robert Thomas and Elizabeth Butler – Cancer: The latest research into lifestyle/nutrition, and caring for the mind, body and soul · Jacqueline Young – Oriental secrets for health and vitality · Dr Marilyn Glenville – Diet and DNA: using the power of nutrigenomics · Niki Gratrix – Adverse childhood events and the impact on health across a lifetime · Panel debate: caring for an aging population– with Margaret Coates, chief executive & registrar at the CNHC; Dr Marilyn Glenville; Dr Robert Verkerk, founder of ANH Int; Tracey Smith, reflexology and research manager at the AoR; and (chair) Jim Manson, editor of Natural Products News Nutrition Theatre (sponsored by Wiley’s Finest) · Gudrun Jonsson – A gut reaction · Dr. Britt Cordi – Ph.D. – Juicing for health: how to maintain and improve your health & wellbeing through juicing and superfood · Dr Robert Verkerk – How baseline and ongoing assessments can transform your practice, whatever your modality · Tam Fry – The government’s childhood obesity strategy – has it got what it takes? · Rick Hay – Vitamin K2 deficiency – its impact on health from infancy to senior years · Natascha Van Zyl – Applied behaviour change for practice · Dr Daniel Jones – Combating osteoarthritis with nutrition · Antony Haynes – Mitochondrial fat burning: how to switch it on! · Umahro Cadogan – The what, why and how to support Methylation for mental health Business Clinic (sponsored by Jayney Goddard’s Masterclasses) · John Prendergast  – Video made easy: simple, best and cheapest way to reach more clients · Jayney Goddard – Jayney Goddard’s top tips · Margaret Coates – How to play your part in a new health and wellbeing workforce · Mark Shields – Achieve business success with The CAM Coach Sunday 25 September: Keynote Theatre (sponsored by the FHT) · Christine Bailey – Feeding our gut microbiota: dietary & nutrition strategies to restore gut health and encourage microbiome diversity · Leon Chaitow – Fascial dysfunction: update on the latest research · Dr Sarah Brewer – Do you need more vitamin D? · Dale Pinnock – The power of three: three dietary elements that deliver the broadest physiological benefit Nutrition Theatre (sponsored by Wiley’s Finest) · Katie Pande – Turmeric, rather a lot more than curcumin · Dr Robert Verkerk – Fast-tracking homeostasis with food, physical activity and complex multi-nutrient nutritional formulas · Dr Marilyn Glenville – Natural alternatives to sugar · Antony Haynes – Mushroom muscle: the powerful benefits of mushroom extracts to counter inflammation and support immunity · Dr. Armin Schwarzbach – Lyme disease: innovative testing and therapy options · Miguel Toribio-Mateas – Keeping the brain young: using the Mediterranean diet as a naturally occurring model for neuroprotection · Nadia Brydon –Sun chlorella for detox and digestion · Emma Lane –The curious case of Subject P Business Clinic (sponsored by Jayney Goddard’s Masterclasses) · Lisa Barber – Marketing demystified: how to help more clients · Ola Agbaimoni – Savvy social selling on Facebook · Dr Robert Verkerk and Meleni Aldridge – Expanding your toolbox to protect your future and leverage your business · Ashley Turner – Business basics 200-strong trade exhibition New additions to the exhibitor line-up this year include Q-Surgical /Mammagard, Bottega Organica, Map my Gut, Beneficial Environments, Elixinol, CB Detox, Living Ayurveda Products Ltd, Nouveau Health, Trevo, Simply Naturals, Sapromax, Hypnotherapy Training, Urban Massage, Lifestyle Vitamins, Rejuvenation Redefined, Sophrology Academy, Tamara Association UK and Incognito Anti-mosquito. They join returning exhibitors including Bionutri, Nature’s Plus, A Vogel (Bioforce), Rio Trading Company Health, Pukka Herbs, Wiley’s Finest, Vega Nutritional, Biodane, Cell Nutrition, Renew Life, Ovio Wellness, Optibac, Bio-Kult, Cytoplan, Wild Nutrition, Biopathica, Abundance & Health, Yogi Tea, The Natural Health Practice, The Really Healthy Company, The Bite Outlet, Hifas da Terra, Biomedica, Lepicol, G&G Vitamins, Sun Chlorella, Pukka Herbs, The Natural Health Practice, Rio Trading, Weleda, Green People, and Complementary Medical Association presents Jayney Goddard MasterClasses (which will also be running an exclusive free prize draw at the show). The full exhibitor list is available at www.camexpo.co.uk/exhibitor-list. New Products Showcase Aside from the wealth of new launches being unveiled at camexpo 2016, this year’s visitors will also be the first to see the results of the show’s annual camexpo Best New Product or Service Award. Entrants include The Hypnotherapy Training Company, Therapy and Coaching Success, Good Health Naturally, Chris James Mind Body, Cell Nutrition Quinton, Wild Nutrition, Probiotics International, Kinetic Natural Products Distributor, ReNew Life UK, Nucleotide Nutrition, Biodane Pharma, and Living Nutrition. The popular New Products Showcase, featuring new innovations from the last twelve months, lets visiting buyers decide the winner.  They get to cast their votes throughout the show’s opening day, with the results to be announced on Sunday 25 September. Entry tickets include access to the Keynote Theatre, Nutrition Theatre, Demo Theatre and Business Clinic (Business Clinic sessions can be reserved at £10 each inc VAT).  Taster Workshops, sponsored by Balens, are £19.50 incl VAT. camexpo returns to Olympia, London, on 24-25 September 2016.  For more information, and to book an entry ticket for £8.50 (saving £16.50 off the door charge), please visit www.camexpo.co.uk and use priority code CAMX524, until 5pm today (Friday 23 September). The show is open from 10am to 6pm on Saturday 24 September (access into Olympia from 9am, last admittance 5pm), and 10am to 5pm on Saturday 24 September (access into Olympia from 9am, last admittance 4pm). ###

Off Shelf Deals now sells internationally famous makeup brands for the lowest price, guaranteed

Beauty fans that love a bargain can now head to online webstore, Off Shelf Deals to find their favourite makeup and cosmetics brands at the lowest price around. The international online store, with a strong reputation of selling premium household goods, appliances, electronics and more from recognised retailers is pleased to enhance its product offering with its new addition of internationally famous makeup brands. As well as offering the most sought after perfumes, Off Shelf Deals now sells a huge selection of luxury cosmetics from some of the most in-demand brands in the industry. Beauty fans will swoon as they stock up their make-up bags with Yves Saint Laurent mascara, Clinique foundation, Estee Lauder lip-gloss and Clarins powder, all for the lowest price, guaranteed. Rita Michel, owner of Off Shelf Deals said, “When I started Off Shelf Deals, my aim was to empower my customers with a platform to enrich their life with the best products available to them, providing a premium experience but at a fraction of the cost. After successfully sourcing the best home appliances, small electronics, gifts and kitchen for years, I could see a gap in the market for offering high-end cosmetics and personal care goods to my customers too, enabling them to treat themselves as well as their home.” Off Shelf Deals prides itself on its unique approach to customer service, ensuring that each new purchase is safely shipped to anywhere across the world within just three days. All items are dispatched within 24 hours, supplied with a tracking number and tracking link to give each customer peace of mind. With the new make-up range from Off Shelf Deals, even those with a busy lifestyle can ensure that they have the most glamorous cosmetics kit in time for the weekend, when ordering on Wednesday or before. Rita Michel continued, “For many people their make-up bag is their ultimate luxury. I believe that everyone deserves to own the best products in the industry, which is why I have chosen brand leaders such as Estee Lauder, Dior, Maybelline and Guerlain to stock my new range of make up at Off Shelf Deals.” Off Shelf Deals offers worldwide delivery at a standard flat delivery rate, with a 24/7 online chat available to support customers through their purchase. To find out more and to subscribe to the newsletter,  visit http://offshelfdeals.com/ and view the new   makeup range at http://offshelfdeals.com/en/779-make-up?p=2 Stay connected via Facebook: https://www.facebook.com/offshelfdeals

Chassis Cab Delivers 600th FTP DAF Truck to Turners to Keep Mega Fleet Rolling

Cambridgeshire-based haulage firm Turners (Soham) has just taken delivery of its 600th specialised DAF FTP truck to meet the requirements of the highly flexible, fast growing East of England-based business. The FTP XF tractor unit from the Cambridgeshire and Suffolk based DAF family-owned dealership Chassis Cab has been added to the 1750-strong fleet which makes Turners the largest privately owned logistics company in the UK and the largest operator of this model worldwide. The DAF FTP - sporting its own personal plate T600 FTP - was purchased outright from Chassis Cab. It features a PACCAR MX-11 Euro 6 emissions-compliant engine, luxury SpaceCab, AS-tronic automated gear box and Drivers Performance Assist to help the driver to operate the truck to the best fuel economy. The truck – voted MotorTransport Fleet Truck of the Year 2016 - will cover over 100,000km per year and during its three-year warranty supporting dealer Chassis Cab will be responsible for the service and maintenance. A variety of other DAF models have also been purchased by Turners ranging from FTG XFs for use up to 44 tonnes gross combination weight; down to FA LF Models for up to 18 tonnes gross weight and fitted with fuel tanker bodies. Tim King, Group Fleet Engineer of Turners (Soham), said: ‘Our nationwide operations cover the movement of containers, chilled and refrigerated product distribution and tankers carrying liquids and bulk materials. We cover all product sectors including food, building materials and fuels and currently business is extremely buoyant.’ ‘Our continuous investment in DAF trucks shows our allegiance to the brand and our commitment to keep our fleet in premium condition. The FTP 440 tractor unit is a top-performer; probably the best lightweight truck ever. They are so flexible that they are the optimum truck in weight sensitive work. And that’s why we are proud to be one of the top buyers worldwide.’ ‘We are all looking at the future with interest particularly with regards to how Brexit will affect our daily operations but we are confident that as a business we are in the strongest position possible to make the most of any additional trading opportunities or challenges that may present themselves. Business is what you make it – and we are always optimistic.’ Founded in 1930, Turners (Soham) Limited is today one of the largest independently-owned transport and distribution businesses in the UK. It specialises in bulk tanker and temperature-controlled work and runs trucks from 36 locations in the UK. With over 3200 full time employees, it also has six subsidiary companies: PPL, Pro-Fresh Solutions, Browns, Lewis Tankers, Macintyre Transport and Goldstar. The company’s turnover in 2014 was £238m with a projected turnover for 2017 of £400m. Eddie Hennessy, Regional Manager of DAF Trucks, delivered the latest truck to Tuners. He is about to retire after nearly 40 years of service with DAF Trucks. He said: ‘Turners is such a successful family haulage business – its growth has been unprecedented and we are delighted that DAF Trucks has played such a key role in the company’s development. It has been a pleasure to work with clients like Turners and to support the work of dealerships such as Chassis Cab. It’s good to know that collectively we are keeping products rolling - around the UK and beyond - in the greenest and most efficient way.’  Robert Baxter, Dealer Principal, at Chassis Cab, said: ‘We are extremely proud of this long association with Turners. We know that the business is benefiting from optimum operating costs and many efficiencies that are preparing the way for a steep increase in business in the months and years ahead. This is a family business gearing up for future development on a grand scale. Chassis Cab has bases at Ipswich, Bury St Edmunds and Cambridge. The Cambridge base is located on Newmarket Road. Chassis Cab is a family owned business that has been the main DAF dealer for Suffolk since the early 1990s; and for Cambridgeshire since 2014 maintaining the dealership’s status as the only HGV commercial franchise located within Cambridge. Starting out as a commercial vehicle accident repair centre, Chassis Cab has grown to become one of the premier dealers for DAF and a leading supplier of trucks in the region. Based at Addison Way in Great Blakenham, Ipswich, Northern Way in Bury St Edmunds, Newmarket Road in Cambridge and Isleham in Cambridgeshire, Chassis Cab now employs over 110 members of staff. Photo Caption DAF Truck Handover featuring Tim King, Group Fleet Engineer at Turners (Soham) (left) and Eddie Hennessy, Regional Manager of DAF Trucks UK representing Suffolk and Cambridgeshire dealership Chassis Cab. Ends Robert Baxter @ ChassisCab on tel 01473 833003,or email robert.baxter@chassis-cab.co.uk Alison Baker @ Madhouse PR on tel 01284 830321, or email madhousepr@aol.com

Jackpot joy as €5million drops on NetEnt’s Mega Fortune slot

The Norwegian man, playing on the Betsson.com website, is the second multi-millionaire to be created playing Mega Fortune this year, following a €2.7m windfall in the UK in January. Initially the man, in his 20s, thought he’d won 45,000 kroner (€4,900), before realising he’d won the life-changing amount. He said: “I was playing NetEnt’s Mega Fortune game a little before bed, and then suddenly the jackpot hit. I was unsure at first if it was true, but it has gradually dawned on me how much I’ve won. I’ll build a house with the money, but otherwise want to just carry on as normal.” Simon Hammon, Chief Product Officer at NetEnt, said: “Mega Fortune continues to be one of NetEnt’s best performing and most played games, and we’re over the moon that another jackpot has dropped. We’re looking forward to even more players enjoying the great gameplay and features in the future, and I’m sure it won’t be too long before the slot changes another life for the good.” For additional information please contact: Simon Hammon, Chief Product Officer NetEnt, Phone +356 2276 8145simon.hammon@netent.comMarianne Eklund, PR Manager, Phone +46 760 024 808marianne.eklund@netent.com About NetEnt  NetEnt AB (publ), is a leading digital entertainment company, providing premium gaming solutions to the world’s most successful online casino operators. Since its inception in 1996, NetEnt has been a true pioneer in driving the market with thrilling games powered by a cutting-edge platform. NetEnt is committed to helping customers stay ahead of the competition, is listed on NASDAQ OMX Stockholm (NET–B) and employs 800 people in Stockholm, Malta, Kiev, Gothenburg, Krakow, New Jersey and Gibraltar. www.netent.com (http://file:///C:/Users/Admin/AppData/Local/Microsoft/Windows/Temporary%20Internet%20Files/Content.Outlook/P2W12YLV/www.netent.com) 

ATS EUROMASTER MAKES SECOND PIT STOP AT LAKESIDE FOR BLACKCIRCLES

ATS Euromaster, in partnership with Blackcircles, has opened its second quick tyre change facility at the Lakeside Shopping Centre in Essex, following the success of the first Pit Stop location in Cambridge. Pit Stop centres offer retail customers the ultimate in flexibility when buying tyres, combined with the trusted ATS Euromaster quality and service in an easily accessible, convenient location. Via Blackcircles.com, customers purchase competitively priced tyres prior to booking their car into the Pit Stop site for fitting. Upon arrival, all they have to do is leave their vehicle in the hands of ATS Euromaster technicians, head to the shops or for a bite to eat, and then return to the expertly completed job before heading home. Peter Tye, Group Operations Manager at ATS Euromaster, says: “Pit Stops make it even easier for customers to have quality tyres fitted by ATS Euromaster. The model enhances our excellent relationship with Blackcircles, as well as expanding our presence in areas where we currently don’t have full retail centres.” In addition to tyre fitment, the new Lakeside Pit Stop has been set up for air conditioning re-charge, nitrogen tyre inflation and wheel alignment. Because the centre forms part of the ATS Euromaster network, every customer can be sure that their vehicle will receive expert attention from the safest tyre service provider in the country – underlined by its recent RoSPA Gold Award for health and safety, which it has now received for a third year running. The second Pit Stop site at Lakeside marks out plans for further expansion. Tye says: “The Pit Stop centres underline our commitment to making the customer journey as simple as possible. We wanted to offer our honest, open approach to tyre fitting to our customers at a location and time that suits them – without losing any of the precision, expertise or quality of service they have come to expect. As we proved with the Cambridge site, it’s an approach that works and I am certain Lakeside will also be a resounding success – paving the way for more centres in the future.” ends About ATS Euromaster Birmingham-based ATS Euromaster Ltd (http://www.atseuromaster.co.uk), part of the Euromaster Group (http://www.euromaster.com/), was established in 1965 and operates approximately 340 centres, more than 820 service vans and employs nearly 2,600 people, providing coverage across Great Britain. It is the country’s largest comprehensive tyre distributor, supplying tyres for cars, vans, trucks, buses/coaches, materials handling equipment, agricultural machinery and construction plant. The company’s expertise also extends to car and van service, maintenance and repair (SMR), including: menu-driven servicing, Class IV & Class VII MoT tests, brakes, batteries, shock absorbers, oil, exhausts, fault diagnostics and air-conditioning servicing. ATS Euromaster is accredited by both safecontractor (http://www.safecontractor.com/) and the Contractors Health and Safety Scheme (http://www.chas.co.uk/) (CHAS) and has been granted a Royal Warrant (http://www.royalwarrant.org/) as tyre specialists to Her Majesty The Queen. It is also an official ‘industry partner’ to the Freight Transport Association’s Van Excellence (http://www.vanexcellence.co.uk/) programme. For further information visit: http://www.atseuromaster.co.uk/business Note to editor: For press information visit ATS Euromaster’s online newsroom (http://news.cision.com/ats-euromaster) or contact James Boley on 020 8647 4467, or by email to james.boley@garnettkeeler.com. ATS/667/16

Grand slam at Pentawards for BillerudKorsnäs innovation and design agency NINE

The gold is awarded to a packaging concept for travel size organic beauty products, made by the extremely stretchable paper FibreForm from BillerudKorsnäs. This introduces a renewable material as an alternative to a product area today completely dominated by fossil materials. The bronze is awarded to a concept paper bottle for carbonated beverages, which is an ongoing innovation project within BillerudKorsnäs and an example of how the company is challenging conventional packaging for a sustainable future. - NINE works on the forefront of our packaging solutions offer with deep consumer insights and an ear to the market. It is a strength to BillerudKorsnäs to be in this position in the value chain and very pleasing that Pentawards once again confirms NINE’s ideas and innovative approach within our industry, says Henrik Essén, Senior Vice President Communication and Sustainability. BillerudKorsnäs has clear goals for sustainable and profitable growth, which in part is created by strengthening its position in the value chain. Therefore the company's sustainable materials are gradually and increasingly complemented with offering packaging solutions based on many years of expertise on packaging's role in society and their life cycle from manufacture to recycling. The orientation towards solutions is a natural development as new markets often demand comprehensive solutions when new materials are introduced.[Download photos] (http://images.billerudkorsnas.com/portals-public/pincollection.jspx?collectionName=%7be701ee57-d46c-4ea3-a2de-f285788b1e23%7d) [Caption:] Pentawards Gold: Renewable packaging for organic beauty products. Each origami-inspired container consists of a single sheet that is folded and pressed into shape, a tear-off corner reveals a wood twist cap. [Caption:] Pentawards BRONZE: What if carbonated drinks could be packaged in paper! BillerudKorsnäs challenges conventional packaging with new solutions and innovation projects. NINE is an innovation and design-oriented agency with clear focus on strategic business development and packaging design. BillerudKorsnäs is its principal owner. Its vast experience within fast moving consumer goods has given NINE an in-depth understanding of packaging innovation and a unique position in the market. www.nine.se

Updated interim phase IIa data demonstrate that the combination of simeprevir, odalasvir and AL-335 has a high level of efficacy in HCV patients

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that updated interim data from a phase IIa study being conducted by Alios BioPharma Inc., part of the Janssen Pharmaceutical Companies (Janssen), were presented on September 23rd at the European Association for the Study of the Liver (EASL) Special Conference in Paris, France. The updated results, which include expanded safety and efficacy data, were presented in the ePoster entitled "Short duration treatment with AL-335 and odalasvir (ODV), with or without simeprevir (SMV), in treatment naïve patients with hepatitis C virus (HCV) genotype (GT) 1 infection." The data show that 100 percent of patients receiving treatment for as short as six weeks with a triple combination of once-daily (QD) simeprevir 75mg and AL-335 800mg with 50mg every other day (QOD) of ODV achieved a sustained viral response 12 weeks after the completion of treatment (SVR12) as shown in the table below. +------+----------+---------+-----------+------------------+-------------------+|Cohort|Simeprevir|Odalasvir|AL-335 dose|Treatment Duration| Number (%) with ||# | dose | dose | (mg) | (weeks) | SVR12 or SVR24 || | (mg) | (mg) | | | |+------+----------+---------+-----------+------------------+-------------------+|1 | 100 QD | 50 QD | 400 QD | 8 |20/20 (100%), SVR24|+------+----------+---------+-----------+------------------+-------------------+|2 | -- | 50 QOD | 800 QD | 8 |18/20 (90%), SVR12 |+------+----------+---------+-----------+------------------+-------------------+|3 | 75 QD | 50 QOD | 800 QD | 8 |20/20 (100%), SVR12|+------+----------+---------+-----------+------------------+-------------------+|4 | 75 QD | 50 QOD | 800 QD | 6 |20/20 (100%), SVR12|+------+----------+---------+-----------+------------------+-------------------+ QD: every day; QOD: every other day; SVR: sustained virologic response. This study was designed to determine the safety, pharmacokinetics, and efficacy of different dosing regimens containing ODV and AL-335, with or without SMV, in treatment naïve patients with GT1 HCV infection for treatment durations of eight or six weeks. In all of these cohorts, the dosing regimens were generally well-tolerated. The majority of adverse events (AEs) were mild and the most commonly reported events were headache, fatigue, and upper respiratory tract infection. As previously reported in the abstract, there was one serious adverse event (SAE) in cohort 1 that resulted in premature discontinuation of all study drugs. This consisted of a Mobitz Type 1 2nd degree atrioventricular block and was deemed probably related to ODV and possibly related to AL-335 and simeprevir. The event was not associated with clinical or echocardiographic abnormalities, did not require any therapeutic intervention, resolved following treatment discontinuation, and the patient went on to achieve SVR24. No clinically significant laboratory, echocardiography, or ECG abnormalities (except the SAE) were reported.Selection of the triple combination for further developmentBased on the interim data from this study, the triple combination of simeprevir 75mg QD, odalasvir 25mg QD and AL-335 400mg QD has been selected for further development. The development program for the triple combination will include a multi-center, randomized, open-label study that will enroll treatment-naive and treatment-experienced non-cirrhotic patients chronically infected with hepatitis C virus genotypes 1, 2, 4, 5, and 6. In addition, the ongoing phase IIa study is assessing the triple combination in patients with or without compensated cirrhosis, and with HCV genotype 3 infection.Further information on these studies is available at www.clinicaltrials.gov with the reference numbers NCT02569710 and NCT02765490For further information, please contact:Ola Burmark, CFO Medivir AB, mobile: +46 (0) 725 480 580Richard Bethell, CSO Medivir AB, mobile +46 (0)72 704 3211Medivir is required under the Securities Markets Act to make the information in this press release public. The information was submitted for publication at 17.50 CET on 23rdSeptember 2016.About MedivirMedivir is a research based pharmaceutical company with a research focus on oncology and infectious diseases. We have a leading competence within protease inhibitor design and nucleotide/nucleoside science and we are dedicated to develop innovative pharmaceuticals that meet great unmet medical need. Our commercial organization provides a portfolio of specialty care pharmaceuticals on the Nordic market.Medivir is listed on the Nasdaq Stockholm Mid Cap List.

Citi to Launch Direct Custody and Clearing Services in Denmark

Reto Faber, head of Direct Custody and Clearing in EMEA for Citi, said: “The opening of Denmark DCC further expands Citi’s unique custody footprint as the largest provider of custody services in the region and globally. It also supports our ambition to provide custody services as a direct participant in all of the major T2S markets, thereby enabling clients to benefit from the consistency and connectivity of our integrated network.” Citi will partner with VP SECURITIES, a leading provider of securities and investor services in Denmark. VP is the central securities registration agent in Denmark and an approved CSD as stipulated by the Danish Securities Trading Act. Birger Schmidt, Chief Commercial Officer for VP SECURITIES, said: “We warmly welcome Citi as a direct market participant and look forward to collaborating with Citi in the Danish securities market alongside local and regional financial institutions. We expect that in the future even more key players in the global market will launch direct market access to the Danish market.” DCC plays an integral role in the capital markets by providing clearing and settlement services for the trading and investing activities of broker dealers as well as offering local market sub-custody services to banks and global custodians around the world. Andrew Man, Country Officer for Citi in Denmark, said: “Citi has a long-standing presence in Denmark; we have been here for over four decades. Denmark is a very important country for us and we recognise the opportunities for growth here. Our new DCC business compliments the existing wide range of products that we deliver on the ground. We are delighted to be providing this service to our international and local clients.” About Citi Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management. Additional information may be found at http://www.citigroup.com | Twitter: @Citi | YouTube: http://www.youtube.com/citi | Blog: http://new.citi.com | Facebook: http://www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi. Citi Media Contacts:  Anneli Sundström  +46 70 250 35 91Anneli.sundstrom@citi.com (mailto:) Aurelie Leonard     +44 (0)20 7500 4012     aurelie.leonard@citi.com

Arbitration panel’s partial award regarding the sale of Starman

The arbitration panel established in a partial award on 24 September 2016 that Polaris, in light of the parties’ respective actions, pursuant to the parties’ shareholders’ agreement in relation to Starman has not waived its pre-emption right. As announced on 14 March 2016, East Capital Explorer had agreed to sell its entire 63% interest in Starman Group to Providence Equity for an equity value of approximately EUR 81m, with the potential for an additional earn-out of up to EUR 5m payable in 2017. The transaction would represent an implied total enterprise value of approximately EUR 210m. The transaction was originally expected to be completed in the second quarter 2016. Due to the ongoing dispute related to Polaris’ right of first refusal and pre-emption right, it was on 30 June announced that the completion of the share transfer would be delayed until the third quarter. Today’s announcement means that the transaction will be further delayed. Contact information Mia Jurke, CEO, East Capital Explorer, +46 8 505 885 32 Lena Krauss, CFO and Head of Investor Relations, East Capital Explorer, +46 73 988 44 66 About East Capital Explorer  East Capital Explorer AB (publ) is a Swedish investment company, offering unique investment opportunities in Eastern Europe, where the Baltic countries represent the company’s largest investment region. The company primarily invests in unlisted assets within the private equity and real estate segments. East Capital Explorer’s main investment theme is domestic growth and the company targets fast growing sectors such as Retail and Consumer goods, Financials and Real Estate. East Capital Explorer is listed on Nasdaq Stockholm, Mid Cap. Listing: Nasdaq Stockholm, Mid Cap - Ticker: ECEX - ISIN: SE0002158568 -Reuters: ECEX.ST - Bloomberg: ECEX SS Equity This information is information that East Capital Explorer AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08:00 CET on 26 September 2016. 

Milan Zdravkovic joins Sobi as Senior Vice President, Head of Research & Development

Swedish Orphan Biovitrum AB (publ) (http://www.sobi.com/) (Sobi™) (STO: SOBI) today announced that Milan Zdravkovic has been appointed Senior Vice President, Head of Research & Development (R&D). Milan joins Sobi from Novo Nordisk where he has had an 18 year tenure in the Research and Development organisation responsible for therapeutic areas including diabetes, growth hormone deficiency, obesity and immunology. Milan’s experience spans early stage development to post-approval life-cycle management in these areas. His most recent role was as Corporate Vice President, Obesity. “We are delighted to welcome Milan to Sobi”, said Geoffrey McDonough, President and CEO at Sobi. “Milan brings a creative global translational and development profile which can build and expand upon our strong legacy of biologics innovation.” Milan will lead Sobi’s R&D efforts from post-proof of concept to late life cycle development, focusing on advancing and expanding Sobi’s early and mid-stage pipeline under a unified innovation strategy.  “I am looking forward to joining the team at Sobi and to advancing  Sobi’s mission to develop and deliver innovative therapies to people with rare diseases,” said Milan. Milan will join Sobi on 1 November 2016. - - - About Sobi™ Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2015, Sobi had total revenues of SEK 3.2 billion (USD 385 M) and about 700 employees. The share (STO: SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com. For more information please contact Media relations Investor relationsLinda Holmström, Sr Jörgen Winroth, ViceCommunications Manager  President, Head of Investor RelationsT: + 46 708 73 40 95, + 46   T: +1 347-224-0819, +1 2128 697 31 74            -579-0506, +46 8 697 2135linda.holmstrom@sobi.com    jorgen.winroth@sobi.com  The above information was released for public distribution on 26 September 2016, at 08:00 CET. 

Sino Agro Food Inc. Retains KCSA Strategic Communications as Investor Relations Counsel

September 26, 2016 GUANGZHOU, China-- Sino Agro Food, Inc. (OTCQX: SIAF | OSE: SIAF-ME), an agriculture technology and natural food company that produces and sells protein food including seafood and cattle, today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations program. KCSA intends to deploy a comprehensive investor relations campaign designed to increase awareness of Sino Agro Food among the investment community through a comprehensive shareholder communications strategy. KCSA’s objectives include, among others, increased reporting on the Company’s strategic milestones and the hosting of institutional investor roadshows. Since KCSA’s inception over forty years ago, the firm has developed a strong reputation for its work representing public companies. Todd Fromer, Managing Partner of KCSA, will lead the KCSA team and provide strategic counsel on financial communication matters.  "We are excited to begin working with KCSA Strategic Communications to enhance our shareholder communications program and generate greater investor awareness for Sino Agro Food as we enter an inflection point in the Company’s development," said Solomon Lee, Sino Agro Food’s Founder, Chairman and Chief Executive Officer. "We are currently implementing a multi-pronged long term strategy to maximize shareholder value, including the restructuring and carve-out of our fast-growth aquaculture business segment into a stand-alone entity, and the carve-out of our beef operations segment. We believe this strategic plan will enable each of our business segments to realize their true value, thereby maximizing shareholder returns for our U.S., Nordic and Asia-Pacific investors. KCSA has decades of experience advising fast-growing public companies on how to optimize the impact of strategic milestones as they progress through their growth strategies; we are confident that working with them to maximize our exposure to Wall Street at this time will be greatly advantageous during this process.” Todd Fromer, Managing Partner of KCSA Strategic Communications, commented, “With its ongoing construction of the world’s largest recirculating aquaculture (farm) system (“RAS”), its shift toward offering higher-margin, premium quality food items, and with an established track record, Sino Agro Food is extremely well-positioned to address the ramp-up in demand for seafood and beef occurring in China. We are pleased to implement a communications plan based on best practices to provide strategic counsel to Sino Agro Food and help the Company tell its story clearly and effectively to both existing and potential shareholders as it executes on its strategic plan.” For more information about KCSA Strategic Communications, a leading, NYC-based communications firm, please visit www.kcsa.com

Changes in Stora Enso’s Group Leadership Team

Stora Enso’s current EVP Human Resources Lars Häggström has decided to leave the company. After heading Stora Enso’s Human Resources for six years, he will take up the position of Executive in Residence at the Swiss-based business school IMD. Malin Bendz, currently SVP Human Resources in Stora Enso’s Paper division, will be appointed as EVP Human Resources and member of the Group Leadership Team as of 1 November 2016. She has been with Stora Enso since year 2000, working in international human resources positions while being based in Sweden and Brazil. Furthermore, she has also worked in business development and purchasing. She holds a BSc degree in Personnel Management & Organisational Development and an MBA degree. Malin Bendz will be based in Stockholm. “I am very happy to welcome Malin to our Group Leadership Team. With her extensive and diverse experience in the field of human resources, she will bring valuable insights to our business as we develop into a renewable materials growth company,” says Stora Enso’s CEO Karl-Henrik Sundström. “I would also like to thank Lars for his work in developing our human resources, especially in taking our leadership culture to a new level. I wish him all the best as he moves on to new challenges.” A photo of Malin Bendz is available at: http://bmt.storaenso.com/l/JW2BkXv8SC8Z For further information, please contact:Ulrika Lilja, EVP Communications, tel. +46 1046 71668 Investor enquiries:Ulla Paajanen-Sainio, SVP, Investor Relations, tel. +358 40 763 8767Stora Enso is a leading provider of renewable solutions in packaging, biomaterials, wooden constructions and paper on global markets. Our aim is to replace fossil based materials by innovating and developing new products and services based on wood and other renewable materials. We employ some 26 000 people in more than 35 countries, and our sales in 2015 were EUR 10.0 billion. Stora Enso shares are listed on Nasdaq Helsinki (STEAV, STERV) and Nasdaq Stockholm (STE A, STE R). In addition, the shares are traded in the USA as ADRs (SEOAY) on the International OTCQX over-the-counter market. storaenso.com (http://www.storaenso.com/)  STORA ENSO OYJ

The Marketing Group Acquires TDA GROUP And Addiction Advertising Increasing The Group’s EPS And EBITDA

•    EBITDA per share forecast to increase to 36.52 cents in 2016*.•    Total EBITDA forecast to increase to €12,486,392 in 2016*.•    Number of new ordinary shares created is 2,962,085.•    Wholly owned subsidiaries now total 19.•    Total number of employees increase to 533.*Based on a pro forma forecast of the whole group of 19 companies for 2016.Stockholm, September 26th, 2016 – THE MARKETING GROUP PLC (“the Group”), the world’s leading digital marketing and advertising agglomeration, announces the strategic acquisition of TDA Group and Addiction Advertising, strengthening its digital marketing and advertising capabilities in the US and Singapore. The acquisitions continue the Group’s expansion strategy to add profitable, debt-free and well-managed private businesses that enhance its suite of digital services in key markets.The two companies were incorporated through the special purpose holding company Rinnik Group. The transaction was completed at a strike price of EUR 4.22 per share (based on a 10-day volume weighted average price). This requires the creation of 2,962,085 new ordinary shares, such that the total number of Ordinary shares issued by The Marketing Group has increased from 31,223,827 to 34,185,912.The acquisitions bring the total number of portfolio businesses within The Marketing Group to 19. Together these businesses have 32 offices in 8 countries, serving clients across the USA, Europe, Asia, Australia and New Zealand.The new subsidiary businesses added to The Marketing Group are:1.    TDA Group LLC, established in 1986 and based in Silicon Valley, is a B2B marketing and advertising agency for the US high-tech industry. It plans, creates and manages content marketing programs for clients including IBM, Intel, Dell and Lenovo. It has 25 employees. For more information, visit the Company’s website at www.tdagroup.com.2.    Addiction Advertising Pte. Ltd., established in 2011 and based in Singapore, is an advertising agency serving public and private sector clients including the Monetary Authority of Singapore, the Singapore Building and Construction Authority, Standard Chartered Bank, OCBC Bank and China Life Insurance. It has 11 employees. For more information, visit the Company’s website at www.addictionadvertising.com.  The acquired businesses will retain their own unique brands while benefitting from the scale, global reach and access to new products and services that come with being part of The Marketing Group’s global network. Collaborations and partnerships between portfolio businesses will lead to new client relationships, help to attract new business opportunities and offer the potential for significant cost synergies.Jeremy Harbour, Executive Chairman, The Marketing Group plc comments: “We are delighted to add TDA Group and Addiction Advertising to The Marketing Group’s portfolio of businesses. Each brings valuable talent and expertise that complement our existing service offering and help to further strengthen our positions in the US and Singapore. Going forwards, we continue to identify and execute further accretive acquisitions that create value for our shareholders and support our ambition to build a global business, offering clients a full spectrum of digital services.”Financials*EBITDA (The Marketing Group) for year ending 2016    €11,064,384EBITDA (Rinnik) for year ending 2016    €1,422,008Post Acquisition EBITDA    €12,486,392Current Earnings per Share    35.45cEarnings per Share post acquisition    36.52c% EBITDA Increase    12.85%% Share cap Increase    9.49%% Earnings Per Share Increase    3.03%* Based on a pro forma forecast for the whole group of 19 companies for 2016. Rinnik Ltd Headline Financials    2015    2015    2016E    2016ECompany    T/O    EBITDA    T/O    EBITDAAddiction Advertising    €1,300,513    €233,239    €2,964,565    €790,406TDA Group    €3,866,869    €826,664    €3,476,311    €631,601Total    €5,167,382    €1,059,902    €6,440,876    €1,422,008Jeremy Harbour will be conducting an Investor Video Call regarding this press release on the 27th September 2016, 9AM CET. Kindly join the call with the following link: https://zoom.us/j/985562612For more information, please contactHannah Middleton, Director and Communications DirectorPhone: +65 8193 7625E-mail: hannah.middleton@marketinggroupplc.comMalcolm Robertson / Tom EvrardPhone: +65 6831 7829 / 6831 7801E-mail: unitygroup@fticonsulting.comThis information is information that The Marketing Group plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8am CET on 26th of September 2016.The Marketing Group in briefThe Marketing Group plc is a global marketing and advertising company that brings together a portfolio of successful and independent digital marketing businesses, each offering unique and complementary products and services. Together these businesses make up a global network offering a full suite of digital marketing and advertising services. The consolidated group supports its subsidiaries with management and coordinating activities as well as a common operating platform. The Marketing Group was incorporated in May 2015 and listed on Nasdaq First North Stockholm on 8 June 2016. Mangold Fondkommission AB, +46 8-5030 15 50, is the Company’s Certified Adviser and liquidity provider.For more information, please visit the Company’s website www.marketinggroupplc.com.

Husqvarna AB’s Nomination Committee for the 2017 Annual General Meeting

In accordance with the decision by Husqvarna’s Annual General Meeting (“AGM”) on April 6, 2016, the members of the Nomination Committee for the 2017 AGM are to be appointed by the four largest shareholders in terms of voting rights in the company as of the last banking day in August, August 31, 2016, who have expressed a wish to participate in the nomination committee work. In addition, the Nomination Committee shall also include the Chairman of the Husqvarna Board. On August 31, 2016, the four largest shareholders in terms of voting rights were Investor AB, L E Lundbergföretagen AB, If Skadeförsäkring AB and Didner & Gerge Fonder AB. Each has appointed one member, as shown below, who will form Husqvarna’s Nomination Committee together with the Chairman of the Husqvarna Board. The Nomination Committee’s members:Petra Hedengran (Chairman), Investor ABClaes Boustedt, L E Lundbergföretagen ABRicard Wennerklint, If Skadeförsäkring ABHenrik Didner, Didner & Gerge Fonder ABTom Johnstone, Chairman of Husqvarna AB The Nomination Committee will prepare proposals for the AGM in 2017, including proposals for the Chairman of the AGM, Board members, Chairman of the Board, remuneration for Board members, fees to the auditors, and to the extent deemed necessary, the tasks and composition of the Nomination Committee for the AGM in 2018. The AGM of Husqvarna AB (publ) will be held in Jönköping, Sweden on April 4, 2017. Shareholders who wish to submit proposals to the Nomination Committee may do so by email to nominationcommittee@husqvarnagroup.com if possible by February 7, 2017.

Alprolix® obtains reimbursement across the United Kingdom

Swedish Orphan Biovitrum AB (publ) (Sobi™) (http://www.sobi.com/) today announces that the company’s product Alprolix® (eftrenonacog alfa), a recombinant human factor IX Fc-fusion protein with extended half-life for the treatment of haemophilia B, has now been approved for reimbursement across the UK. National Health Service (NHS) England has confirmed reimbursement alongside Scotland, Wales and Northern Ireland where Alprolix is already reimbursed. Alprolix is also approved for reimbursement in Germany and the Netherlands. This expansion of availability in the UK is supported by global experience. With more than two years of post-authorisation real-world experience with Alprolix, more than 1,000 patients have been treated in countries where Alprolix is commercially available, corresponding to approximately 1,100 patient-years of experience. “Securing reimbursement for Alprolix across the UK, relatively soon after EU marketing authorisation approval is an important milestone toward making this new development in haemophilia B therapy available to people and families living with haemophilia B,” said Neil Dugdale, General Manager UK & Republic of Ireland at Sobi. Alprolix was first approved for the treatment of Haemophilia B in the USA in March 2014 and in the EU in May 2016. ----------------- About haemophilia B Haemophilia B is a rare, genetic disorder in which the ability of a person's blood to clot is impaired. Haemophilia B occurs in about one in 25,000 male births annually, and more rarely in females. Worldwide, it is estimated that more than 70,000 people are living with haemophilia. People with haemophilia B experience prolonged bleeding episodes that can cause pain, irreversible joint damage and life-threatening haemorrhages. Prophylactic infusions of factor IX can temporarily replace the clotting factor that is needed to control bleeding and prevent new bleeding episodes.[i] (http://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/044_Alprolix%20reimbursement%20UK/04Xe_Alprolix%20reimbursement%20UK_final.docx#_edn1) The World Federation of Hemophilia recommends prophylaxis as the optimal therapy as it can prevent bleedings and joint destruction.[ii] (http://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/044_Alprolix%20reimbursement%20UK/04Xe_Alprolix%20reimbursement%20UK_final.docx#_edn2) About Alprolix®Alprolix® (eftrenonacog alfa) is a recombinant clotting factor therapy developed for haemophilia B by fusing factor IX to the Fc portion of immunoglobulin G subclass 1, or IgG1 (a protein commonly found in the body). This enables Alprolix to use a naturally occurring pathway to prolong the time the therapy remains in the body. While Fc fusion technology has been used for more than 15 years, Sobi and Biogen are the first companies to utilise it in the treatment of haemophilia. Alprolix is currently approved for the treatment of haemophilia B in the European Union as well as Iceland, Liechtenstein Norway, the US, Canada, Japan, Australia and New Zealand. As with any factor replacement therapy, allergic-type hypersensitivity reactions and development of inhibitors may occur following administration of Alprolix. About Sobi™Sobi is an international specialty healthcare company dedicated to rare diseases. Sobi’s mission is to develop and deliver innovative therapies and services to improve the lives of patients. The product portfolio is primarily focused on Haemophilia, Inflammation and Genetic diseases. Sobi also markets a portfolio of specialty and rare disease products across Europe, the Middle East, North Africa and Russia for partner companies. Sobi is a pioneer in biotechnology with world-class capabilities in protein biochemistry and biologics manufacturing. In 2015, Sobi had total revenues of SEK 3.2 billion (USD 385 M) and about 700 employees. The share (STO: SOBI) is listed on Nasdaq Stockholm. More information is available at www.sobi.com. About the Sobi and Biogen CollaborationSobi and Biogen collaborate on the development and commercialisation of the haemophilia products Elocta and Alprolix. Sobi has final development and commercialisation rights in the Sobi territory (essentially Europe, North Africa, Russia and most Middle Eastern markets). Biogen has manufacturing responsibility for Eloctate® and Alprolix® and has final development and commercialisation rights in North America and all other regions in the world excluding the Sobi territory. For more information please contact Media relations Investor relationsLinda Holmström, Senior Jörgen Winroth, Vice President Head of InvestorCommunications Manager RelationsT: + 46 708 73 40 95, + T: +1 347-224-0819, +1 212-579-0506, +46 8 69746 8 2135697 31 74                       linda.holmstrom@sobi.com  jorgen.winroth@sobi.com (jorgen.winroth@sobi.com)           ---------------------------------------------------------------------- [i] (http://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/044_Alprolix%20reimbursement%20UK/04Xe_Alprolix%20reimbursement%20UK_final.docx#_ednref1) World Federation of Hemophilia. About Bleeding Disorders – Frequently Asked Questions. Available at: http://www.wfh.org/en/page.aspx?pid=637#Difference_A_B. Accessed on: June 17, 2016. [ii] (http://teamsites.sobi.com/s/corporate-communications/Shared%20Documents/Press%20releases/044_Alprolix%20reimbursement%20UK/04Xe_Alprolix%20reimbursement%20UK_final.docx#_ednref2) Guideline for the management of hemophilia, World Federation of Hemophilia, 2nd edition, http://www1.wfh.org/publication/files/pdf-1472.pdf. Accessed in December 2015

Skanska builds Nedre Otta power plant in Norway for NOK 657M, about SEK 650M

The hydropower project involves about 12 000 meters of tunnel work, construction of the power station and transformer hall in the mountain and concrete work around the intake, power plant area, outflow and portal. Nedre Otta power plant will use the existing intake dam at Eidefossen power plant. The water will travel through tunnel from the intake to the new power plant. It will have an installed capacity of 85 MW and the annual production from the plant will be about 315 GWh, equivalent to the consumption of around 15,000 households. Of all current hydropower projects in Norway Nedre Otta will become the power plant that will contribute most to achieving the climate targets 2020. Since the existing dam at Eidefossen will be used as intake and the powerplant is mainly built in the mountain, the impact of nature will be limited. It will also be ensured that the practice of rafting, canoeing and fishing basically can continue as before in the area during summer. The construction work will commence in October 2016 and the project will be completed in the spring in 2020. Skanska Norway focuses on construction and civil engineering operations. The unit has approximately 4,000 employees. In 2015, Skanska Norway reported revenue of about SEK 12 billion. In Norway, Skanska is also active in development of residential, commercial properties and public private partnerships (PPP) projects.

Changes in Gjensidige’s Group management

- We will further strengthen our efforts to deliver the best digital customer experiences in the Nordic general insurance industry. At the same time, we intend to increase our presence in the growing market for health and personal insurance, says CEO Helge Leiro Baastad. -  We must constantly make sure that we run our operation as efficiently as possible, and we will now reduce costs in certain areas to make room for investments in technology, brand and skills to strengthen Gjensidige’s position going forward, Baastad says. Jostein Amdal will take over as CFO after Catharina Hellerud, who will continue as executive vice president, now with responsibility for Analytics, Product and Price. Amdal has been head of capital management and M&A for the past two years, and was previously head of Group risk. Martin Danielsen will leave the Group management to head Gjensidige’s strategic initiatives within data mining and analytics, reporting to Hellerud. Krister Aanesen will assume the role as acting executive vice president with responsibility for the Private segment during Hege Yli Melhus Ask’s parental leave. Aanesen has been in charge of performance management in the Private segment for the past year and previously managed Gjensidige’s motor insurance department. During 2017, Gjensidige will reduce the number of employees by about 190 full-time equivalents within staff and support functions across the Group. A non-recurring provision of about NOK 120 million will be made in the third quarter 2016 to cover restructuring costs. - We hope to avoid lay-offs by offering voluntary solutions to employees, Baastad says. From 1 October 2016, Gjensidige’s Group management will consist of: · Helge Leiro Baastad, CEO · Jostein Amdal, CFO · Sigurd Austin, EVP Claims · Cecilie Ditlev-Simonsen, EVP Brand and Communications · Mats C. Gottschalk, EVP Commercial · Catharina Hellerud, EVP, Analytics, Product and Price · Jørgen Ringdal, EVP Group Staff and General Services · Kim Rud-Petersen, EVP Nordic · Kaare Østgaard, EVP Technology and Development · Krister Aanesen, EVP (acting) Private (while Hege Yli Melhus Ask is on parental leave) This information is subject to disclosure under the Norwegian Securities Act section §5-12. MediaØystein Thoresen. Tel.: 47 952 33 382Investor RelationsJanne Merete Flessum Tel.: 47 915 14 739Katharina Helena Hesbø Tel.: 47 993 62 804

Forestry is becoming increasingly digitised

In 2012, Södra launched the forest owner’s app. Four years after the launch, there has been a drastic increase in number of users, services and volume of forest data in the app. While initially only property borders could be viewed, forest owners can now track ongoing forestry assignments in real time, and, in principle, manage their own forests through a green forestry plan directly in the app. “The digital technology represents an enormous development, both for forest owners and for us,” says Håkan Larsson, President of the Södra Skog business area. “We have improved overview and the ability to make better decisions while contributing to both increased production and improved nature conservation.” Laser scanning reveals watercoursesThe most recent step in Södra’s development of digital forestry was taken last summer, when the “water map” was launched as a feature of the forest owner’s app. The service enables both forest owners and contractors to make calculations from laser scans to obtain a map sheet that indicates where the ground is wet or humid. This provides increased protection from driving injuries while undertaking forestry assignments that require heavy machinery. In June, Södra launched its most recent app, the contractor’s app. Continuous access to up-to-date information provides Södra’s contractors with more opportunities to improve the efficiency and precision of the assignments they carry out daily. As with the forest owner’s app, the number of users has been increasing steadily since its launch. For comments: Håkan Larsson, President of the Södra Skog business areaTel: +46 (0)470-159 81 Södra’s PressroomTel: +46 (0)470-890 90

Mevion and RaySearch extend collaboration to support RayCare oncology information system and HYPERSCAN Adaptive Aperture advanced IMPT capabilities

RaySearch and Mevion Medical Systems, two leaders in the field of technology for proton therapy, are extending their collaboration agreement to support the RayCare® oncology information system (OIS), which is currently in development at RaySearch, and to take full advantage of the advanced treatment capabilities of the MEVION S250i with HYPERSCAN and Adaptive Aperture. The agreement was announced at the 58th annual meeting of the American Society for Radiation Oncology (ASTRO) in Boston. RayCare is the next-generation OIS, developed from the ground up by RaySearch to support the complex logistical challenges in modern, large-scale radiation therapy centers. RayCare integrates the high-performance radiation therapy algorithms available in RayStation® and adds advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy. The system is expected to be released in 2017. Adaptive Aperture is a proprietary low-profile micro-multileaf collimator system designed specifically for HYPERSCAN pencil beam scanning. Its unique layer-by-layer beam collimation and blocking achieves unprecedented one to three millimeter collimated spot sizes, for all energies, at any depth. Under the agreement, RaySearch will develop planning capabilities to support the layer-by-layer collimation of Adaptive Aperture.  Previous collaboration between RaySearch and Mevion has led to impressive results at Mevion customer sites, such as Ackerman Cancer Center (ACC) in Jacksonville, Florida. ACC commissioned RayStation for its MEVION S250 in just two weeks, achieving the fastest clinical ramp-up in proton therapy history. The center is now treating more than 40 patients per day in a single proton therapy room. Townsend Zwart, Senior Director of Advanced Development at Mevion Medical Systems, says: “Adaptive Aperture is ideal for intensity modulated proton therapy (IMPT) because it creates the sharpest penumbra physically achievable without the need for manual apertures and adjustments. We are excited to extend our relationship with RaySearch to help radiation oncologists make the most of this advanced technology.” Johan Löf, CEO of RaySearch, says: “Partnering with Mevion, the market leader in compact proton therapy systems, enables us to provide cancer centers with a complete turnkey solution to deliver the world’s most advanced proton therapy treatment.” More information about the collaboration between RaySearch and Mevion is available at the RaySearch booth (#12012) and the Mevion booth (#10031) in the ASTRO exhibit hall. RayCare and the MEVION S250i Proton Therapy System with HYPERSCAN with Adaptive Aperture are not yet FDA cleared.

Castellum invests SEKm 222

“This means that we will strengthen our position in Smista - an area which the last fifteen years developed into Stockholm's main cluster for car sales”, says Henrik Saxborn, Castellum's CEO, in a summary comment. One investment, which involves a new property for the expanding Hedin Bil, refers to the a new construction of approx. 12,500 sq.m. of which 5,500 sq.m. will be premises for car dealership and 7,000 sq.m. garage. The investment is calculated to SEKm 162, of which SEKm 14 refers to own land. The new building is expected to be completed during the fourth quarter of 2017 and implemented in accordance with environmental certification system Miljöbyggnad, with the ambition to reach the Silver level. A 15-year lease has been signed with Hedin Bil with an annual rental value of SEKm 13.5.The second investment refers to a new construction of approx. 6,900 sq.m. for the tenant Veho Bil´s expansion, where 2,200 sq.m. are premises for a car dealership and the residue for a garage. The investment is calculated to SEKm 60, of which SEKm 1 refers to own land, and to be completed during the third quarter of 2017. The new construction is carried out according to the environmental certification system Miljöbyggnad with the ambition to reach the Silver level. A 10-year lease has been signed with Veho Bil with an annual rental value of SEKm 5.8.Castellum has unutilized credit facilities of approx. SEK 8 billion, which will be used for investments. This information is information that Castellum is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 9.15 am CET on September 26, 2016.  For additional information, please contact:Henrik Saxborn, verkställande direktör Castellum, 031-60 74 50Ulrika Danielsson, ekonomi- och finansdirektör Castellum, 0706-47 12 61 www.castellum.se Castellum is one of the major listed real estate companies in Sweden. The fair value of the real estate portfolio amounts to approx. SEK 72 billion, and comprises of commercial properties for office, retail, warehouse and industrial with a total lettable area of approx. 4.7 million sq.m. Castellum own and manage properties through one common brand in five geographical regions with strong local presence. The five geographical regions are: Central, North, Stockholm, West and Öresund. In 2016, Castellum sustainability performance was awarded two top distinctions: First Prize for sustainability reporting in Europe from EPRA and Global Sector Leader, handed out by GRESB which means that Castellum is ranked first in the world within the office- and industrial-properties sector. Further Castellum has been selected as an index component of the Dow Jones Sustainability Indices (DJSI), which includes the companies in all industries in the world with best performance in terms of sustainability. The Castellum share is listed on Nasdaq Stockholm Large Cap. Castellum AB (publ), Box 2269, SE-403 14 Gothenburg | Org nr/Corp Id no SE 556475-5550 | Phone +46 31 60 74 00 Fax +46 31 13 17 55

Coor extends contract with The Swedish Transport Administration

 The Swedish Transport Administration is an authority responsible for road, rail, maritime and air traffic. Coor has been collaborating with the Administration since 2012, which announced that Coor has been granted a new four-year contract with a further two-year extension option, after a public tendering process. The contract consists of a subscription volume plus the option of supplementary project volumes, with an estimated total value of SEK 100 m per year. “We’re pleased about this decision, which we won after a public procurement process. The Swedish Transport Administration is an important customer. Over the years, we’ve worked hard to satisfy its high standards of quality, service mindedness and efficiency. We’ve created good management and collaboration jointly with the Administration, and we’re looking forward to our ongoing mission of continuing to develop our delivery in partnership with them,” commented Klas Elmberg, Executive Vice President of Coor Sweden. The assignment is an IFM (integrated facility management) deal, including services such as cleaning, mail, workspace planning and care, reception services and hot beverages. “Coor is the Nordic market leader in IFM solutions. We are convinced that there is also great potential to identify effective and innovative IFM solutions in the public sector, where these assignments are still fairly uncommon. Apart from The Swedish Transport Administration, we also currently deliver integrated service solutions to among others the NKS teaching hospital and Danish Police Service, which we’re really proud of,” commented Mikael Stöhr, Coor’s CEO and President. A customary contract restriction applies for ten days after the award decision. For more information, images etc., please visit www.coor.com or contact: Mikael Stöhr, President and CEO, Coor Group, +46 10 559 59 35, mikael.stohr@coor.com Klas Elmerg, Excecutive vice President, Coor in Sweden, +46 10 559 59 35, klas.elmberg@coor.com Åsvor Brynnel, Communications and Sustainability Director, +46 10 559 54 04, asvor.brynnel@coor.com This information is information that Coor Service Management Holding AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at September, 26, 2016, at 09:30 CET.

Zlatan Ibrahimovic’s sportswear brand is coming to Poland.

”A-Z sportswear is made for training, all kinds of training. And you don’t need a lot of gear to train hard. All you really need is one t-shirt, one pair of shorts, one pair of shoes. And then it’s up to you. With a strong mindset you can accomplish anything you want.”   - Zlatan Ibrahimovic. This June, Zlatan Ibrahimovic launched his sportswear brand A-Z, a brand with one mission - to make it possible for anyone to play sports. Some weeks later, he announced his next destination as a football player, making Manchester United his new home. His successful start on the field is already paying off for sportswear brand A-Z. In territories such as the UK and Scandinavia sales are booming. Now, the brand is taking on new challenges and expanding to 10 new markets, being made available in a total of 21 markets - only three months prior to its launch. ”We’re only in the beginning of our journey and we’re learning new things every day. It’s about not letting success slow you down and always staying on your feet.”  - Knut-Erik Kollberg, CEO Varner Ibrahimovic AB. ”It’s great to see how people are appreciating our products and training in our gear. We've received so much positive feedback from our customers and we know that there are a lot of them out there waiting for A-Z to drop in their territories. For some of them, the wait is finally over.”  - Jens Bonesmo, CMO Varner Ibrahimovic AB. A-Z provides sportswear targeted at all types of training, and is now coming to Poland, available at a-z.com. The brand initially launched in 11 European markets: Sweden, Norway, Finland, Denmark, Germany, The Netherlands, France, United Kingdom, Austria, Spain, and Italy. On September 28th, A-Z will be made available in 10 more markets across Europe. These include: Poland, Belgium, Greece, Romania, Hungary, The Czech Republic, Ireland, Croatia, Portugal and Bulgaria. Today, Polish fans can sign up at http://bit.ly/2cqHoTW, for a chance to win the very first A-Z kit in their country (worth €227.75). The winner will be the first ever in the country with A-Z products. Accompanying the launch A-Z are releasing a new logo tee, along with new photos of Zlatan training in the tee. View the material here: http://bit.ly/2cWw4TG. Lookbook and press material available at http://bit.ly/2ct8aA7 (Password: innervoice). For press inquiries please contact a-z@borglundell.se.

Scania takes lean production efficiency into mining

With mine operators around the world facing overcapacity and low commodity prices, their need for ‘lean’ efficiency measures is becoming crucial. Now Scania, which has more than doubled its output per employee in production over the last twenty years, can bring its experience of lean production in truck manufacturing to the mining sector.  “Scania Site Optimisation is a framework of tools and methods which identifies inefficiencies in logistical flows,” explains Björn Winblad, Head of Scania Mining. “We are able to find and target bottlenecks in those flows using information relayed to us from communication units in each vehicle. That helps us map the flow in the mine – such as where the trucks load and unload – and provide us with data that we can analyse.” “Based on our analysis, we can provide the customer with a choice of services, products and actions to help them improve efficiency. We believe that Scania Site Optimisation could have a huge positive impact on a mining operator’s bottom line.” A truly holistic approach Scania Site Optimisation measures and evaluates production performance factors in five aspects, all of which are issues commonly faced by the mining industry: · Time (e.g. cycle time, uptime, queues of trucks, etc.) · Road (e.g.  route design, maintenance issues, etc.) · Load (e.g. equipment matching, overloading, spilling, etc.) · Safety (e.g. overspeeding, etc.) · Sustainability (e.g. fuel consumption, emissions, etc.). Customers can then choose from a full range of solutions according to their individual needs, whether it be data reporting, advisory services, improvement services, or even the outsourcing of the management of parts of their whole transport operation to Scania. “We are leading the way with this holistic approach,” says Winblad. “And we can also use our expertise and smart solutions from other industries, such as long haulage transport or bus transport, and apply them in mining. The services that Scania Site Optimisation can incorporate are all individually tried and tested modules that already exist.” Launching at MINExpo, but proof of concept already achieved Scania Site Optimisation is being unveiled during MINExpo, the world’s largest mining and equipment exhibition, which is held every four years in Las Vegas. The 2016 MINExpo will take place 26–28 September. Scania has been trialling this new concept for the past couple of years at various sites around the world, and customers have discovered its potential for efficiency improvements. For additional information, please contact: Björn Winblad, Head of Scania Mining, tel +46 70 666 1046 e-mail: bjorn.winblad@scania.com

Iveco Stralis Hi-Street fleet delivers for North West Roofing Supplies

Basildon, September 26, 2016 North West Roofing Supplies is expanding its fleet with two new Iveco Stralis Hi-Street trucks, featuring the manufacturer’s patented HI-SCR engine technology, after reporting “complete satisfaction” with a seed Stralis acquired in 2014. The two 26-tonne 6x2 Stralis Hi-Street rigids both feature a plant body, an Atlas 165.2A2 crane and a lifting and rear-steering axle, providing increased manoeuvrability for the company’s delivery operations in congested urban environments. Supplied by Iveco dealership Walton Summit Truck Centre, the first of the company’s new acquisitions has entered service, with the second due for delivery in December. The two new trucks are being supplied on a five-year Iveco Elements repair and maintenance package, and finished in the company’s distinctive, bright orange livery. North West Roofing Supplies’ Managing Director, Stephen Phillips, says: “We first decided to trial an Iveco in 2014, after speaking to another operator that recommended the Hi-Street for our line of work. We took on a similar 26-tonne rigid from another manufacturer at the same time, and found the Iveco quickly surpassing its competitor in terms of on-the-job reliability. The drivers love the truck, and we’re completely satisfied – the Hi-Street is ideal.” Phillips adds: “We’ve come to really appreciate the vehicle’s 18.8-tonne payload capacity – which is very competitive given our body and crane combination. It means we can collect from our suppliers just once per day in the morning, and spend the rest of the day delivering what our customers ordered.” The two new Stralis trucks (AD260S31Y/PS) join a fleet of nine 26-tonne rigids, and will be in operation six days per week. The pair are expected to clock up 50,000 miles each, annually, and remain part of the company’s fleet for the next five to seven years. Both trucks are powered by the Iveco Cursor 9 engine, which produces up to 310 hp between 1,675 and 2,400 rev/min, and up to 1,300 Nm of torque between 1,200 and 1,675 rev/min. The vehicles also benefit from the proven EuroTronic fully-automated gearbox, manufactured for Iveco by ZF. The Cursor engine stands out for featuring Iveco’s HI-SCR technology, which meets the stringent Euro VI emissions limits. This means vehicle productivity is increased, as Iveco’s HI-SCR system requires neither driver involvement nor downtime from active regeneration. Also, no fuel is utilised to burn particulates and no energy is lost to cool down exhaust gases. The simpler technology is also lighter than Euro VI engines from other manufacturers – contributing to the vehicle’s payload advantage. Established in St Helens in 2001, North West Roofing Supplies has since expanded across the region, opening branches in St Annes, Manchester and most recently Morecambe – sites from which its fleet transports everything from slate and tiles to windows and skylights. Iveco Iveco is a brand of CNH Industrial N.V., a World leader in Capital Goods listed on the New York Stock Exchange (NYSE: CNHI) and on the Mercato Telematico Azionario of the Borsa Italiana (MI: CNHI). Iveco designs, manufactures and markets a wide range of light, medium and heavy commercial vehicles, off-road trucks, and vehicles for applications such as off-road missions. The brand’s wide range of products include the Daily, a vehicle that covers the 3 – 7 tonne vehicle weight segment, the Eurocargo from 6 – 19 tonnes, the Trakker (dedicated to off-road missions) and the Stralis, both over 16 tonnes. In addition, the Iveco Astra brand builds off-road trucks, rigid and articulated dumpers as well as special vehicles. Iveco employs close to 21,000 individuals globally. It manages production sites in 7 countries throughout Europe, Asia, Africa, Oceania and Latin America where it produces vehicles featuring the latest advanced technologies. 4,200 sales and service outlets in over 160 countries guarantee technical support wherever an Iveco vehicle is at work. To download supporting imagery: http://news.cision.com/ivecoFor further information about Iveco: www.iveco.comFor further information about the Iveco dealer network: http://www.iveco-dealership.co.uk  For further information about CNH Industrial: www.cnhindustrial.com For more information contact: Lisa Fuller, Brand Marketing and Communications ManagerIveco Ltd  Tel. +44 (0)7740 448110  lisa.fuller@iveco.com  www.iveco.co.uk  2683/16 ref : IVECO 16042

YIT revalues the book values of its asset in the Housing Russia segment and books a cost of EUR 27 million

YIT is completing its three-year capital release program where it has succeeded to release capital by approximately EUR 340 million from different assets in order to strengthen its balance sheet. Compared to the initial target, approximately EUR 45 million of assets classified as slow-moving, located mainly in Russia, are yet to be released. The company estimates that constructing projects on these plots or selling the assets profitably with their current value is not possible in the near future. Thus, the company recognises approximately a EUR 18 million impairment charge related to these plots. At the same time, YIT has decided that the primary method of divestment of these plots is to sell the plots.  Additionally, YIT books a cost of approximately EUR 9 million to the book value of four plots located in Moscow region so that their value relates to the current dialog with the authorities. These plots are not included in the capital release program. The building permits have not been granted in past three years due to the changes in regulatory requirements and conflicts in the investment requirements compared to the initial investment requirements. YIT has attempted to negotiate compromises that would be acceptable for both parties for the past three years. There has been progress in negotiations but the final agreement to the matters is still missing.   The booked cost totals approximately EUR 27 million, and will be recorded in the third quarter results that will be published on October 27, 2016. The cost represents approximately 7 per cent of the company’s Housing Russia segment’s operative invested capital at the end of the second quarter of 2016. YIT aims to achieve positive adjusted operating profit in the second half of the year for the Housing Russia segment, and according to company’s estimate, adjusted operating profit will be around zero already in the third quarter of the year. The company announced in the second quarter interim report that it aims at positive operating result for the second half of the year. The booked costs do not have an impact on YIT’s guidance for 2016 on revenue growth and adjusted operating profit.    For additional information, please contact: Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fiKari Kauniskangas, President and CEO, YIT Corporation, tel. +358 040 570 1313, kari.kauniskangas@yit.fi  YIT CORPORATION Hanna JaakkolaVice President, Investor Relations  Distribution: NASDAQ Helsinki, major media, www.yitgroup.com  YIT creates sustainable cities and better living environment by developing and constructing housing, business premises, infrastructure and entire areas. We focus on providing a first-class customer experience, high quality and continuous development of our diverse expertise. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2015, our revenue amounted to nearly EUR 1.7 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com 

Change to YIT Corporation's Management Board – Juha Kostiainen nominated as a member of Group Management Board

YIT Corporation's Board of Directors has today nominated M.Sc. (Tech.), D.Sc. (Adm.) Juha Kostiainen (51), as a member of Group Management Board at YIT as of October 1, 2016. He will take the lead and responsibility of sustainable urban development operations. He reports to the President and CEO Kari Kauniskangas. Previously, Kostiainen has had several positions within YIT in 2001–2008, and onwards from 2012.  During his career, Kostiainen has also worked in Finnish Innovation Fund (Sitra), and as the director of economic development of the city of Tampere.   “In YIT’s renewed strategy, urban development will be the engine for growth. The nomination of Juha Kostiainen strengthens the implementation of our strategy. He has a significant role in innovating and developing upcoming major real estate development projects. In addition to that, leading the Regenero collaboration is on his responsibility”, Kari Kauniskangas says.    Juha Kostiainen’s CV and photo will be available on the company's website: http://www.yitgroup.com/YIT_GROUP/Investors/Corporate-Governance/management-board  For further information, please contact: Hanna Jaakkola, Vice President, Investor Relations, YIT Corporation, tel. +358 40 5666 070, hanna.jaakkola@yit.fi  YIT CORPORATION Hanna JaakkolaVice President, Investor Relations Distribution: NASDAQ Helsinki, major media, www.yitgroup.com  YIT creates sustainable cities and better living environment by developing and constructing housing, business premises, infrastructure and entire areas. We focus on providing a first-class customer experience, high quality and continuous development of our diverse expertise. Our operating area covers Finland, Russia, the Baltic countries, the Czech Republic, Slovakia and Poland. In 2015, our revenue amounted to nearly EUR 1.7 billion, and we employ about 5,300 employees. Our share is listed on Nasdaq Helsinki. www.yitgroup.com

Nolato acquires Swiss company Treff

Nolato has entered into an agreement to acquire Swiss company Treff AG. The company, which has annual sales of just over SEK 450 million with healthy profitability, will strengthen the customer base and geographical expansion of both Nolato Medical and Nolato Industrial. Treff manufacturers supply products for medical and self-care diagnostics (in-vitro diagnostics, IVD), as well as technically advanced precision components for various industrial segments. The company’s sales for 2016 are estimated at just over SEK 450 million, with an EBITDA margin of around 11.5%.  “The acquisition gives us a presence in the German-speaking part of Europe. It will open doors to a large group of new and internationally leading customers, particularly within medical technology, several of which are existing customers of Treff,” said Nolato President and CEO Christer Wahlquist. Treff employs approximately 190 people at its plant in Degersheim, in the canton of St. Gallen, Switzerland. The company was established in 1946 and has been family-owned ever since. The current management will remain with the company. “The acquisition is an important part of our growth strategy, and we are continually working to boost shareholder value by identifying companies that complement our offering, hold solid market positions and have a high level of technical expertise. Treff is a well-managed and well-invested company that will fit well with our corporate culture.”  The transaction will be completed during the first week of October, when the firm will be consolidated into the Group. It is expected to have a marginal positive effect on Nolato’s earnings per share for the current year. Around two thirds of Treff’s operations will be reported within Nolato Industrial in future, and one third within Nolato Medical.     The acquisition will be financed using existing credit agreements. Nolato will continue to enjoy a strong financial position following the acquisition. ---------For further information, please contact:Christer Wahlquist, President and CEO, +46 (0)705 804848Per-Ola Holmström, CFO, +46 (0)705 763340 Nolato will be holding a conference call today, Monday 26 September at 3.30 pm CET, where President and CEO Christer Wahlquist and CFO Per-Ola Holmström will comment on the acquisition. To participate call +468 301 790 and enter the code 389 917.  Nolato is a Swedish group with operations in Europe, Asia and North America. We develop and manufacture products in polymer materials such as plastic, silicone and TPE for leading customers within medical technology, pharmaceuticals, telecom, automotive, hygiene and other selected industrial sectors. Nolato’s shares are listed on Nasdaq Stockholm in the Mid Cap segment, where they are included in the Industrials sector. This information is information that Nolato AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2.00 pm CET on 26 September, 2016.  www.nolato.com

VocaliD teams with Tobii Dynavox to Humanize the Voice within Assistive Communication Devices

Stockholm, September 26, 2016: Tobii Dynavox and VocaliD announced today a partnership agreement to bring a new generation of truly personalized voices for those with speech impairment. The partnership gives new and existing users of Tobii Dynavox devices the option to be heard through their own VocaliD voice. “Pairing VocaliD’s personalized, natural-sounding voices with Tobii Dynavox’s industry-leading assistive devices is a game-changer for the millions who have historically relied on a handful of generic, computerized voices,” said Rupal Patel, Founder and CEO of VocaliD. “Every person living with a speech impairment has a unique vocal identity that deserves to be heard, and this partnership will help make this a reality.” VocaliD’s customized voices are uniquely crafted by blending the recipient’s “vocal DNA” with recordings from a matched speech donor from the company’s Voicebank of 14,000+ contributors of all ages from over 110 countries around the world. Any voice donor can also use their own recordings to craft a personalized voice without the need for blending. For users with progressive conditions, such as ALS, this solution is a means to preserve and digitize their unique voice for their Tobii Dynavox device. “We are excited to offer this cutting-edge innovation to our customers and provide a new dimension in personalization,” says Fredrik Ruben, President of Tobii Dynavox. “Our partnership with VocaliD presents an extraordinary opportunity for people to express their thoughts and personality like never before.” Now, Tobii Dynavox users like Max Plansky, a teenager with cerebral palsy from Danvers, MA, finally has a voice of his own. As Max’s father Michael explains, “Max’s device allowed him to participate in conversations. With his VocaliD voice, Max is now empowered to be himself as he gets to express his thoughts in his own voice, not someone else’s. Whenever he speaks I can hear his soul in his voice – can't put a price on that.” To order a Tobii Dynavox compatible custom VocaliD voice visit https://www.vocalid.co/products or http://www.tobiidynavox.com/VocaliD.

Getinge Group Launch Endoscopic Vessel Harvesting Club

Getinge Group announces the successful launch of the European Harvester Club event which took place at the EMEA Academy in Rastatt, Germany (15-16 September 2016). This event was attended by over 80 participants (cardiothoracic surgeons and surgical care practioners) from 18 different European countries who are either responsible for or will be responsible for Endoscopic Vessel Harvesting (EVH) in their respective hospital. "The EVH Meeting was, in my opinion, exceptional. The lectures, case presentations and discussion were extremely valuable for both beginners as well as very experienced harvesters and this is exactly the type of training needed to drive the adoption of this therapy across Europe." said Prof. Dr. med. Yeong-Hoon Choi, University of Cologne, Germany. EVH is performed for patients during coronary artery bypass graft surgery (CABG, or "bypass surgery") and is done by taking or "harvesting" a healthy blood vessel from the leg or forearm via a minimally invasive procedure, which is then used to bypass a blockage in the patient’s heart. This procedure has increasingly become the standard of care for bypass surgery given the significant clinical and cosmetic benefits without compromising long-term patient outcomes or safety. Getinge Group’s Maquet brand has been at the forefront of EVH technology and been working with clinicians to make the procedure easier, faster, and more protective of the harvested blood vessel, ultimately leading to better patient outcomes. "We, at Getinge Group, are committed to partnering in training with the medical community and are therefore actively supporting education programs ranging from basic product training courses to advanced workshops and symposia in the field of Endoscopic Vessel Harvesting. As Maquet took an early leadership position in this procedure over the years, we have introduced improvements to our EVH system utilizing real-world, clinical user input and addressing the needs of our customers who use endoscopic vessel harvesting in their daily practice as a standard of care. Our commitment to enabling best in class EVH procedures is reflected in this initiative" says Markus Stirner-Schilling, Vice President, Marketing & Academy Getinge Group, Europe, Middle East & Africa About Getinge Group Getinge Group is a leading global provider of innovative solutions for operating rooms, intensive-care units, Hospital wards, sterilization departments, elderly care and for life science companies and institutions. With genuine passion for life we build quality and safety into every system. Our unique value proposition mirrors the continuum of care, enhancing efficiency throughout the clinical pathway. Based on our first-hand experience and close partnerships, we are able to exceed expectations from customers – improving the every-day life for people, today and tomorrow. For further information please contact: Tracey Dawe: Director Communications, Europe, Middle East & Africa tracey.dawe@getinge.com Tel: +44 7717784965

Gränges Nomination Committee appointed

Gränges Nomination Committee for the 2017 Annual General Meeting shall consist of representatives from the three largest shareholders and the Chairman of the Gränges Board. On 31 August 2016, Gränges’ three largest shareholders were Fourth National Swedish Pension Fund (AP4), AFA Insurance and JP Morgan Asset Management which have been invited to nominate candidates for the Nomination Committee. JP Morgan Asset Management has however declined to participate and SEB Funds was invited. The Nomination Committee for the 2017 Annual General Meeting has the following members: Jannis Kitsakis (AP4), Anders Algotsson (AFA Insurance), Rikard Andersson (SEB Funds) and Anders G Carlberg (Chairman of the Gränges Board). The Chairman of the Nomination Committee is Jannis Kitsakis. Gränges’ 2017 Annual General Meeting will be held on Thursday, 4 May, 2017 at 16.00 CET at Näringslivets Hus, Stockholm. Gränges shareholders who have proposals and views relating to the work of the Nomination Committee are requested to submit these to the secretary of the Nomination Committee, who is also Gränges’ General Counsel, Niclas Nelson. To enable the Nomination Committee to examine proposals received with sufficient care, these should be submitted no later than 27 January 2017. For further information, please contact: Niclas Nelson, General Counsel, Grängesniclas.nelson@granges.com, tel: +46 708 34 96 16Gränges ABBox 5505SE-114 85 Stockholm The information in this press release is such that Gränges must disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on Monday, 26 September, 2016, at 16.00 CET. About GrängesGränges is a leading global supplier of rolled aluminium products for heat exchanger applications and other niche markets. In materials for brazed heat exchangers Gränges is the global leader with a market share of approximately 20%. The company develops, produces and markets advanced materials that enhance efficiency in the customer manufacturing process and the performance of the final products; brazed heat exchangers. The company’s geographical markets are Europe, Asia and the Americas. Its production facilities are located in Sweden, China and the United States, and have a combined annual capacity of 400,000 metric tonnes. Gränges has some 1,500 employees and net sales of more than SEK 10 billion. The share is listed on Nasdaq Stockholm. More information on Gränges is available at granges.com. 

Knorr-Bremse's offer for Haldex: offer document made public

“Haldex shareholders now have the opportunity to tender their shares into our superior offer. Following the acquisition of a stake on Friday, we are confident that additional investors will recognize the value we are bringing to the table. Haldex would find an excellent home at Knorr-Bremse where it would play a major role in joining a fast growing systems solutions provider for the commercial vehicle industry,” said Klaus Deller, Chairman of the Executive Board of Knorr-Bremse.  The Offer On 5 September 2016, Knorr-Bremse AG ("Knorr-Bremse") announced a public offer to the shareholders of Haldex AB (publ) ("Haldex") to tender all shares in Haldex to Knorr-Bremse (the "Offer") for a consideration of SEK 110.00 in cash per share. On 16 September 2016 the consideration in the Offer was increased to SEK 125.00 in cash per share. Offer document The offer document relating to the Offer has been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen). The offer document has been made public today and is available on Knorr-Bremse's website (www.Knorr-BremseandHaldex.com) and on SEB's website for prospectuses (www.sebgroup.com/prospectuses), and will be available on the Swedish Financial Supervisory Authority's website (www.fi.se) in Swedish. The acceptance form related to the Offer can be found on the first two of these websites. A copy of the offer document and a pre-printed acceptance form will be made mailed to all direct-registered shareholders of Haldex as of 26 September 2016, except for those domiciled in the excluded countries (see above). Acceptance period and settlement The acceptance period of the Offer starts on 27 September 2016 and ends on 5 December 2016. Settlement is expected to commence on or about 14 December 2016.     Knorr-Bremse AG For additional information contact: Knorr-Bremse AG Dr. Detlef HugEmail: Detlef.Hug@knorr-bremse.comPhone: +49 89 3547 1402 Eva DopplerEmail: Eva.Doppler@knorr-bremse.comPhone: +49 89 3547 1498 Additional contacts for media in Germany FTI Consulting SCCarolin AmannEmail: Carolin.Amann@fticonsulting.comPhone: +49 69 92037 132 Thomas M. KrammerEmail: Thomas.Krammer@fticonsulting.comPhone: +49 89 71042 2116 Additional contacts for media in Sweden ComirJohan HähnelEmail: Johan.Hahnel@comir.sePhone: +46 8 31 17 70 For information and documentation regarding the Offer: www.Knorr-BremseandHaldex.com This press release was submitted for publication on 26 September 2016 at 4:00 p.m. CEST.     Important notice The Offer is not being made, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand or South Africa by use of mail or any other means or instrumentality (including, without limitation, facsimile transmission, electronic mail, telex, telephone and the Internet) of interstate or foreign commerce, or of any facility of national security exchange, of Australia, Canada, Hong Kong, Japan, New Zealand or South Africa, and the Offer cannot be accepted by any such use, means, instrumentality or facility of, or from within, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. Accordingly, this announcement and any documentation relating to the Offer are not being and should not be sent, mailed or otherwise distributed or forwarded in or into Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. This announcement is not being, and must not be, sent to shareholders with registered addresses in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. Banks, brokers, dealers and other nominees holding shares for persons in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa must not forward this announcement or any other document received in connection with the Offer to such persons. Statements in this announcement relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “intends”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Knorr-Bremse AG. Any such forward-looking statements speak only as of the date on which they are made and Knorr-Bremse AG has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations. Special notice to shareholders in the United States  The Offer described in this announcement is made for shares of Haldex AB, a company incorporated under Swedish law, and is subject to Swedish disclosure and procedural requirements, which are different from those of the United States. The Offer is made in the United States in compliance with Section 14(e) of, and Regulation 14E under, the U.S. Securities Exchange Act of 1934, as amended (the “U.S. Exchange Act"), subject to the exemptions provided by Rule 14d-1(d) under the U.S. Exchange Act and otherwise in accordance with the requirements of Swedish law. Accordingly, the Offer is subject to disclosure and other procedural requirements, including with respect to withdrawal rights, the offer timetable, settlement procedures and timing of payments that are different from those applicable under U.S. domestic tender offer procedures and laws. To the extent permissible under applicable law or regulation, Knorr-Bremse AG and its affiliates or brokers (acting as agents for Knorr-Bremse AG or its affiliates, as applicable) may from time to time, and other than pursuant to the Offer, directly or indirectly purchase, or arrange to purchase, shares of Haldex AB, that are the subject of the Offer or any securities that are convertible into, exchangeable for or exercisable for such shares. To the extent information about such purchases or arrangements to purchase is made public in Sweden, such information will be disclosed by means of a press release or other means reasonably calculated to inform U.S. shareholders of Haldex AB of such information. In addition, the financial advisors to Knorr-Bremse AG, may also engage in ordinary course trading activities in securities of Haldex AB, which may include purchases or arrangements to purchase such securities. Knorr-Bremse AG and/or its affiliates or brokers have purchased shares of Haldex AB during the period following the announcement of the Offer on 5 September 2016. NEITHER THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION NOR ANY U.S. STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THIS OFFER, PASSED UPON THE FAIRNESS OR MERITS OF THIS ANNOUNCEMENT OR DETERMINED WHETHER THIS ANNOUNCEMENT IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE IN THE UNITED STATES.

Dcore invests heavily in Polygiene Odor Control Technology

The focus on odor control means that the fitness clothing manufacturer Dcore now treats about 90 percent of its workout wear with Polygiene Odor Control Technology. Dcore is primarily known for its high quality gym and fitness apparel sold online. Now Dcore is expanding its product range and complementing online sales clothing with sales through traditional brick-and-mortar retail stores. “I am really pleased with how well Polygiene works to make our workout clothes odor-free and how environmentally friendly Polygiene is compared to other alternatives,” says Dcore’s CEO Adam Tell, who has been convinced about the efficacy of Polygiene after extensive testing. The treatment is permanent and lasts at least 100 washes despite the fact that only a very small amount of silver salt is used. Polygiene is the only odor-control supplier that guarantees functionality throughout the lifetime of the garment.  In addition, Polygiene Odor Control Technology meets the requirements of European Union REACH regulations and certified according to the environment, health and safety standards of bluesign® and Oeko-tex for environment, health and safety issues. A positive environmental impact of using Polygiene-treated workout clothes is that they can be washed less frequently. This helps reduce water and energy consumption as well as fabric wear and tear, making garments last longer. “Dcore’s investment in Polygiene speaks volumes for our company,” says Christian von Uthmann, CEO, Polygiene. “We value long-term customer relationships and appreciate the strengthening collaboration with a brand of Dcore’s high caliber." Polygiene is the global market leader within odor control and has more than 100 international premium brands as its clients, including Adidas, Patagonia, Athleta and Salomon. About Dcore  Dcore (dcore.com) is a Swedish fitness wear clothing brand established in 2006 by former personal trainer Adam Tell and is sold worldwide through major retail establishments and online stores in the sports and fitness segment. More about bluesign:             http://www.bluesign.com     More about oeko-tex:            https://www.oeko-tex.com/en/business/business_home/business_home.xhtml        This information is information that Polygiene AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 07.45 CET on September 27, 2016.

Arise has entered into an agreement with Kraftö for the acquisition of a project portfolio of 370 MW

Arise AB (publ) (”Arise”) has entered into an agreement with Kraftö AB (”Kraftö”) for the acquisition of parts of Kraftö’s project portfolio. In total, the acquisition comprises five projects corresponding to approx. up to 370 MW, provided that all projects obtain legal force permits. The transaction is estimated to be completed on 1 January, 2017. The transaction is a consequence of Arise’s strategy to grow within wind power development while Kraftö is planning to concentrate on projects that are in a later stage of development or are entering the construction phase.Through the transaction Arise will assume responsibility for further project development with the goal to develop the projects to legal force and sell the projects when they become construction- ready. In all material aspects, the purchase price comprises of an earn-out when and if the projects are sold on to third party investors. ”We are very pleased with the agreement and believe that the projects have good pre-conditions for realisation. Two smaller projects have legal force permits where focus will be to optimise the projects ahead of a pending sale. In addition, there are three larger projects comprising approx. up to 300 MW which have yet to be granted permits. It is satisfying that Kraftö values our ability to realise projects and do transactions in a challenging market”, says Daniel Johansson, CEO Arise AB. ”We believe that Arise has good financial prospects and the capability to deliver large scale projects to the market. The company has demonstrated a track record of successfully developing and selling large projects to international investors. This deal allows us to secure project costs and agree on a plan for development of the five projects being sold. Our involvement with a company with the strength and capability of Arise is a very positive step forward for Kraftö and its shareholders”, says Fredrik A. Svensson, CEO Kraftö AB. Halmstad 27 September, 2016ARISE AB (publ) For further information, please contactDaniel Johansson, CEO Arise AB, +46 702 244 133Linus Hägg, CFO Arise AB, +46 702 448 916 This information is information that Arise AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on 27 September 2016. About AriseArise is one of Sweden´s leading wind power companies, with the business concept to develop, build and manage onshore wind farms for its own account and on behalf of investors. The company is listed on NASDAQ OMX Stockholm.Arise AB (publ), P.O. Box 808, SE-301 18 Halmstad, Sweden, telephone +46 (0)35 20 20 900, corporate id .no. 556274-6726,E-mail info@arise.se, www.arise.se    

Nokian Tyres’ President and CEO to change

Nokian Tyres plc Stock Exchange Release 27 September 2016 09.00 a.m. Nokian Tyres’ President and CEO Ari Lehtoranta has resigned his position in order to pursue new opportunities outside of Nokian Tyres. He continues in his present position until the end of 2016. Company’s Board of Directors will start the recruitment process to select a new President and CEO for the company. - I want to thank Ari Lehtoranta for his contribution in leading and developing the Company. Nokian Tyres’ position in the market is strong and the outlook positive. Several significant strategic development projects are under way in the Company. Most important among these has been the increase in sales in the Company’s growth markets Central Europe and North America. Company’s management and personnel are highly skilled, and now we will select a new and best possible CEO for the Company, says Petteri Walldén, Nokian Tyres’ Chairman of the Board of Directors. - Nokian Tyres is in excellent condition. Our customers are satisfied with our products and services. I am proud of our personnel and their capability. I will continue my work in full until the end of the year. At this point, however, I already want to thank everybody at Nokian Tyres and the Board of Directors for excellent cooperation, says Ari Lehtoranta. Teleconference on 27 September at 1:00 p.m. EET Chairman of the Board Petteri Walldén and CEO Ari Lehtoranta will be answering questions in a teleconference that will be arranged today, 27 September at 1:00 p.m. EET.  You can participate in the telephone conference by calling one of the numbers below 5–10 minutes before the scheduled starting time: FI: +358981710495UK: +442031940552SE: +46856642702US: +18557161597 Nokian Tyres plcPetteri WalldénChairman of the Board of Directors Further information: Chairman of the Board Petteri Walldén, tel. +358 10 401 7476 Distribution: Nasdaq Helsinki, the media and www.nokiantyres.com

Sami Eronen appointed Head of Ruukki Construction at SSAB

Sami Eronen joins Ruukki Construction from SSAB Europe division, where he is currently Head of Supply Chain Management and IT. Sami has a sound track record in the steel construction business. Before working for SSAB Europe he worked many years for Rautaruukki Corporation, where his responsibilities included the building projects business, building construction in Northern Europe and infrastructure construction. The interim head of Ruukki Construction, Jarmo Tonteri, will leave the company as of November 30, 2016. “Jarmo has successfully led Ruukki Construction through restructuring and I want to thank him for a job well done. I’m convinced that Sami, with his thorough background in the industry, is the right person to lead and develop Ruukki Construction going forward,” said Martin Lindqvist. Ruukki Construction is a European provider of energy-efficient building and construction solutions serving the construction industry and is part of the SSAB Group. For further information, please contact:Taina Kyllönen, Head of Group Communications, taina.kyllonen@ssab.com,phone: +358 40 582 2175 Viktoria Karsberg, Head of Corporate Communications, viktoria.karlsberg@ssab.com,phone: +46 72 233 5288 SSAB AB is obliged to make this information public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on September 27, 2016 at 8.00am CEST. Attachment: Sami Eronen’s photo

Caverion appoints Ari Lehtoranta as Group President and CEO

Caverion appoints Ari Lehtoranta as Group President and CEO The Board of Directors of Caverion Corporation has appointed Ari Lehtoranta (b. 1963), M.Sc. (Eng.), as the new President and CEO of Caverion Corporation. He will assume the new position on January 1, 2017. Ari Lehtoranta is currently President and CEO of Nokian Tyres plc. He has previously worked as Executive Vice President, Central and North Europe, at KONE Corporation. Lehtoranta has been a member of the Board of Caverion Corporation since 2013, and the Chairman of the Board since 2015. “Ari Lehtoranta has a strong background in business development and especially in the service and project business. He has a fantastic track record in driving continuous growth and improving profitability in an international business environment. As a leader, Ari is an open and charismatic person, who is able to build strong teams in which expertise meets the organisation’s development needs,” says Michael Rosenlew, Vice-Chairman of the Board of Caverion Corporation. “The Board is convinced that Lehtoranta is the best possible person to lead Caverion into the future. Having been a member of the Board since 2013 and its Chairman since 2015, Ari is thoroughly familiar with the company, its strategy and operational challenges”, Rosenlew concludes. “I have been committed to developing Caverion on its Board of Directors, and am now proud to take the helm in leading the company to the next phase. Caverion has every opportunity to become the industry leader; the company’s service portfolio and industry knowledge are great and it has made rapid progress in digitalisation. Next, we need to establish a leadership and organisational model and a business culture that support the service and project business in the best possible way. Closer cooperation with our customers is also a critical success factor. This is something I want to make happen together with the company’s 17,000 employees,” says Ari Lehtoranta. The CV and the photo of Ari Lehtoranta are available on Caverion’s website at http://www.caverion.com/investors/corporate-governance/management-board. CONFERENCE CALL Caverion will arrange a conference call for analysts, investors and media on September 27, 2016, at 16:00 p.m. (Finnish Time, EEST). The call can be accessed by calling +44 (0)20 7026 5967. Participant code for the conference call is 1751667/Caverion. CAVERION CORPORATION Distribution: Nasdaq Helsinki, principal media, www.caverion.com 

SenzaGen invited to prestigious meeting at ICCVAM, US

US ICCVAM is a permanent committee consisting of representatives from 15 federal regulatory and research agencies that requires, uses, generates, or disseminates toxicological and safety testing information to replace animal experiments. ICCVAM take expert advice from SACATM **, whose members include stakeholders from regulated industries, animal welfare organizations, academia, U.S. state or international regulatory bodies, and companies or organizations that develop, market or use test methods.In connection with the SACATM meeting SenzaGen was invited together with their partner Burleson Research Technologies to make a statement in the session for Skin Sensitization Testing.- It is a great achievement for us that we now have the opportunity, together with our partner Burleson Research Technologies, to give our views on the future development of testing in the U.S and to present GARD, before members of the prestigious SACATM. This shows that GARD is already on their radar, as the next-generation of sensitization testing. Only by cooperating at the highest level can we set a new industry standard for allergy testing in the US market, says Anki Malmborg Hager, CEO of SenzaGen.The ICCVAM meeting is being held in Research Triangle Park, North Carolina on Tuesday, 27 September and the CEO of SenzaGen AB, Anki Malmborg Hager will make her statement and give the recommendations in the session ICCVAM Roadmap to Skin Sensitization Testing at 11.25 am (EDT).* ICCVAM: The Interagency Coordinating Committee on the Validation of Alternative Methods** SACATM: Scientific Advisory Committee on Alternative Toxicological Methods  

Tieto strengthens its digital offering in the education sector – acquires assets and rights of Oppad in Norway

Tieto strengthens its ambitions to offer user-friendly, digital solutions in the education sector and has acquired the assets and rights of Oppad, a provider of administrative solutions for schools and kindergartens. On Monday September 18th, the Norwegian company Oppad AS was declared bankrupt and Tieto now has bought the assets and rights from the bankruptcy estate. The aim is to maintain and enhance the offering to Oppad’s customers. - Given the situation, we are very pleased to take over the assets and rights of Oppad. In combination with Tieto’s offering, we will do our utmost to make sure that the offering is maintained and enhanced so that the customers can get even greater benefit from the solutions than before, says Gunnar Nybø, Head of Public Sector in Tieto Norway. Tieto is now in dialogue with existing customers and former employees to identify how the EdTech services could be continued and further enhanced. - The Norwegian EdTech market is very interesting, and this transaction gives us the opportunity to reinforce our footprint within education while we can utilize and further develop the many excellent solutions we have in Sweden and Finland, says Fredrik Pantze, Head of Nordic Education in Tieto. Tieto is a leading provider of ICT solutions for education, healthcare and welfare in the Nordic countries, with growth ambitions in Norway. Oppad was established in 2004 with offices in Kongsvinger and Oslo. The company offered integrated IT solutions for children and youngsters, with a vision to become the leading supplier of administrative systems to schools and kindergartens. The company’s employees had broad background as managers in kindergartens, teachers, superintendent and principals, as well as in-depth experience and expertise in modern IT solutions and services. Tieto and Oppad has had a strong relationship for several years, with Oppad building its solutions based on the Nordic systems developed by Tieto. For more information: Fredrik Pantze, Head of Education, Tietophone: +46 70 226 74 80, e-mail: fredrik.pantze[at]tieto.com  Tieto aims to capture the significant opportunities of the data-driven world and turn them into lifelong value for people, business and society. We aim to be customers’ first choice for business renewal by combining our software and services capabilities with a strong drive for co-innovation and ecosystems. www.tieto.com 

Eltel’s power distribution business wins a three-year contract in Finland at a value of approximately EUR 18 million

This three-year frame agreement with Elenia Oy is to build and maintain their distribution network in Finland. The contract comprises four geographical areas in the western part of Finland and in the Tampere region. The contract period starts in February 2017 and runs until January 2020. The contract also includes options for two additional two-year periods until January 2024. The value of the contract is estimated to be approximately EUR 18 million. Juha Luusua, President – Eltel Power Distribution comments:“Elenia’s high level of investments in the power network, driven also by weatherproof infrastructure, offers us good growth potential going forward. Since a few years, we have introduced new methods for example in underground cabling where Eltel’s quality of work and performance have constantly improved. The winning of three new areas for Elenia is good evidence of this. We aim to continue this development and boost further our delivery capabilities. Our partnership with Elenia is very important as Elenia is one of the frontrunners in the European power distribution business.” For further information:Ingela UlfvesVP – Investor Relations and Group CommunicationsTel: +358 40 311 3009, ingela.ulfves@eltelnetworks.com  Hannu TynkkynenDirector – External Communications and SustainabilityTel: +358 40 311 4503, hannu.tynkkynen@eltelnetworks.com  About EltelEltel is a leading European provider of technical services for critical infrastructure networks – Infranets – in the segments of Power, Communication and Transport & Security, with operations throughout the Nordic and Baltic regions, Poland, Germany, the United Kingdom and Africa. Eltel provides a broad and integrated range of services, spanning from maintenance and upgrade services to project deliveries. Eltel has a diverse contract portfolio and a loyal and growing customer base of large network owners. In 2015 Eltel net sales amounted to EUR 1,255 million. The current number of employees is approximately 9,600. Since February 2015, Eltel AB is listed on Nasdaq Stockholm.

Natural Beauty Retail Awards winners & industry hotlist announced

The UK’s best natural beauty retailers have been announced today with the publication of the autumn edition of Natural Beauty News, published by Diversified Communications UK. Waitrose, Debenhams, Holland & Barrett, LoveLula, Beauty Kitchen, and Amaranth have all been recognised with Natural Beauty Retail Awards, while Jayn Sterland, managing director of Weleda UK, landed the top spot in this year’s Who’s Who in Natural Beauty. Voted for by the natural and organic beauty industry, the hotlist – also known as the ‘Who’s Who’ in natural beauty Top 25 – provides an essential snapshot of the leading personalities driving the newest trends and best products on the market. Whilst this is the first time she’s been voted number one, Jayn Sterland has regularly appeared in the ‘Who’s Who’ top 25 since its launch in 2007. She joined Weleda eight years ago and brought the original products she found in the Weleda archives, such as the iconic Skin Food, to the mass market.  Appointed managing director of Weleda UK earlier this year, she has transformed Weleda into a truly customer-focused business and regularly speaks about the value of authentically natural and organic cosmetics. “I am so thrilled to be voted number one in the natural beauty industry’s Top 25 - what an incredible honour!” says Jayn Sterland, MD of Weleda UK.  “I am delighted for all my team; it is gratifying to know our voice for authentically natural products is being heard in a world where organic beauty is so often veiled in green-washing and dubious claims. “In the year Weleda Skin Food celebrates its 90th birthday, it is encouraging that old is the new new!  A true testament to lasting sustainability in a very transient beauty industry," she says. Last year’s winner Sonia White, managing director of Lovelula, was voted number two, closely followed by Luke and Kirstie Sherriff, co-founders of Pinks Boutique.  Alexander and Kim Barani, founders of Kinetic Enterprises, were voted fourth, and Graeme Hume, owner of Pravera was fifth favourite overall. The 2016 Who’s Who in natural beauty top 25 personalities (as voted for by the industry) are: 1. Jayn Sterland – Weleda 2. Sonia White – Lovelula 3. Luke & Kirstie Sherrif – Pinks Boutique 4. Kim & Alexander Barani – Kinetic Enterprises 5. Graeme Hume – Pravera 6. Ben Wigley – Big Green Smile 7. Tabitha James Kraan – Tabitha James Kraan 8. Sarah Brown – Pai Skincare 9. Francesca Morgante – NATRUE 10. Dr Cristina Llamas-Rey – Naturisimo 11. Fiona Klonarides – Beauty Shortlist 12. Janey Lee Grace – broadcaster & journalist 13. Catkin Wemyss-Bodmer – BRYT Skincare 14. Noelle O’Connor – TanOrganic 15. Imelda Burke – Content Beauty 16. Kate Humble – Humble Beauty / broadcaster 17. Amber Felce – AmbersBeautyTalk.com 18. Jo Chidley – Beauty Kitchen 19. Dr Mariano Spiezia – Inlight Organic Skincare 20. Michell Thew – Cruelty Free International 21. Lauren Bartley – Soil Association 22. Rebecca Goodyear – Biteablebeauty.com 23. Sarah Stacey – author and editor 24. Lorraine Dallmeier – Formula Botanica 25. Sascha Layne – Freshious Life & Beauty The Natural Beauty Retail Awards 2016 Highlighting the valuable contributions and support of retailers to the vibrant natural and organic beauty market, the Natural Beauty Retail Awards celebrate the industry’s dedication and innovations in offering their customers a great retail experience, at the same time as promoting natural and organic beauty for all. “The standard of excellence within the natural beauty industry has never been higher,” comments Julia Zaltzman, editor of Natural Beauty News.  “With product innovations, customer care and consumer awareness all at the forefront of this pioneering sector, we are proud to be able to highlight those who are truly trailblazing within their categories.” The Natural Beauty Retail Awards 2016 winners are: · Best Supermarket – Waitrose · Best Chain Store – Holland & Barrett · Best Department Store – Debenhams · Best Online Retailer – Lovelula · Best Branded Store – Beauty Kitchen · Best Independent Retailer – Amaranth “Our customers love natural beauty products so we’re really happy to win this award for a second year running,” says Jo Skelton, Waitrose beauty buying manager.  “We've been working hard to make natural beauty more accessible, so it’s brilliant this has been recognised.  The award is a fantastic vote of confidence in the quality and choice we offer our customers.  We remain dedicated to leading the industry in this area and enhancing our range, and we've been given a great boost of encouragement by winning this award.” Natural Beauty News Formerly The Natural Beauty Yearbook, Natural Beauty News is the definitive trade publication for the natural and organic beauty industry.  It covers the best in seasonal trends whilst also retaining the Yearbook’s most popular elements, such as Retailers Choice and the ‘Who’s Who’ in Natural Beauty.  For further information, please visit www.naturalbeautynews.co.uk. ###

Farstad Shipping ASA – Charter Agreement

Total E&P Congo has through Petro Services awarded the CSV Far Sleipner (2015, VARD 3 07, 9,200 DWT) a contract of 18 months to support their subsea development activity in Congo. Commencement of the contract will take place during Q4 2016. Total has option to extend the contract by 6 x 2 months periods. The commercial terms of the agreement will be kept private and confidential between the parties. - Over the last 18 months, Far Sleipner has developed very good relations with Total through the work performed on the MOHO North field development project in Congo. We are very pleased to be selected as Total’s preferred partner for the next phase of this project. This contract shows the attractiveness of our new series of subsea vessels that meet our client’s expectations for advanced subsea operations in deep water production developments. We highly appreciate the confidence Total, as one of our key clients, is showing us again, says Karl-Johan Bakken, CEO of Farstad Shipping ASA. Contacts: CEO Karl-Johan Bakken –  tel. +47 901 05 697 CFO Olav Haugland – tel. +47 915 41 809 Farstad Shipping’s fleet currently consists of 56 vessels (28 AHTS, 22 PSV and 6 SUBSEA) and 1 SUBSEA vessel under construction. The company’s operations are managed from Aalesund, Melbourne, Perth, Singapore, Macaé and Rio de Janeiro with a total of 1,780 employees engaged onshore and offshore. The company’s strategy is to be a leading quality provider of large, modern offshore service vessels to the oil industry. www.farstad.com

Scania delivers comprehensive solution for Indonesian mining operator

In the face of tough competition from other manufacturers, Scania was chosen as the supplier of transport solutions to Indonesian mining operator BUMA. The order comprises 266 trucks, plus parts and services on site over the next five years and is worth approximately USD 30 million. “This is a perfect fit for our ‘tailor-made for application’ approach,” says Björn Winblad, Head of Scania Mining. “By utilising our experience from lean production and continuous improvement, we intend to help BUMA to improve its mining operations across Indonesia.” Scania has worked with continuous improvements in its own business for decades, and is now drawing on that experience to offer its know-how to customers within application areas such as mining and forestry. The order includes Scania P 410 8x4 and R 580 6x4 models. The vehicles and services will be delivered by United Tractors, Scania’s partner in Indonesia. In August 2016, the first 14 vehicles were delivered, and another 86 vehicles will be delivered in 2016. BUMA (PT Bukit Makmur Mandiri Utama) was established in 1998 and provides services to Indonesian coal producers across all production stages, including geology and planning, overburden removal, coal mining, coal hauling and reclamation and rehabilitation. The company has some 11,000 employees and operates more than 3,000 heavy vehicles. United Tractors is the leading and the largest distributor of heavy equipment in Indonesia, providing products from world-renowned brands, including Scania. United Tractors’ distribution network includes 19 branch offices, 22 site support offices and 11 representative offices in 22 provinces across the country. The company has played an active role in the Indonesian mining industry for many years by delivering top-tier products and services to its customers.  For further information, please contact: Björn Winblad, Head of Scania MiningTel: +46 8 553 810 46E-mail: bjorn.winblad@scania.com Claes Nyqvist, Director Scania Representative Office JakartaTel: +62 21 788 488 70E-mail: claes.nyqvist@scania.com

Michelin solutions Go-Ahead with EFFITIRES™ extension

A history of superb service and top-notch tyre technology has seen UK transport company Go-Ahead renew a 20-year relationship with Michelin, after agreeing a three-year contract for the continued support of Michelin solutions’ EFFITIRES™ comprehensive tyre management programme. The price-per-mile deal will cover 100 per cent of Go-Ahead’s expanding bus fleet – 4,800 vehicles – operating from more than 50 depots around the country, with the EFFITIRES™ contract offering a combination of outsourced tyre procurement and expert management solutions; helping keep Go-Ahead’s mix of single- and double-decker buses on the road as they transport more than 2 million passengers daily. “Go-Ahead has built a strong relationship with Michelin solutions since the company first signed up to the EFFITIRES™ programme in 1997. After a review of our tyre strategy, it was the right decision to agree to extend our current EFFITIRES™ contract,” says Jim Collins, Go-Ahead’s Group Chief Engineer (Bus). He adds: “We believe that a managed price-per-mile solution is the correct strategy for our business, and it is clear that Michelin solutions’ programme fits our needs as a large national fleet operation. Our experience of Michelin solutions and the economies of scale the managed service brings means we are happy to have reached an agreement to extend our current contract.” Founded in 1987, Go-Ahead has grown to become one of the country’s largest passenger transport groups. The company is London’s biggest bus operator, and manages smaller regionally-branded firms around the country, including a fleet of 800 vehicles in Newcastle, 300 in Oxford and Brighton, 800 ‘Go South Coast’ buses serving the beaches of Bournemouth and Poole and smaller operations in East Anglia and Plymouth. The EFFITIRES™ solution provides Go-Ahead with a dedicated team of fleet operators, auditors, operations managers and technicians, as well as a predictable tyre budget linked to fleet activity, all of which work together to ensure Go-Ahead’s fleet stays on the road, and hits targets for safety, reliability, tyre longevity and regulatory compliance. Michelin solutions will develop a shared action plan with Go-Ahead to ensure continued harmonised operations, while cutting the administrative burden of managing a diverse and widely distributed fleet. The company will also carry out fleet-wide tyre safety inspections, ensure a productive and responsive supply chain and closely monitor stock levels. Go-Ahead’s fleet will continue to fit high-quality Michelin urban bus tyres, which feature reinforced sidewalls to protect against kerbing and cut down on wheel interventions and downtime. ends About Michelin solutions Michelin solutions is part of the Michelin Group and was established in May 2013, replacing the entity previously known in the UK as Michelin Fleet Solutions. It currently employs around 800 people globally and is responsible for in excess of 300,000 vehicles currently on contract. Michelin solutions is dedicated to designing, commercialising and developing solutions for fleets of trucks, buses, coaches, cars and vans. Its solutions are aimed at fleets wanting to improve their efficiency, productivity, and environmental footprint, in a global and customised way. http://fleetstreet.michelin-solutions.com/http://news.cision.com/michelin-solutions For further press information please contact: James Keeler or Andy Hemphill, Garnett Keeler PRTel: +44 (0)20 8647 4467E-mail: james.keeler@garnettkeeler.com and andy.hemphill@garnettkeeler.com MICH_SOL/014/16

MTG issues SEK 500 million bond

· Four year corporate bond extends debt maturity profile · Part of Medium Term Note programme established in 2016 MTG today successfully issued a SEK 500 million four year corporate bond that will be listed on Nasdaq Stockholm. The notes have been placed with Swedish and international investors, and the coupon is based on the three month STIBOR rate plus 1.4%. The financing proceeds will be used to replace part of the Group’s existing short term funding. Maria Redin, Chief Financial Officer of MTG: “This is our second listed bond offering and investor interest was again high. This issue further enhances the mix of our funding structures, and provides long term funding for the continued development of the business and delivery of our strategy.” MTGs’ domestic Medium Term Note (MTN) programme was established in 2016 with a framework amount of up to SEK 2 billion. Swedbank (publ) and SEB (publ) acted as joint bookrunners of the issue. **** Any questions?mtg.com  (http://media.ne.cision.com/l/qeixyqnq/mtg.com/)  facebook.com/MTGAB  (https://wpyadmin.ne.cision.com/l/qeixyqnq/www.facebook.com/MTGAB?fref=ts)  @mtgab (https://twitter.com/intent/follow?original_referer=http://mtg.com/&screen_name=MTGAB&tw_p=followbutton&variant=2.0)  press@mtg.com / +46 (0)73 699 27 09 investors@mtg.com / +46 (0)73 699 27 14 MTG (Modern Times Group MTG AB (publ.)) is a leading international digital entertainment group and we are shaping the future of entertainment by connecting consumers with the content that they love in as many ways as possible. Our popular entertainment brands span Content Production, TV, Radio and eSports, and are available around the world. Born in Sweden, our shares are listed on Nasdaq Stockholm (‘MTGA’ and ‘MTGB’).  

M7 Group to broadcast esportsTV channel in multiple European markets

· MTG signs agreement with M7 Group, one of Europe’s largest satellite and IPTV operators · ESL’s esportsTV channel to be available in the Nordics, the Baltics, the Netherlands, Belgium, the Czech Republic and Slovakia · Next up is live coverage of ESL One New York in October, the East’s Coast’s largest and most anticipated esports event MTG and M7 Group have concluded an agreement to make ESL’s esportsTV channel available in HD quality from 27 September on M7 Group’s satellite TV platforms in the Netherlands (Canal Digitaal), Belgium (TV Vlaanderen), the Czech Republic and Slovakia (Skylink), with more platforms to follow. esportsTV was launched in May 2016 as the world’s first 24/7 dedicated esports channel, and is already available on MTG’s Nordic and Baltic Viasat satellite platforms, and through third party distributors including Telenor, Com Hem, Telia and Waoo. The channel is operated by MTG-owned ESL, the world’s leading esports company and the brand behind the most popular esports competitions and live mega events in the ESL One, Intel® Extreme Masters and Pro League series. esportsTV brings viewers thousands of hours of live content, featuring the leading esports stars and teams and coverage of the leading professional esports leagues and international tournaments. The content line-up includes ESL’s professional circuits, which generate hundreds of millions of views online every year on platforms such as Twitch, Azubu, Hitbox and Yahoo. Find out more at www.eslgaming.com.  Jørgen Madsen Lindemann, President and CEO, MTG: “Esports is the world’s fastest growing professional sport and is expected to engage more than 250 million people already this year. It is also a hugely popular entertainment format that is pulling in massive online viewing and attracting big stadium audiences around the world, and esportsTV will raise awareness levels even further.” Bill Wijdeveld, VP of Business Development, M7 Group: “We are very excited to have an agreement with MTG that allows us to offer esportsTV with content from the largest and most important tournaments around the world. Moreover, the launch of esportsTV fits very well with our strategy to broaden our content portfolio and thereby address new and under-served audiences.” Arnd Benninghoff, CEO, MTGx “There is so much great content to share and this new partnership with M7 Group will bring the excitement of esports to even more TV homes and devices. The channel is attracting interest from everywhere and provides viewers with 24/7 access to esports coverage from around the world.” The agreement also includes the possibility for MTG to deliver the channel to other third-party distributors through the same satellite feed, increasing the technical penetration of esportsTV in Europe.

New Toyota C-HR Model Rocks Out With JBL Premium Audio System

STAMFORD, CT – HARMAN International Industries (http://www.harman.com/), Incorporated (NYSE:HAR), the premier connected technologies company for automotive, consumer and enterprise markets, today announced it is supplying a tailor-made JBL premium audio system for the new Toyota C-HR, featuring two newly designed acoustic JBL wave guides for a concert hall-like sound experience. The interior design of the Toyota C-HR and its new audio system will be unveiled for the first time to the public at the upcoming Paris Motor Show.   With its custom tuning and tailor-made components, the JBL system has been designed to help the Toyota C-HR, or Coupé High-Rider, stand out both within the Toyota line-up and in its segment. Drivers of the Toyota C-HR will be able to enjoy the same GRAMMY and Oscar-winning JBL sound they enjoy in their home and through their headphones or portable speakers. Two newly-designed acoustic JBL wave guides, known as Horn Tweeters, increase the sound dispersion: you hear a cleaner sound over a wider area. Thanks to the acoustic wave guides, the JBL sound system gives drivers big, rich sound and a feeling they’re at a venue like UK’s O2 Arena or New York's Madison Square Garden.  JBL conducted an in-depth customer analysis before designing the system. It resulted in a front cabin orientation, and a precisely integrated, A-pillar-mounted horn tweeter – a JBL system signature – to deliver crisp, clear sound. Because various elements of the interior such as the windows, sunroof and upholstery can have a significant impact on system sound quality, the system is the result of a particularly close collaboration between JBL and Toyota's engineers from early in the design process.  The high performance nine-speaker JBL sound system comprises the two 25 mm horn tweeters and acoustic wave guides, plus two 80 mm wide-dispersion midrange speakers and two 170 mm sub-woofers in the front of the Toyota C-HR, and, in the rear, two 150 mm full-range speakers and a 190 mm sub-woofer in a dedicated, 10-litre, ported enclosure – all powered by a 576 Watt stereo amplifier. Available in combination with the navigation option, the JBL premium audio system also incorporates lossless audio encoding.  In a custom blend of art and science, JBL selects, places, and fine-tunes each speaker to sound perfect in a car's interior. The engineers at JBL spent hundreds of hours precisely tuning the system in the Toyota C-HR to deliver a bold, powerful soundtrack for drivers and passengers alike. Quality is the common focus of both companies, which has resulted in the all-new, uncompromised premium audio system specifically tailored for the Toyota C-HR.  “The brand new Toyota C-HR was painstakingly designed to establish a new direction amongst mid-sized crossovers, and we needed a tailored audio system that would match this new vision,” said André Schmidt, Marketing Director at Toyota Motor Europe. “JBL understands our new direction and designed this industry-leading audio solution specifically for the Toyota C-HR customer.” “As JBL’s relationship with Toyota reaches a 20-year milestone, we see this latest collaboration as a perfect way to celebrate. The powerhouse JBL audio system in the Toyota C-HR will further bring to life the already excellent Toyota driving experience,” said Michael Mauser, President, Lifestyle Audio Division at HARMAN. “Whether listening to the radio, streaming music from your mobile device or connecting your MP3, the JBL premium sound system provides consistently stunning sound on the road.” JBL is a force behind music's most pivotal moments — revolutionary recordings, legendary concerts like Woodstock, and record-breaking rock tours. For the last seven decades, it has delivered nothing but the best in its industry-leading audio in concert venues, in the home, and of course in the car. The partnership between JBL and Toyota started in 1996 and has been successfully expanded regularly during that time. JBL audio systems are used in major concert halls, venues and stadiums throughout the world, including 80% of live concerts, 70% of all recording studios and 90% of all THX-certified movie theatres.   Toyota and HARMAN are showcasing this technology at the Paris Motor Show in the Toyota booth from 1-16 October 2016. Visitors can also experience a specially designed Toyota C-HR studio app that will allow them to mix their own music and hear it in the car.

Notice of a change of control event

We refer to the terms and conditions dated 26 June 2014 for the up to SEK 525,000,000 senior secure callable floating rate bonds due 2019 issued by Ceratiidae II AB (publ) (the "Issuer") (the "Terms and Conditions"). We further refer to an assignment, accession and resignation agreement dated 25 July 2016 and made between Ceratiidae I AB as original obligor, Heinrich Bauer Verlag Beteiligungs GmbH as new obligor and Nordic Trustee & Agency AB (publ) as security agent, and as confirmed by the Issuer. Terms defined in the Terms and Conditions shall have the same meaning when used in this notice, unless otherwise defined herein. Pursuant to Clause 12.1(c) (Information from the Issuer) in the Terms and Conditions, we hereby give you notice that a Change of Control Event has occurred under the Terms and Conditions and that Heinrich Bauer Verlag Beteiligungs GmbH has acquired all shares in the Issuer and that the acquisition has been completed on the date hereof. Due to the occurrence of a Change of Control Event and pursuant to Clause 10.5 (Mandatory Repurchase due to a Change of Control Event) of the Terms and Conditions, each Bondholder has the right to request that all, or only some, of its Bonds are repurchased at a price per Bond equal to 101.00 per cent. of the Nominal Amount together with accrued but unpaid Interest. If a Bondholder wants to exercise its right to request that all, or only some, of its Bonds are repurchased on the terms set out above, such Bondholder shall within 15 Business Days from the date hereof (being 18 October) send notice to: Ceratiidae II AB (publ)Att. Joakim Lundqvistc/o Freedom Finance Kreditservice ABBox 1068, 262 21 Ängelholm, Sweden Email: joakim.lundqvist@zmartagroup.com The Issuer will repurchase the relevant Bonds and pay the repurchase amount on a date occurring no later than 20 Business Days after the 15 Business Day's period referred to above. The Issuer will in due time inform the Bondholders about the relevant repurchase date and the Record Date for such repurchase by way of publishing a press release. 

Scandic launches fifth signature hotel – nature makes an entrance in Stockholm at Downtown Camper

Downtown Camper by Scandic will be a social meeting place for travelers and Stockholmers alike. The concept brings nature into Stockholm’s most urban district at Brunkeberg square. In line with Scandic’s existing signature hotels, it will have a unique interior and design – a “base camp” in an urban environment. In addition to a “lifestyle concierge,” in-room bartender and shop, guests will be able to relax year round under the stars.   – The hotel offers the same complete, unique offering as our other signature hotels at the same time as it has drawn inspiration from two worlds – the local urban environment and our longing for nature. We want to create a new type of meeting place that offers a wide range of experiences and an oasis for mindfulness in the middle of the big city, says Thomas Engelhart, Chief Commercial Officer.  A lifestyle concierge will be on hand to offer tips on unusual experiences to enjoy at the hotel and in the city such as discovering Stockholm by kayak, in-depth mindfulness sessions, rooftop tours of the city, evening group runs and rooftop yoga. There will be no traditional conference rooms here – they have been replaced by more personal rooms and spaces for events, meetings and get-togethers where the boundary between work and leisure is blurred. The hotel will have its own graphic identity and toiletries with a scent signed Downtown Camper. The hotel will open after the summer of 2017. About Signature hotelsSignature hotels are marketed under their own hotel names with the extension “by Scandic” and are characterized by their unique history, personality and enhanced customer offering. The hotels have been designed as distinct meeting places with the ambition to be natural social venues for locals and travelers alike. With its collection of signature hotels, Scandic aims to attract new customers and meet the demands of travelers looking for unique hotel experiences. Today, Haymarket by Scandic and Grand Central by Scandic are operated as signature hotels. In 2017 and 2018, Downtown Camper, Hotel Norge in Bergen and Scandic Marski in Helsinki will open as signature hotels. For more information, please contact:Thomas Engelhart, Chief Commercial OfficerEmail: thomas.engelhart@scandichotels.comHeidi Wold, Communication Director Scandic SwedenEmail: heidi.wold@scandichotels.comPhone: +46 (0)706 305 817

NOBINA DELIVERS CONTINUED STRONG RESULTS

THE HALF-YEAR PERIOD 1 MARCH–31 AUGUST 2016 • Net sales of SEK 4,370 million (3,977), an increase of 9.9 per cent. • Operating profit increased to SEK 263 million (39)1). • Profit after tax of SEK 149 million (–104), and earnings per share of SEK 1.68 (–1.43)1). • The cash flow from operations was SEK 622 million (319). • Cash flow for the period was SEK –141 million (–129). Cash flow for the period included disbursement of SEK 230 million (0)1) dividend for the preceding year. IMPORTANT EVENTS IN THE SECOND QUARTER • Well-implemented traffic starts in Sweden and Finland. • Nobina won a tender for traffic in Oslo worth SEK 150 million over a three-year contract period. • Nobina won a tender for traffic in Lund Väster (West) worth SEK 400 million over a four-year contract period. • The share of Nobina’s total bus fleet operating on renewable fuel increased from 50 per cent to 55 per cent, and to 75 per cent in Sweden. IMPORTANT EVENTS SINCE THE END OF THE QUARTER • CEO Ragnar Norbäck announced his decision to retire in October 2017. Accordingly, the board has commenced work on recruiting a new CEO. • Nobina’s contract regarding bus services in Norrtälje was extended by two years until June 2021. CEO’S COMMENTS Nobina delivered continued strong results in the second quarter, driven primarily by increased revenues from extra traffic as well as positive development of existing contracts. In addition, Nobina has carried out cost-efficient traffic starts and contract closures in Sweden and Finland. The contracts won in Lund and Oslo during the quarter, as well as agreements signed in Östergötland and Borås, compensate for the traffic contracts that are expiring. It is, of course, positive that we are improving our margin despite a younger contract portfolio, with its attendant negative short-term impact on earnings. Furthermore, I note that Nobina’s focus on innovation through Nobina Technology has attracted increased attention from PTAs and partners. It is also pleasing that our employees are being invited to participate in a number of forums in order to contribute to the development of the public transport industry. Another positive trend is the improved profitability of our public transport industry competitors, albeit from low levels. I have informed the board that I have decided to retire next autumn, after 13 years as CEO of the Nobina Group. These have been eventful years and there is much to be pleased with. I am particularly proud of the skills and commitment of our employees. Last year’s successful IPO has laid the foundation for an even more successful company. Thus, conditions are favourable for a continued positive development. Ragnar Norbäck, President and CEO The information comprises such as Nobina AB (publ) is obliged to publicly disclose pursuant to the EU Market Abuse Regulation and the Securities Market Act. Through the above contact person, the information was submitted for publication at 8.00 am CET on 28 September 2016.

Allgon AB acquires the IoT-company Wireless System Integration Sweden AB

Wireless System Integration Sweden AB (WSI) is a design house developing wireless products and systems. The company has in recent years experienced a strong growth and influx of new customers. Before the summer, WSI was chosen as partner for development and manufacturing of products to American Nvidia, one of the largest companies for graphics processors used for artificial intelligence, deep learning and virtual reality. WSI, based in Kista, Stockholm, currently has 20 employees. In 2015, WSI had a turnover of SEK 32 million with an operating profit of SEK 2,4 million while the turnover of 2016 is estimated to an amount of approximately SEK 45 million with an operating profit of SEK 4,5 million. Allgon makes the acquisition, which is planned to be completed in the fourth quarter of this year, through buying shares of WSI from the four current owners at a price equivalent to SEK 41 million. The purchase price will be paid partly in cash of SEK 25 million, partly by a promissory note of SEK 11 million as well as a directed share issue of SEK 5 million.  - Through this acquisition, we are putting the first piece of the puzzle in establishing a new business area, Industrial IoT. WSI has an exciting business that complements the offers from other companies within our group. We have followed WSI for some time and are impressed by their success journey. We are looking forward to working with the founders and their team to develop the business further, says Johan Hårdén, CEO of Allgon AB.  - We can see that our major international customers as well as the smaller clients become more and more dependent on collaborations with flexible specialized companies to keep up with the ongoing global digitalization. WSI has a sound knowledge and an extensive experience in offering clients a full responsibility in the process from idea to final product within IoT, Virtual Reality and advanced radio solutions. This agreement with Allgon puts WSI into a larger context in which we can get further exchange on our continuous expansion and growth, says Jan-Åke Lindqvist, CEO of Wireless System Integration Sweden AB. WSI has, based on turn-key costumer offering, a strong growth within IoT for industrial applications. The company offers customers comprehensive solutions in the development and industrialization of IoT applications and advanced radio solutions. Their client portfolio ranges from small companies in an early stage of product development to major international players in a wide variety of industries. Homepage www.wsisweden.com Contact: Johan HårdénAllgon ABTel.0733 859219E-mail: johan.harden@allgon.se Jan-Åke LindqvistWireless System Integration Sweden ABTel. 070-555 49 17E-mail: jaln@wsi.nu

All European Seqr users can now use Seqr to pay all over the world – Contactless payment technology allows payments in 30 mln point-of-sales globally

The new Seqr contactless technology increases the freedom and independence for our users from old and inefficient technologies and financial services. Contactless technology makes Seqr into a truly global service and also increases the safety for users as a lost or stolen wallet doesn’t have to ruin a vacation or a business trip anymore. Seqr now is a fully global, fully functioning payment alternative wherever you are. – Seqr is solidifying its position as the standard for mobile payments with the most versatile technology and the largest physical acceptance network of any of our competitors in the global mobile payments market. At the same time our consumer uptake area is by far the largest with 16 countries where the Seqr app can be downloaded, says Peter Fredell, CEO of Seamless. Payments with Seqr via contactless technology is supported on telephones with Android operative system, currently approximately 80 % of the smartphone market globally. The number of contactless payment terminals is increasing fast and it has been planned and projected by the card networks that all card terminals globally should accept contactless payments by 2020. According to card network rules no terminals without contactless technology can be sold or installed in Europe after 2018. Seqr can today be downloaded by consumers in Sweden, Romania, Finland, Belgium, Netherlands, Germany, France, Portugal, Spain, Great Britain, Austria, Ireland, Malta, Luxembourg, Italy and the USA.